0000950123-11-103695.txt : 20111221 0000950123-11-103695.hdr.sgml : 20111221 20111221084950 ACCESSION NUMBER: 0000950123-11-103695 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20110930 FILED AS OF DATE: 20111221 DATE AS OF CHANGE: 20111221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cereplast Inc CENTRAL INDEX KEY: 0001324759 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34689 FILM NUMBER: 111273392 BUSINESS ADDRESS: STREET 1: 300 N. CONTINENTAL STREET 2: SUITE 100 CITY: EL SEGUNDO STATE: CA ZIP: 90245 BUSINESS PHONE: 310-676-5000 MAIL ADDRESS: STREET 1: 300 N. CONTINENTAL STREET 2: SUITE 100 CITY: EL SEGUNDO STATE: CA ZIP: 90245 10-Q/A 1 c26125e10vqza.htm FORM 10-Q/A Form 10-Q/A
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q/A
Amendment No. 1
     
þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2011
OR
     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934
Commission File Number 001-34689
CEREPLAST, INC.
(Exact name of registrant as specified in its charter)
     
Nevada
(State or Other Jurisdiction of Incorporation or Organization)
  91-2154289
(I.R.S. Employer Identification No.)
     
300 N. Continental Boulevard, Suite 100    
El Segundo, California   90245
     
(Address of Principal Executive Office)   (Zip Code)
(310) 615-1900
(Registrant’s Telephone Number, Including Area Code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 or Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No o
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
             
Large accelerated filer o   Accelerated filer o   Non-accelerated filer o
(Do not check if a smaller reporting company)
  Smaller reporting company þ
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ
The number of shares of common stock outstanding as of November 11, 2011 is 15,793,553.
 
 

 

 


 

CEREPLAST, INC.
FORM 10-Q
TABLE OF CONTENTS
         
    Page  
PART I—FINANCIAL INFORMATION  
 
       
    3  
 
       
    3  
 
       
    4  
 
       
    5  
 
       
    6  
 
       
    16  
 
       
    24  
 
       
    24  
 
       
PART II—OTHER INFORMATION  
 
       
    25  
 
       
    25  
 
       
    26  
 
       
    26  
 
       
    26  
 
     
    27  
 
       
    28  
 
       
 Exhibit 31.1
 Exhibit 31.2
 Exhibit 32.1
 Exhibit 32.2
 EX-101 INSTANCE DOCUMENT
 EX-101 SCHEMA DOCUMENT
 EX-101 CALCULATION LINKBASE DOCUMENT
 EX-101 LABELS LINKBASE DOCUMENT
 EX-101 PRESENTATION LINKBASE DOCUMENT
 EX-101 DEFINITION LINKBASE DOCUMENT
Unless otherwise indicated or unless the context requires otherwise, all references in this report to “we,” “us,” “our,” “Cereplast” or the “Company” shall refer to Cereplast, Inc.

 

2


Table of Contents

Explanatory Note
Cereplast, Inc. is filing this Amendment No. 1 (the “Amendment”) to its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2011, filed with the Securities and Exchange Commission on November 14, 2011 (the “Form 10-Q”), to revise the disclosure in “Concentration of Credit Risk” and “Revenue Recognition” in Note 2 of the notes to the financial statements contained in the Form 10-Q.
No other changes have been made to the Form 10-Q. This Amendment speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.

 

3


Table of Contents

PART I — FINANCIAL INFORMATION
ITEM 1.  
CONSOLIDATED FINANCIAL STATEMENTS
CEREPLAST, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except shares data)
                 
    September 30, 2011     December 31, 2010  
    (Unaudited)        
ASSETS
               
Current Assets
               
Cash
  $ 4,030     $ 2,391  
Accounts Receivable, Net
    19,119       5,289  
Inventory, Net
    3,486       1,392  
Prepaid Expenses and Other Current Assets
    1,593       65  
 
           
Total Current Assets
    28,228       9,137  
 
           
 
               
Property and Equipment
               
Property and Equipment
    7,007       5,564  
Accumulated Depreciation and Amortization
    (2,894 )     (2,213 )
 
           
Property and Equipment, Net
    4,113       3,351  
 
           
 
               
Other Assets
               
Restricted Cash
    43       43  
Deferred Loan Costs
    1,459       266  
Intangible Assets, Net
    160       173  
Deposits
    49       14  
 
           
Total Other Assets
    1,711       496  
 
           
 
               
Total Assets
  $ 34,052     $ 12,984  
 
           
 
               
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
Current Liabilities
               
Accounts Payable
  $ 3,207     $ 2,567  
Accrued Expenses
    2,095       1,251  
Capital Leases, Current Portion
    36       9  
Loan Payable, Current Portion
    1,504       149  
 
           
Total Current Liabilities
    6,842       3,976  
 
           
 
               
Long-Term Liabilities
               
Loan Payable
    3,318       2,119  
Convertible Subordinated Notes
    12,500        
Capital Leases, Long-Term
    59        
 
           
Total Long-Term Liabilities
    15,877       2,119  
 
           
Total Liabilities
    22,719       6,095  
 
           
 
               
Equity
               
Shareholders’ Equity
               
Preferred Stock, $0.001 par value; 5,000,000 shares authorized and none outstanding
           
Common Stock, $0.001 par value; 495,000,000 shares authorized; 15,793,553 and 12,992,195 shares issued and outstanding at September 30, 2011 and December 31, 2010, respectively
    16       13  
 
               
Additional Paid in Capital
    61,992       49,737  
Accumulated Deficit
    (50,658 )     (42,933 )
Accumulated Other Comprehensive Income
    (21 )     72  
 
           
Total Shareholders’ Equity
    11,329       6,889  
Noncontrolling Interests
    4        
 
           
Total Equity
    11,333       6,889  
 
           
 
               
Total Liabilities and Shareholders’ Equity
  $ 34,052     $ 12,984  
 
           
See accompanying notes to unaudited consolidated financial statements.
CEREPLAST, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME
(unaudited, in thousands, except per share data)
                                 
    Three months ended     Nine months ended  
    September 30, 2011     September 30, 2010     September 30, 2011     September 30, 2010  
 
               
GROSS SALES
  $ 5,414     $ 1,515     $ 20,849     $ 2,519  
Sales Discounts, Returns and Allowances
    (45 )     (2 )     (628 )     (70 )
 
                       
NET SALES
    5,369       1,513       20,221       2,449  
 
                               
COST OF SALES
    4,475       1,132       17,701       1,778  
 
                       
 
                               
GROSS PROFIT
    894       381       2,520       671  
 
                               
Research and Development
    280       106       789       302  
Selling, General and Administrative
    3,689       2,233       8,457       5,432  
 
                       
 
                               
LOSS FROM OPERATIONS BEFORE OTHER EXPENSES
    (3,075 )     (1,958 )     (6,726 )     (5,063 )
 
                               
OTHER EXPENSES
                               
Restructuring Costs
          (275 )           (586 )
Interest Expense, Net
    (513 )     1       (999 )      
 
                       
 
                               
TOTAL OTHER EXPENSE, NET
    (513 )     (274 )     (999 )     (586 )
 
                       
 
                               
NET LOSS BEFORE PROVISION FOR INCOME TAXES
    (3,588 )     (2,232 )     (7,725 )     (5,649 )
 
                               
Provision for Income Taxes
                       
 
                       
 
                               
NET LOSS
    (3,588 )     (2,232 )     (7,725 )     (5,649 )
 
                               
OTHER COMPREHENSIVE INCOME
                               
Gain (Loss) on Foreign Currency Translation
    (54 )     52       (93 )     52  
 
                       
 
                               
TOTAL COMPREHENSIVE LOSS
  $ (3,642 )   $ (2,180 )   $ (7,818 )   $ (5,597 )
 
                       
 
                               
BASIC AND DILUTED LOSS PER SHARE
  $ (0.23 )   $ (0.17 )   $ (0.50 )   $ (0.49 )
 
                       
 
                               
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, BASIC AND DILUTED
    15,778       12,925       15,470       11,400  
 
                       
See accompanying notes to unaudited consolidated financial statements.

 

4


Table of Contents

CEREPLAST, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited, in thousands, except shares data)
                 
    Nine Months Ended  
    September 30, 2011     September 30, 2010  
 
             
CASH FLOWS FROM OPERATING ACTIVITIES:
               
Net Loss
  $ (7,725 )   $ (5,649 )
Adjustment to Reconcile Net Loss to Net Cash Used in Operating Activities
               
Depreciation and Amortization
    694       588  
Allowance for Doubtful Accounts
    1,780       33  
Common Stock Issued for Services, Salaries and Wages
    874       1,333  
Amortization of Loan Discount
    57        
Loss on Disposal of Leasehold Improvements
          15  
Impairment of Intangible Assets
    64        
Changes in Operating Assets and Liabilities
               
Accounts Receivable
    (15,609 )     (1,263 )
Deferred Loan Costs
    223        
Inventory
    (2,095 )     (210 )
Deposits
    (35 )     56  
Prepaid Expenses and Other Current Assets
    (1,514 )     92  
Restricted Cash
          (43 )
Accounts Payable
    269       (315 )
Accrued Expenses
    864       58  
 
           
NET CASH USED IN OPERATING ACTIVITIES
    (22,153 )     (5,305 )
 
           
 
               
CASH FLOWS FROM INVESTING ACTIVITIES:
               
Purchase of Property and Equipment, and Intangibles
    (1,290 )     (184 )
 
           
NET CASH USED IN INVESTING ACTIVITIES
    (1,290 )     (184 )
 
           
 
               
CASH FLOWS FROM FINANCING ACTIVITIES:
               
Payments on Capital Leases
    (13 )     (23 )
Proceeds from Capital Leases
    96        
Noncontrolling Interest Activities
    4        
Payments made on Notes Payable
          (59 )
Proceeds from Loan Payable, Net of Loan Costs
    2,500       20  
Proceeds from Convertible Subordinated Notes, Net of Issuance Costs
    11,225        
Proceeds from Issuance of Common Stock and Subscriptions, Net of Issuance Costs
    11,363       7,507  
 
           
NET CASH PROVIDED BY FINANCING ACTIVITIES
    25,175       7,445  
 
           
 
               
FOREIGN CURRENCY TRANSLATION
    (93 )     52  
 
           
 
               
NET INCREASE IN CASH
    1,639       2,008  
 
               
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD
    2,391       1,306  
 
           
CASH AND CASH EQUIVALENTS, END OF PERIOD
  $ 4,030     $ 3,314  
 
           
 
           
 
               
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
               
Cash Paid During the Year For:
               
Interest
  $ 417     $ 2  
Income Taxes
  $     $  
During the nine months ended September 30, 2011, the Company issued 2,596,500 shares in exchange for net proceeds of $11,208 under a private placement. During the nine months ended September 30, 2010, the Company issued 2,842,642 shares in exchange for net proceeds of $7,507 under a private placement.
SUPPLEMENTAL DISCLOSURE OF NON-CASH TRANSACTIONS
During the nine months ended September 30, 2011, the Company issued 153,796 shares valued at $657 for services to directors and employees, 35,000 shares valued at $155 for exercise of common stock warrants, 12,000 shares valued at $59 for prepaid services and 4,062 shares valued at $20 for a settlement agreement. The Company also recognized $157 of expense related to vesting of employee stock options for the same period. During the nine months ended September 30, 2010, the Company issued 31,250 shares valued at $125 for fees associated with an early lease termination, 12,500 shares valued at $50 for board member services, 151,302 shares valued at $770 for prepaid services and rent, 78,605 shares valued at $301 for employee services and 20,162 shares valued at $75 pursuant to a settlement agreement.
See accompanying notes to unaudited consolidated financial statements.

 

5


Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
September 30, 2011
(Unaudited)
1. ORGANIZATION AND LINE OF BUSINESS
Organization
We were incorporated on September 29, 2001 in the State of Nevada under the name Biocorp North America Inc. On March 18, 2005, we filed an amendment to our articles of incorporation to change our name to Cereplast, Inc. (the “Company”).
Line of Business
We have developed and are commercializing proprietary bio-based resins through two complementary product families: (1) Cereplast Compostables® resins which are renewable, ecologically sound substitutes for traditional petroleum-based non-compostable plastics and (2) Cereplast Sustainables® resins, which replace up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources. Our resins aim to be competitively priced compared to fully petroleum-based plastic resins and can be converted into finished products using conventional manufacturing equipment without significant additional capital investment by downstream converters.
The demand for non-petroleum based, clean and renewable sources for materials, such as bioplastics, and the demand for compostable/biodegradable products is each being driven globally by a variety of factors, including environmental concerns, new stringent regulations on compostable material, fossil fuel price volatility, and energy security. These factors have led to increased spending on clean and sustainable products by corporations and individuals as well as legislative initiatives at the local and state level.
We are a full-service resin solution provider uniquely positioned to capitalize on the rapidly increasing demand for sustainable and environmentally friendly alternatives to traditional plastic products.
We primarily conduct our operations through two product families:
   
Cereplast Compostables® resins are compostable and bio-based, ecologically sound substitutes for petroleum-based plastics targeting primarily compostable bags, single-use food service products and packaging applications. We offer 13 commercial grades of Compostables resins in this product line. These resins are compatible with existing manufacturing processes and equipment making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Compostables line in November 2006.
   
Cereplast Sustainables® resins are partially or fully bio-based, ecologically sound substitutes for fully petroleum-based plastics targeting primarily durable goods, packaging applications and applications other than single-use food service items. We offer six commercial grades of Sustainables resins in this product line. These resins are compatible with existing manufacturing processes and equipment, making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Sustainables line in late 2007 under the name “Cereplast Hybrid Resins®.”
   
Cereplast Hybrid Resins® replace up to 50% of the petroleum content in conventional plastics with bio-based materials such as industrial starches sourced from plants. The Hybrid resins line is designed to offer similar properties to traditional polyolefins such as impact strength and heat deflection temperature, and is compatible with existing converter processes and equipment. Cereplast Hybrid Resins® provide a viable alternative for brand owners and converters looking to partially replace petroleum-based resins in durable goods applications. Hybrid resins address this need in a wide range of markets, including automotive, consumer goods, consumer electronics, medical, packaging, and construction. We commercially introduced our first grade of Hybrid resin, Hybrid 150, at the end of 2007. We currently offer three commercial grades in this product line.
   
Cereplast Algae Plastic® resins. In October of 2009 we announced that we have been developing a new technology to transform algae into bioplastics and intend to launch a new resin family containing algae-based materials that will complement our existing line of resins. The first commercial product with Cereplast Algae Plastic® resin is now being produced and sold as part of our Sustainables resin family. We believe that it is important to enhance research on non-food crops as we expect a surge in demand in bioplastics in future years, thus potentially creating pressure on food crops. Algae is the first non-food crop project that we have introduced and our R&D department is contemplating the development of additional non-food crop based materials in future years.
Our patent portfolio is currently comprised of five U.S. patents, one Mexican patent, and eight pending patent applications in the U.S. and abroad. Our trademark portfolio is currently comprised of approximately 41 registered marks and 11 pending applications in the U.S. and abroad.

 

6


Table of Contents

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Consolidation
The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). The unaudited consolidated financial statements include the financial condition and results of operations of our wholly-owned subsidiary, Cereplast International, S.A., a Luxembourg company organized during the year ended December 31, 2008, for the purpose of conducting sales operations in Europe. Intercompany balances and transactions have been eliminated in consolidation. The results of operations for interim periods are not necessarily indicative of the results that may be expected for a full year. These financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2010.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, the allowance for doubtful accounts and the fair value of stock options. Actual results could differ from those estimates.
Cash and Cash Equivalents
We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents. At various times throughout the year, we may have exceeded federally insured limits. At September 30, 2011 and December 31, 2010, balances in our cash accounts exceeded federally insured limits of $0.25 million by approximately, $4.0 million and $2.3 million, respectively. We have not experienced any losses in such accounts and we do not believe we are exposed to any significant credit risk on cash and cash equivalents.
Concentration of Credit Risk
We had unrestricted cash, cash equivalents, and short-term investments totaling $4.0 million and $2.4 million at September 30, 2011 and December 31, 2010, respectively. The unrestricted cash and cash equivalents are held for working capital purposes. We do not enter into investments for trading or speculative purposes. Some of the securities in which we invest, however, may be subject to market risk. This means that a change in prevailing interest rates may cause the principal amount of the investment to fluctuate. To minimize this risk, we intend to maintain our portfolio of cash equivalents and short-term investments in a variety of securities, including commercial paper, money market funds, debt securities and certificates of deposit. Due to the short-term nature of these investments, we believe that we do not have any material exposure to changes in the fair value of our investment portfolio as a result of changes in interest rates. We actively monitor changes in interest rates.
Concentration of credit risk with respect to accounts receivable is limited to certain European customers to whom we make substantial sales. As of September 30, 2011 we had one large European customer that accounted for $7.6 million, or 36% of our accounts receivable balance, which is past due. We have another large European customer with $6.1 million, or 29% of our receivable balance, which is expected to be paid as current invoices come due, during the period December 2011 through February 2012, in accordance with agreed payments terms. Agreed upon payment terms for both of these customers are 90 days from receipt of goods. These customers have acknowledged to us their agreement with the amounts owing and no amounts recognized in revenue or recorded in accounts receivable from these customers are in dispute. To reduce risk, we routinely assess the financial strength of our most significant customers, using standard credit risk evaluation methods with reference to publicly available and customer supplied information, and monitor the amounts owed to us, taking appropriate action when necessary. As a result of the recent deterioration in the general economic conditions in Europe and the slow payment by some of our European customers, we have increased our allowance for doubtful accounts by $1.7 million to reflect management’s assessment of credit risk associated with these customer balances. We are working with all customers to mitigate credit risk and ensure collection of all outstanding amounts.

 

7


Table of Contents

Other Concentration
During the nine months ended months ended September 30, 2011, we had two significant suppliers that accounted for 34.0% and 27.6% of total cost of goods sold, respectively. During the same period in the prior year, we had two significant suppliers that accounted for 25.7% and 24.7% of total cost of goods sold, respectively. No other suppliers accounted for more than 10% of cost of goods sold during these periods.
Restricted Cash
We had restricted cash in the amount of approximately $43,000 on September 30, 2011 and December 31, 2010. The restricted cash amount consists of a “Certificate of Deposit” which supports a “Letter of Credit” for a leased facility.
Fair Value of Financial Instruments
The carrying amounts of our financial instruments as of September 30, 2011, which include cash equivalents, accounts receivable, accounts payable, accrued expenses, loans payable and convertible subordinated notes approximate their fair values due to the short-term nature of these instruments.
Accounts Receivable
We maintain an allowance for doubtful accounts for estimated losses that may arise if any of our customers are unable to make required payments. Management performs a review of the receivables past due from customers on a monthly basis and reserves against uncollectible items for each customer after all reasonable means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was approximately $1.8 million and $66,000 as of September 30, 2011 and December 31, 2010, respectively.
Inventory
Inventories are stated at the lower of cost (first-in, first-out basis) or market and consist primarily of raw materials used in the manufacturing of bioplastic resins, finished bioplastic resins and finished goods. Inventories are reviewed for excess and obsolescence and a reserve is established accordingly. Inventories consisted of the following (in thousands):
                 
    September 30, 2011     December 31, 2010  
    (Unaudited)        
Raw Materials
  $ 2,029     $ 936  
Bioplastic Resins
    1,542       318  
Finished Goods
    41       44  
Packaging Materials
    66       53  
WIP
          41  
Obsolescence Reserve
    (192 )      
 
           
Inventory, Net
  $ 3,486     $ 1,392  
 
           

 

8


Table of Contents

Property and Equipment
Property and equipment are stated at cost and depreciation is computed on the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are between five and seven years. Repairs and maintenance expenditures are charged to expense as incurred. Property and equipment consist of the following (in thousands):
                 
    September 30, 2011     December 31, 2010  
    (Unaudited)        
Equipment
  $ 5,506     $ 5,074  
Construction in Progress
    952       135  
Furniture & Fixtures
    296       279  
Automobile
    25       25  
Leasehold Improvements
    228       51  
 
           
 
    7,007       5,564  
Less Accumulated Depreciation
    (2,894 )     (2,213 )
 
           
Property and Equipment, Net
  $ 4,113     $ 3,351  
 
           
Intangible Assets
Intangible assets are stated at cost and consist primarily of patents and trademarks. Amortization is computed on the straight-line method over the estimated life of these assets, estimated to be between five and fifteen years. Intangible assets consist of the following (in thousands):
                 
    September 30, 2011     December 31, 2010  
    (Unaudited)        
Intangible Assets
  $ 196     $ 206  
Less Accumulated Amortization
    (36 )     (33 )
 
           
Intangible Assets, Net
  $ 160     $ 173  
 
           
Deferred Income Taxes
Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment.
The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.
Interest and penalties associated with unrecognized tax benefits are classified as additional income taxes in the statement of income.

 

9


Table of Contents

Revenue Recognition
We recognize revenue at the time of shipment of products, when the following fundamental criteria are met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred; (iii) the price to the customer is fixed or determinable; and (iv) collection of the sales price is probable.
Certain of our product sales are made to distributors under agreements with generally the same terms of sale and credit as all other customer agreements. Revenue from product sales to our customers, including our customers who are distributors, is recognized upon shipment provided the above noted fundamental criteria of revenue recognition are met. The sale of products to our customers who are distributors is not contingent upon the distributor selling the product to the end-user, and our current agreements with distributors do not have any rights of return.
Marketing and Advertising
We expense marketing and advertising costs as incurred. Marketing and advertising costs for the three months ended September 30, 2011 and 2010 were approximately $0.1 million and $0.2 million, respectively. Marketing and advertising costs for the nine months ended September 30, 2011 and 2010 were approximately $0.3 million and $0.5 million, respectively.
Stock-Based Compensation
Compensation cost for all stock-based awards is measured at fair value on the date of grant and recognized over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes valuation model. Such value is recognized as expense over the service period, net of estimated forfeitures, using the straight-line method. Adjustments to this expense are made periodically to recognize actual rates of forfeiture which vary significantly from estimates.
Loss Per Share Calculations
Basic loss per share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares available. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Our diluted loss per share is the same as the basic loss per share for the three months and nine months ended September 30, 2011 and 2010 as inclusion of any potential shares would have had an anti-dilutive effect due to our generation of a net loss.
Legal Proceedings
From time to time, we may become involved in various lawsuits and other legal proceedings, which arise in the ordinary course of business. Legal proceedings are subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.
Comparative Figures
Certain of the prior year figures have been reclassified to conform to the presentation adopted in the current year.

 

10


Table of Contents

3. CAPITAL STOCK
Reverse Stock Split
On March 15, 2010, we implemented a reverse split of our common stock on a 1-for-40 basis. The reverse split was effective at 6:00 a.m. on March 15, 2010. All historical and per share amounts have been adjusted to reflect the reverse stock split.
Capital Stock Issued
During the nine months ended September 30, 2011, we issued shares of common stock as follows:
   
We issued 2,596,500 shares of common stock and 649,128 warrants with an exercise price of $6.35 for gross proceeds of $12.3 million pursuant to a securities purchase agreement dated January 26, 2011 between us and each of the signatories thereto. We incurred stock issuance costs of $1.1 million.
   
We issued 35,000 shares of common stock pursuant to a warrant exercise for gross proceeds of $0.2 million.
   
We issued 165,796 shares of common stock valued at $0.7 million to various employees, directors, and third parties for services rendered during the period.
   
We issued 4,062 shares of common stock valued at $20,000 pursuant to a settlement agreement.
Valuation Assumptions for Stock Options
During the nine months ended September 30, 2011, we granted options to our employees to purchase an aggregate of 300,000 shares of our common stock, with estimated total grant-date fair values of $0.7 million. We estimate that stock-based compensation for awards not expected to be exercised is $0.2 million. During the three and nine months ended September 30, 2011, we recorded stock-based compensation related to stock options of $23,000 and $0.2 million, respectively. The grant date fair value was estimated at the date of grant using the Black-Scholes option pricing model, assuming no dividends and the following assumptions:
         
    January 14, 2011  
Average risk-free interest rate
    2.29 %
Average expected life (in years)
    6.0  
Volatility
    41.9 %
   
Expected Volatility: The fair values of stock based payments were valued using a volatility factor based on our historical stock prices.
   
Expected Term: We elected to use the “simplified method” as discussed in SAB No. 107 to develop the estimate of the expected term.
   
Expected Dividend: We have not paid any dividends and do not anticipate paying dividends in the foreseeable future.
   
Risk-Free Interest Rate: We base the risk-free interest rate used on the implied yield currently available on U.S. Treasury zero-coupon issues with remaining term equivalent to the expected term of the options.
Stock Option Activity
Under the 2004 Employee Stock Option Plan adopted by our board of directors (the “Plan”), our board of directors may issue incentive and non-qualified stock options to our employees. Options granted under the Plan generally expire at the end of five or ten years and vest in accordance with a vesting schedule determined by our board of directors, usually over three years from the grant date. As of September 30, 2011, we have 34,375 shares available for future grants under the Plan. We settle stock option exercises with newly issued shares of our common stock.

 

11


Table of Contents

The following is a summary of stock option activity (in thousands, except per share data):
                                 
    2011     2010  
            Weighted             Weighted  
            Average             Average  
    Shares     Exercise Price     Shares     Exercise Price  
Outstanding—January 1
    73     $ 22.40       73     $ 22.40  
Granted at fair value
    300       5.31              
Exercised
                       
Canceled/forfeited
                       
 
                       
Outstanding—September 30
    373       8.65       73       22.40  
 
                       
Options exercisable at September 30
    133     $ 14.69       73     $ 22.40  
 
                       
The following table summarizes information about stock options as of September 30, 2011 (in thousands, except per share data):
                                                                 
    Options Outstanding     Options Exercisable  
                    Weighted                             Weighted        
            Weighted     Average                     Weighted     Average        
            Average     Remaining     Aggregate             Average     Remaining     Aggregate  
            Exercise     Contract     Intrinsic             Exercise     Contract     Intrinsic  
Range of Exercise Prices   Shares     Price     Life     Value     Shares     Price     Life     Value  
$0.0 - $5.31
    300     $ 5.31       9.42     $       60     $ 5.31       9.42     $  
$5.32 - $22.40
    73     $ 22.40       3.17     $       73     $ 22.40       3.17     $  
The aggregate intrinsic value in the table above represents the total pretax intrinsic value, based on our closing stock price of $2.80 at September 30, 2011 which would have been received by the option holders had all option holders exercised their options as of that date.
Common Stock Warrants
In connection with the issue of 2,596,500 shares of common stock to accredited investors pursuant to a securities purchase agreement entered into on January 26, 2011, we issued warrants to purchase 649,128 shares of our common stock. The warrants have an exercise price of $6.35 per share and are exercisable until July 31, 2016.
A summary of warrant activity is as follows (in thousands except per share data):
                                 
    2011     2010  
            Weighted             Weighted  
    Number of     Average     Number of     Average  
    Warrants     Exercise Price     Warrants     Exercise Price  
Outstanding— January 1,
    1,273     $ 4.44           $  
Issued
    649       6.35       1,133       4.44  
Exercised
    (35 )     4.44              
 
                       
Outstanding—September 30
    1,887     $ 5.09       1,133       4.44  
 
                       
Warrants exercisable at end of period
    1,887     $ 5.09       1,133     $ 4.44  
 
                       

 

12


Table of Contents

4. LOANS PAYABLE AND CONVERTIBLE SUBORDINATED NOTES
Venture Loan Payable
On December 21, 2010, we entered into a Venture Loan and Security Agreement (the “Loan Agreement”) with Compass Horizon Funding Company, LLC (the “Lender” or “Horizon”). The Loan Agreement provides for a total loan commitment of $5.0 million comprising of Loan A and Loan B, each in the amount of $2.5 million. Loan A was funded at closing on December 21, 2010 and matures 39 months after the date of advance. Loan B was funded on February 17, 2011 and also matures 39 months after the date of advance. We are obligated to pay interest per annum equal to the greater of (a) 12% or (b) 12% plus the difference between (i) the one month LIBOR Rate in effect on the date preceding the funding of such loan by five business days and (ii) .30%. We are required to make interest only payments for the first nine months of each loan and equal payments of principal over the final thirty months of each loan. We granted a security interest in all of our assets to the Lender.
In connection with loan, we issued a seven year warrant to the Lender to purchase 140,000 shares of our common stock at an exercise price of $4.40. The relative fair value of the warrants was $0.2 million and will be recorded as interest expense over the term of the loan. We estimated the fair value of the warrants using the Black-Scholes option pricing model using the following assumptions:
         
    December 22,  
Assumptions:   2010  
Expected Life
  7 years  
Expected volatility
    39.9 %
Dividends
  None  
Risk-free interest rate
    2.74 %
Also in connection with the Loan Agreement, we incurred $0.4 million of debt issue costs which were deferred and are being amortized to interest expense over the term of the loan.
Promissory Note
We signed a promissory note in the amount of $20,359 related to the purchase of an automobile in fiscal year 2010. The note bears interest at 7.69% per annum and is to be repaid over a period of 60 months.
Convertible Subordinated Notes
On May 24, 2011, we issued $12.5 million in aggregate principal amount of 7% Senior Subordinated Convertible Notes due June 1, 2016 (the “Notes”). The Notes were issued pursuant to an indenture (the “Indenture”), entered into between us and Wells Fargo Bank, National Association, as trustee, on May 24, 2011. In connection with the issuance of the Notes, we entered into a Waiver to our Venture Loan and Security Agreement with Horizon, dated May 18, 2011 pursuant to which Horizon provided its consent to the offering of the Notes and waived any restrictions in the Loan Agreement.
The Notes are senior subordinated unsecured obligations which will rank subordinate in right to payment to all of our existing and future senior secured indebtedness and bear interest at a rate of 7% per annum payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2011. The Notes mature on June 1, 2016, with an early repurchase date of June 15, 2014 at the option of the purchaser. The Notes are convertible into shares of our common stock in accordance with the terms of the Notes and the Indenture, at the initial conversion rate of 172.4138 shares of our common stock per $1,000 principal amount of Notes, equivalent to a conversion price of approximately $5.80 per share, subject to adjustment. If the Notes are converted into shares of our common stock prior to June 2, 2014, an interest make-whole payment will be due based on the conversion date up until June 2, 2014. Upon a non-stock change in control, additional shares of our common stock may need to be issued upon conversion, with a maximum additional shares of 25.606 per $1,000 in principal amount of Notes being issuable thereunder, for a total maximum of 198.0198 shares per $1,000 Note. Certain customary anti-dilution provisions included in the Indenture and/or the Notes could adjust the conversion rate. At September 30, 2011, the Notes are convertible into 2,155,173 shares of our common stock.

 

13


Table of Contents

The conversion feature within the Notes is not considered to be a beneficial conversion feature within the meaning of Accounting Standards Codification (“ASC”) 470, Debt, and therefore all of the gross proceeds from the Notes have been classified as long term debt. In connection with the issue of the Notes, we incurred approximately $1.3 million of debt issue costs which were deferred and are being amortized to interest expense over the term to the early repurchase date of June 15, 2014.
Also in connection with the issuance of the Notes, we entered into a Securities Purchase Agreement dated May 18, 2011 pursuant to which we agreed to prepare and file a registration statement with the Securities and Exchange Commission (the “SEC”) registering the resale of the Notes and the shares of common stock underlying the Notes. The registration statement was declared effective on August 10, 2011.
5. LEASES
We currently operate out of El Segundo, California, Seymour, Indiana and Bönen, Germany. The leases underlying these three facilities are summarized below:
California Facility — The El Segundo facility consists of approximately 5,475 square feet of corporate office space. The lease commenced on March 1, 2010 and has a term of five years. The lease was subsequently amended on April 1, 2011 to add additional office space. The lease term relating to the additional office space expires on May 31, 2013. Our current monthly rent is $13,124, with 3% annual escalation.
Indiana Facility — The Seymour facility consists of approximately 105,000 square feet used as a manufacturing and distribution facility for our products. The lease commenced in January 2008, with a ten year term expiring in January 2018. Our current monthly rent is $25,000.
Bönen Facility— The Bönen facility consists of approximately 1,000 square feet of corporate office space. The facility is subject to a lease with monthly rents of approximately $2,000 expiring in December 2018.
6. MAJOR CUSTOMERS AND FOREIGN SALES
The following customers accounted for 10% or more of gross revenue in the periods presented:
                                 
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2011     2010     2011     2010  
Customer A
    68.0 %           27.0 %      
Customer B
    29.2 %           26.8 %      
Customer C
                26.3 %      
Our gross sales were made up of sales to customers in the following geographic regions (in thousands):
                                 
    Three Months Ended September 30,  
    2011     2010  
North America
  $ 81       1.5 %   $ 440       29.0 %
International
                               
Italy
    5,262       97.2 %     1,022       67.5 %
Other
    71       1.3 %     53       3.5 %
 
                       
 
                               
Gross sales
  $ 5,414       100.0 %   $ 1,515       100.0 %
 
                       
                                 
    Nine Months Ended September 30,  
    2011     2010  
North America
  $ 749       3.6 %   $ 1,139       45.2 %
International
                               
Italy
    12,470       59.8 %     1,022       40.6 %
Germany
    5,494       26.4 %     210       8.3 %
Other
    2,136       10.2 %     148       5.9 %
 
                       
 
                               
Gross sales
  $ 20,849       100.0 %   $ 2,519       100.0 %
 
                       

 

14


Table of Contents

7. INCOME TAX
We are subject to U.S. and California income tax. Subject to limited statutory exceptions, we are no longer subject to federal, state and local or non-U.S. income tax examinations by tax authorities for years before 2006. We are not presently liable for any income taxes nor are we undergoing any tax examinations by the Internal Revenue Service. No Deferred Tax Assets or Deferred Tax Liabilities are included in our balance sheets at September 30, 2011 or December 31, 2010.
Our policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.
8. SUBSEQUENT EVENTS
Purchase of Manufacturing Facility in Italy
Effective October 24, 2011, Cereplast Italia S.p.A (“Cereplast Italia”), our wholly owned subsidiary, completed its acquisition of an industrial plant and the real estate on which the industrial plant is located in Cannara, Italy. The Deed of Sale between Cereplast Italia and Societa Regionale Per Lo Sviluppo Economico Dell’Umbria — Sviluppumbria S.p.A, provided for an aggregate purchase price of €4,577,750 ($6,355,748). In connection with the acquisition, Cereplast Italia entered into the following financing transactions:
   
Mortgage loan with Banca Monte Dei Paschi Di Sienna S.p.A for the principal of €3,440,000 ($4,776,096). The loan bears interest of Euribor (6-month) plus 5.7%. The loan is for a term of 15 years with interest only payments for the first two years, payable January 1 and July 1 each year and principal and interest payments thereafter according to an amortization schedule. Twenty percent of the principal is guaranteed for 10 years by Gepafin, a local government agency; €400,000 ($555,360) of the principal is guaranteed by Eurofidi through December 31, 2016.
   
Credit facility with Intesa Sanpaolo for up €500,000 ($694,200). The facility is for a term of eight months with a floating interest rate based on Euribor (3 month), currently 5.85%. Interest is deferred for the first two months of the term. Cereplast Italia obtained a guarantee of 60% of the amount drawn on the facility from Eurofidi.
   
Credit facility with Unicredit Bank for up to €600,000 ($833,040). The facility is for a term of 18 months with a floating interest rate based on Euribor (3 month), currently 5.93%. Cereplast Italia obtained a guarantee of 60% of the amount drawn on the facility from Eurofidi.
We estimate that in addition to the purchase price, Cereplast Italia will incur estimated additional fees of €400,000 ($555,360) in connection with the acquisition.
Registered Direct Offering
On November 10, 2011, we entered into a Placement Agent Agreement, relating to a registered direct offering of up to an aggregate of 3,125,000 Units (“Units”), pursuant to which Lazard Capital Markets LLC served as the lead placement agent and Ardour Capital Investments, LLC served as the co-placement agent. Each Unit consists of one share of common stock, par value $0.001 per share, and one warrant to purchase 0.75 of a share of the Company’s common stock. The sale of the Units is being made pursuant to subscription agreements, dated November 10, 2011, between the Company and each of the investors in this offering. The investors have agreed to purchase the Units for a negotiated price of $1.60 per Unit, resulting in gross proceeds to the Company of approximately $5,000,000, before deducting the placement agents’ fees and estimated offering expenses payable by us. The net offering proceeds to the Company from the sale of the Units, after deducting the placement agents’ fees and other estimated offering expenses payable by the Company, are expected to be approximately $4,345,000.
The per share exercise price of the warrants is $2.20. The warrants are exercisable at any time on or after the date that is 180 days after the initial issuance on the date of closing and will expire on a date that is five years from the date of closing. The closing of the sale and issuance of the Units is expected to take place on or about November 16, 2011, subject to the satisfaction of customary closing conditions.

 

15


Table of Contents

ITEM 2.  
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
CAUTIONARY STATEMENTS
This Form 10-Q may contain forward-looking statements, as that term is used in federal securities laws, about our financial condition, results of operations and business. These statements include, among others, statements concerning the potential benefits that we may experience from our business activities and certain transactions we contemplate or have completed; and statements of our expectations, beliefs, future plans and strategies, anticipated developments and other matters that are not historical facts. These statements may be made expressly in this Form 10-Q. You can find many of these statements by looking for words such as “believe”, “expect,” “anticipate,” “estimate,” “opine,” and similar expressions used in this Form 10-Q. These forward-looking statements are subject to numerous assumptions, risks and uncertainties that may cause our actual results to be materially different from any future results expressed or implied by us in those statements. The most important facts that could prevent us from achieving our stated goals include, but are not limited to, the following:
   
inability to raise sufficient additional capital to finance operations;
   
potential fluctuation in quarterly results;
   
failure to earn profits;
   
inadequate capital to expand our business;
   
decline in demand for our products and services;
   
inability to source raw materials in sufficient quantities to support growth in customer demand;
   
rapid and significant changes in markets and other factors, including national, state and local legislation, that encourage use of bioplastics;
   
failure to commercialize new grades of resin being pursued in our technical / market development “pipeline;”
   
competitor actions that curtail our market share, negatively affect pricing or limit sales growth;
   
inability of our customers to pay amounts owing to us;
   
litigation with or legal claims and allegations by outside parties;
   
insufficient revenues to cover operating costs;
There can be no assurance that we will be profitable. We may not be able to successfully manage or market our products, attract or retain qualified executives and technology personnel or obtain additional customers for our products. Our products may become obsolete, government regulation may hinder our business, additional dilution in outstanding stock ownership may be incurred due to the issuance of more shares, warrants, stock options and/or other securities convertible into, and/or exercisable or exchangeable for, shares of our common stock, or the exercise of outstanding warrants and stock options and other risks inherent in our business.
Because forward-looking statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by the forward-looking statements. We caution you not to place undue reliance on these statements, which speak only as of the date of this Form 10-Q. The cautionary statements contained or referred to in this section should be considered in connection with any subsequent written or oral forward-looking statements that our company or persons acting on our behalf may issue. We do not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date of this Form 10-Q other than as required by law, or to reflect the occurrence of unanticipated events.

 

16


Table of Contents

OVERVIEW
General
We have developed and are commercializing proprietary bio-based resins through two complementary product families: (1) Cereplast Compostables® resins, which are compostable and bio-based, ecologically sound substitutes for traditional petroleum-based non-compostable plastics, and (2) Cereplast Sustainables® resins, which replace up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources. Our resins aim to be competitively priced compared to fully petroleum-based plastic resins and can be converted into finished products using conventional manufacturing equipment without significant additional capital investment by downstream converters.
The demand for non-petroleum based, clean and renewable sources for materials, such as bioplastics, and the demand for compostable/biodegradable products, is each being driven globally by a variety of factors, including environmental concerns, new stringent regulations on compostable material, fossil fuel price volatility and energy security. These factors have led to increased spending on clean and sustainable products by corporations and individuals as well as legislative initiatives at the local and state level.
We are a full-service resin solution provider uniquely positioned to capitalize on the rapidly increasing demand for sustainable and environmentally friendly alternatives to traditional plastic products.
We primarily conduct our operations through two product families:
   
Cereplast Compostables® resins are compostable and bio-based, ecologically-sound substitutes for petroleum-based plastics targeting primarily compostable bags, single-use food service products and packaging applications. We offer 13 commercial grades of Compostables resins in this product line. These resins are compatible with existing manufacturing processes and equipment making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Compostables line in November 2006.
   
Cereplast Sustainables® resins are partially or fully bio-based, ecologically-sound substitutes for fully petroleum-based plastics targeting primarily durable goods, packaging applications and applications other than single-sue food service items. We offer six commercial grades of Sustainables resins in this product line. These resins are compatible with existing manufacturing processes and equipment, making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Sustainables line in late 2007 under the name “Cereplast Hybrid Resins®.”
   
Cereplast Hybrid Resins® replace up to 50% of the petroleum content in conventional plastics with bio-based materials such as industrial starches sourced from plants. The Hybrid resins line is designed to offer similar properties to traditional polyolefins such as impact strength and heat deflection temperature, and is compatible with existing converter processes and equipment. Cereplast Hybrid Resins® provide a viable alternative for brand owners and converters looking to partially replace petroleum-based resins in durable goods applications. Hybrid resins address this need in a wide range of markets, including automotive, consumer goods, consumer electronics, medical, packaging and construction. We commercially introduced our first grade of Hybrid resin, Hybrid 150, at the end of 2007. We currently offer three commercial grades in this product line.
   
Cereplast Algae Plastic® resin. In October of 2009 we announced that we have been developing a new technology to transform algae into bioplastics and intend to launch a new resin family containing algae-based materials that will complement our existing line of resins. The first commercial product with Cereplast Algae Plastic® resin is now being produced and sold as part of our Sustainables resin family. We believe that it is important to enhance research on non-food crops as we expect a surge in demand in bioplastics in future years, thus potentially creating pressure on food crops. Algae is the first non-food crop project that we have introduced and our R&D department is contemplating the development of additional non-food crop based materials in future years.
Our patent portfolio is currently comprised of five U.S. patents, one Mexican patent, and eight pending patent applications in the U.S. and abroad. Our trademark portfolio is currently comprised of approximately 41 registered marks and 11 pending applications in the U.S. and abroad.

 

17


Table of Contents

Recent Strategic Events
Italian Expansion. On October 24, 2011 we completed the purchase of a manufacturing plant in Cannara, Italy that will serve as the hub for our European bioplastics production. We believe that this purchase will enable us to meet the growing demand for bioplastic resin in Europe while improving efficiencies, reducing transportation costs and minimizing logistics related risks. The plant is located on a 125,000 square foot former industrial plant site, enabling us to benefit from existing infrastructure. Current plans for the plant include a total capacity of approximately 220 million pounds, which will be built in phases; the first phase of 50,000 tons is expected to start operations in late 2012. Additional capacity will be added coincidental with market demand.
The aggregate purchase price of €4,577,750 ($6,355,748) was financed with loan and credit facilities established by Cereplast Italia SpA, our wholly owned subsidiary, and local Italian banking institutions. Additional capital expenditures to complete Phase I of the expansion are estimated at between €6 million and €8 million, or between $8 million and $11 million. We expect that these costs will also be financed entirely through local debt facilities and subsidies from government agencies.
New Distribution Agreements. During 2011, we announced the signing of eight new distribution agreements in Italy, Romania, Poland, Croatia, Slovenia, Turkey, Sweden, Norway and Denmark with multiple companies. These contracts reflect our growth and expansion across the Pan-European marketplace.
European Office. On January 4, 2011 we announced the opening of our European headquarters in Bönen, Germany to support the rapid expansion of our European operations and provide European-based customer with regional support and provide us with an effective platform to support the growth of bioplastics outside of the U.S.
Private Placement. In February, 2011 we raised $12.3 million through a private placement offering pursuant to which we issued 2,596,500 shares of common stock and 649,128 warrants with an exercise price of $6.35 per share. Proceeds of the financing are being allocated to fund working capital needed to meet the growing demand for our products, particularly in the European market.
Venture Loan. In February, 2011 we received additional $2.5 million in growth capital from Horizon Technology Finance Corporation pursuant to a Venture Loan and Security Agreement entered into in December, 2010. Proceeds from the loan are being allocated to fund working capital needed to meet the demand for our resin.
Convertible Subordinated Notes. In May, 2011, we issued $12.5 million in aggregate principal amount of 7% Senior Subordinated Convertible Notes due June 1, 2016 (the “Notes”). Proceeds from the Notes are being allocated to fund working capital needed to meet the growing demand for our products, particularly in the European market.
Registered Direct Offering. On November 10, 2011, we entered into subscription agreements, dated November 10, 2011, for the sale of up to an aggregate of 3,125,000 units in a registered direct offering for gross proceeds of approximately $5,000,000, before deducting the placement agents’ fees and estimated offering expenses payable by us. Each unit consists of one share of common stock, par value $0.001 per share, and one warrant to purchase 0.75 of a share of common stock. The closing of the sale and issuance of the units is expected to take place on or about November 16, 2011, subject to the satisfaction of customary closing conditions. Lazard Capital Markets LLC served as the lead placement agent and Ardour Capital Investments, LLC served as the co-placement agent.
Trends and Uncertainties that May Impact Future Results of Operations
Global Market and Economic Conditions. Recent global market and economic conditions, particularly in Europe, have been unprecedented and challenging with tighter credit conditions and slower growth. These conditions, combined with volatile oil prices, declining business and consumer confidence and increased unemployment have contributed to continued volatility of unprecedented levels.
As a result of these market conditions, the cost and availability of credit has been, and may continue to be, adversely affected by illiquid credit markets and wider credit spreads. Concern about the stability of the markets generally, and the strength of counterparties specifically, has led many lenders and institutional investors to reduce, and in some case cease, to provide funding to borrowers and to developing companies, such as our company. Continued turbulence in the U.S. and international markets and economies may adversely affect our liquidity and financial condition and the liquidity and financial condition of our customers. If these market conditions continue, they may limit our ability, and the ability of our customers, to timely replace maturing liabilities and access the capital markets to meet liquidity needs, resulting in an adverse effect on our financial condition and results of operations.

 

18


Table of Contents

Sales. We record sales at the time that we ship our products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable and collection of the related receivable is reasonably assured. We record sales net of sales discounts and allowances. In 2011, we provided price incentives to several customers that entered into a significant supply contract for their initial purchase commitments to assist in commercial launch activities. In the future, we may offer these incentives on a selective basis as we continue to grow our customer base. The amount of these incentives in future periods will be a function of the growth of our customer base and the particular commercialization. A large portion of our current sales are to European customers and the impact of the recent deterioration in economic and credit conditions in Europe as well as our resulting tighter credit granting policies, may impact customer demand and therefore sales.
Operating Expenses. Operating expenses consist principally of salaries (both cash and non-cash equity-based compensation), professional fees (including legal, accounting, patent-related, government compliance), marketing, sales commissions, rent and research and development and other administrative expenses, including allowances for estimated losses that may arise if any of our customers are unable to make required payments on accounts receivable. Salaries include all cash and non-cash compensation and related costs for all principal selling, general and administrative functions. During recent periods we have made grants of equity awards, including shares of restricted stock and stock options, to attract directors and members of senior management, which have resulted in non-cash compensation expense for the periods reported. We expect that non-cash compensation expense attributed to equity-based awards may increase in future periods as the result of future equity-based incentive compensation awards granted to attract and retain talented employees as we continue to grow our business. In addition, we expect to experience increases in our research and development expenses as we continue to develop new products and formulations, as well as increases in marketing and promotional expenses as we seek to increase our customer base. Recently the financial crisis in Europe and the general economic downturn has resulted in longer customer payment cycles in excess of management’s expectations. If financial or credit conditions worsen in Europe we may continue to experience difficulties collecting these outstanding balances from our European customers, resulting in additional expenses for estimated losses that may arise due to non payment.
CRITICAL ACCOUNTING POLICIES AND USE OF ESTIMATES
Our discussion and analysis of our financial condition and results of operations are based upon our unaudited financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We monitor our estimates on an ongoing basis for changes in facts and circumstances, and material changes in these estimates could occur in the future. Changes in estimates are recorded in the period in which they become known. We base our estimates on historical experience and other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from our estimates if past experience or other assumptions do not turn out to be substantially accurate.
Revenue Recognition
We recognize revenue at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured.

 

19


Table of Contents

Research and Development Costs
Research and development costs are charged to expense as incurred. These costs consist primarily of research with respect to new grades of bioplastic resins, testing of both the bioplastic resins as well as testing of finished products made from the bio-based resins.
Stock-Based Compensation
Compensation cost for all stock-based awards is measured at fair value on the date of grant and recognized over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes valuation model. Such value is recognized as expense over the service period, net of estimated forfeitures, using the straight-line method. Adjustments to this expense are made periodically to recognize actual rates of forfeiture which vary significantly from estimates.
Accounts Receivable
We maintain an allowance for doubtful accounts for estimated losses that may arise if any of our customers are unable to make required payments. Management performs a review of the receivables past due from customers on a monthly basis and reserves against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote.
Inventories
Inventories are stated at the lower of cost (first-in, first-out basis) or market, and consist primarily of raw materials used in the manufacturing of bioplastic resins, finished bioplastic resins and finished goods. Inventories are reviewed for excess and obsolescence and a reserve is established accordingly.
Intangibles
Intangibles are stated at cost and consist primarily of patents and trademarks. Amortization is computed on the straight-line method over the estimated life of these assets, estimated to be between five and fifteen years.
Property and Equipment
Property and equipment are stated at cost, and depreciation is computed on the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are between five and seven years. Repairs and maintenance expenditures are charged to expense as incurred.
Deferred Income Taxes
Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment.
The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

 

20


Table of Contents

RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2011 COMPARED TO THE THREE MONTHS ENDED SEPTEMBER 30, 2010
Sales
Net sales for the three months ended September 30, 2011 were $5.4 million, an increase of $3.9 million or 257.4%, compared to the same period in 2010. The sales increase for the period is attributable to volume increases associated with both existing customer contracts and new contracts with European customers. Environmental legislation, such as that banning the use of plastic bags in Italy that took effect on January 1, 2011, as well as the increased volatility in oil prices, were key drivers of demand for our bioplastic resins in the current year.
Cost of Sales
Cost of sales includes both fixed and variable costs, including materials and supplies, labor, facilities and other overhead costs associated with our product revenues. Cost of sales for the three months ended September 30, 2011 was $4.5 million, or 83.3% of net sales, compared to $1.1 million, or 74.8% of net sales, for the same period in 2010. The increase in cost of sales over the same period in the prior year is attributable to two main factors: (1) Cost of sales in the prior year period cannot be considered representative of normal sales or operations as we were in the process of relocating our production operations from California to Indiana and therefore had minimal production during this period in 2010, and (2) Cost of sales in the current period reflects the tremendous growth in sales volume from the prior year.
Gross Profit
Gross profit for the three months ended September 30, 2011 was $0.9 million, or 16.7% of net sales, compared to $0.4 million, or 25.2% of net sales, for the same period in 2010. The decrease in gross profit margin reflects the unusually high margins on very low volume sales in the prior year period combined our sales strategy to gain critical market share by offering low introductory pricing to some key customers to support their programs to bring new bioplastic products to market. This strategy has proven effective in contributing to strong sales growth and growing market share. We were successful in improving gross profit margins by 37.3% in the three month period ended September 30, 2011 compared to the three month period ended June 30, 2011, in line with expectations that margins will improve gradually through 2011 as we capitalize on demand growth to diversify our customer base, implement strategic price increases, and continue to gain operational efficiencies.
Research and Development Expenses
Research and development expenses for the three months ended September, 2011 were $0.3 million, or 5.2% of net sales, compared to approximately $0.1 million, or 7.0% of net sales, for the same period in 2010. Although research and development expenses decreased as a percentage of net sales, we incurred higher expenses in 2011 related to additional headcount, including the appointment of a new Chief Technology Officer and increased manufacturing supplies used for new product development.
Selling, General and Administrative Expenses
Selling, general and administrative expenses for the three months ended September 30, 2011 were $3.7 million, or 68.7% of net sales, compared to $2.2 million, or 147.6% of net sales, for the same period in 2010. The increase is entirely attributable to the $1.7 million increase in our allowance for doubtful accounts in the quarter. Other than this increase, selling general and administrative expenses remained relatively flat year over year.

 

21


Table of Contents

Other Expense, Net
Other expense, net for the three months ended September 30, 2011 was $0.5 million, as compared to $0.3 million in the same period in 2010. Other expense in 2011 consists of interest expense related to our Loan Agreement and our convertible senior subordinated notes. There was no interest expense reported for the same period in the prior year. Other expense in 2010 consisted of restructuring charges which were not incurred in the current year period.
Net Loss
Net loss for the three months ended September 30, 2011 was $3.6 million, as compared to $2.2 million in the same period in 2010. As discussed above, our results were favorably impacted by increases in net sales and gross profit, offset by interest expense and the increase in the allowance for doubtful accounts in 2011.
RESULTS OF OPERATIONS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2011 COMPARED TO THE NINE MONTHS ENDED SEPTEMBER 30, 2010
Sales
Net sales for the nine months ended September 30, 2011 were approximately $20.2 million, an increase of $17.8 million or 725.7%, compared to the same period in 2010. The sales increase for the period is attributable to volume increases associated with both existing customer contracts and new contracts with European customers. Environmental legislation, such as that banning the use of plastic bags in Italy that took effect on January 1, 2011, as well as the increased volatility in oil prices, were key drivers of demand for our bioplastic resins in the current year.
Cost of Sales
Cost of sales includes both fixed and variable costs, including materials and supplies, labor, facilities and other overhead costs associated with our product revenues. Cost of sales for the nine months ended September 30, 2011 was $17.7 million, or 87.5% of net sales, compared to $1.8 million, or 72.6% of net sales, for the same period in 2010. The increase in cost of sales over the same period in the prior year is attributable to two main factors: (1) Cost of sales in the prior year period cannot be considered representative of normal sales or operations as we were in the process of relocating our production operations from California to Indiana and therefore had minimal production during this period in 2010, and (2) Cost of sales in the current period reflects the tremendous growth in sales volume from the prior year.
Gross Profit
Gross profit for the nine months ended September 30, 2011 was $2.5 million, or 12.5% of net sales, compared to $0.7 million, or 27.4% of net sales, for the same period in 2010. The decrease in gross profit reflects the unusually high margins on very low volume sales in the prior year period combined our sales strategy to gain critical market share by offering low introductory pricing to some key customers to support their programs to bring new bioplastic products to market. This strategy has proven effective in contributing to strong sales growth and growing market share. We expect that margins will improve gradually through 2011 as we capitalize on demand growth to diversify our customer base, implement strategic price increases, and continue to gain operational efficiencies.
Research and Development Expenses
Research and development expenses for the nine months ended September 30, 2011 were $0.8 million, or 3.9% of net sales, compared to approximately $0.3 million, or 12.3% of net sales, for the same period in 2010. Although research and development expenses decreased as a percentage of net sales, we incurred higher expenses in 2011 related to additional headcount, including the appointment of a new Chief Technology Officer, increased manufacturing supplies used for new product development and impairment charges on intangible assets.
Selling, General and Administrative Expenses
Selling, general and administrative expenses for the nine months ended September 30, 2011 were $8.5 million, or 41.8% of net sales, compared to $5.4 million, or 221.8% of net sales, for the same period in 2010. Although selling, general and administrative expenses decreased as a percentage of net sales, we incurred incremental expenses in 2011 across all areas of the business, including compensation associated with increased headcount, performance related compensation, marketing, sales commissions, professional fees (including legal and accounting fees) to support the rapid growth of the business, including the expansion of European operations, specifically in Italy, as well as an increase in our allowance for doubtful accounts.

 

22


Table of Contents

Other Expense, Net
Other expense, net for the nine months ended September 30, 2011 was $1.0 million, as compared to $0.6 million in the same period in 2010. Other expense in 2011 consists of interest expense related to our Loan Agreement and our convertible senior subordinated notes. There was no interest expense related to these items reported for the same period in the prior year. Other expense in 2010 consisted of restructuring charges which were not incurred in the current year period.
Net Loss
Net loss for the nine months ended September 30, 2011 was $7.7 million, as compared to $5.6 million in the same period in 2010. As discussed above, our results were favorably impacted by increases in net sales and gross profit, offset by higher research and development, and selling, general and administrative expenses incurred to support the growth of the business.
LIQUIDITY AND CAPITAL RESOURCES
We require working capital to fund our operations, including payments to finance our research and development and expand sales and marketing, to purchase equipment, service indebtedness, satisfy lease obligations and execute on our business plan and growth strategy.
We had net unrestricted cash of $4.0 million at September 30, 2011 as compared to $2.4 million at December 31, 2010. The net increase in unrestricted cash is attributable principally to funds received through equity sold through a private placement and proceeds received from our venture loan and convertible senior subordinated notes, offset by cash used in operations.
Our working capital increased from $5.2 million at December 31, 2010, to $21.4 million at September 30, 2011. The increase in working capital is due primarily to net proceeds received from our private placement offering, convertible senior subordinated notes and venture loan, combined with increases in accounts receivable associated with higher revenue.
Cash used in operating activities during the nine months ended September 30, 2011 was $22.2 million, compared to $5.3 million during the same period in the 2010. The increase in the use of cash for operating activities was primarily a result of an increase in working capital, including increases in accounts receivable and inventory, which reflect the significant sales growth in the 2011 compared to 2010.
Cash used in investing activities during the nine months ended September 30, 2011 was $1.3 million compared to cash used in investing activities of approximately $0.1 million during the same period in 2010. Investing activities during 2011 consist primarily of purchase of capital equipment to improve operational efficiency and capacity at our Seymour manufacturing facility.
Cash provided by financing activities during the nine months ended September 30, 2011 was $25.2 million compared to $7.4 million provided by financing activities during the same period in 2010. The increase is attributable to an increase in funds received through a private placement offering consummated on February 1, 2011, proceeds from our issuance of convertible senior subordinated notes and proceeds from a venture loan from Compass Horizon Technology.

 

23


Table of Contents

OFF-BALANCE SHEET ARRANGEMENTS
We do not have any relationships with unconsolidated entities or financial partnerships such as entities often referred to as structured finance or special purpose entities that would have been established for the purpose of facilitating off-balance-sheet arrangements or for other contractually narrow or limited purposes. As such, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.
ITEM 3.  
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to a number of market risks in the ordinary course of business. These risks, which include interest rate risk, foreign currency exchange risk and commodity price risk, arise in the normal course of business rather than from trading. We have examined our exposures to these risks and concluded that none of our exposures in these areas is material to fair values, cash flows or earnings. We regularly review these risks to determine if we should enter into active strategies, such as hedging, to help manage the risks. At the present time, we do not have any hedging programs in place and we are not trading in any financial or derivative instruments.
At September 30, 2011 we had only fixed rate debt and therefore do not have interest rate risk from a liability perspective. We do have a significant amount of cash and short-term investments with maturities less than three months. This cash portfolio exposes us to interest rate risk as short-term investment rates can be volatile. Given the short-term maturity structure of our investment portfolio, and the high-grade investment quality of our portfolio, we believe that we are not subject to principal fluctuations and the effective interest rate of our portfolio tracks closely to various short-term money market interest rate benchmarks.
ITEM 4.  
CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this report, we conducted an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based upon this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is: (i) recorded, processed, summarized and reported, within the time periods specified in the SEC rules and forms, and (ii) accumulated and communicated to our management, including our chief executive officer and chief financial officer, or persons performing similar functions as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting, as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act, during the fiscal quarter ended September 30, 2011 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

24


Table of Contents

PART II — OTHER INFORMATION
ITEM 1.  
LEGAL PROCEEDINGS
From time to time, we may become involved in various lawsuits and legal proceedings that arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in matters that may harm our business may arise from time to time. We are currently not aware of nor have any knowledge of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.
ITEM 1A.  
RISK FACTORS
There are no material changes, other than as noted below, from the risk factors previously disclosed in the Registrant’s Form 10-K filed on March 31, 2011.
We have a large accounts receivable balance, any default in payment by one or more customers could adversely impact our results of operations, financial condition and liquidity.
As of September 30, 2011, we had an aggregate amount of $21 million in accounts receivable. Our European customers account for $20.9 million or 99.7% of our accounts receivable balance with average days outstanding of 270. One large European customer accounting for $7.6 million, or 36% of our receivables, is past due. Another of our European customer accounting for a significant portion of our accounts receivables, which amount is not currently due, is a newly formed company with limited operating history. The current financial crisis in Europe and the general economic downturn has resulted in longer payment cycles in excess of management’s expectations. If financial or credit conditions worsen in Europe we may continue to experience difficulties collecting these outstanding balances from our European customers. If these customers were to become insolvent or otherwise are unable or unwilling to make timely payments for any reason, our business, results of operation, financial condition and liquidity will be adversely affected. As a result of the deterioration in economic conditions in Europe and the slow payment by some of our European customers, we have increased our allowance for doubtful accounts by $1.7 million to reflect management’s assessment of the credit risk associated with these customer balances. If there is additional deterioration in European economic conditions or additional delays or unwillingness of our customers to pay amounts due to us, such allowance will increase.
We may not be successful in protecting our intellectual property and proprietary rights and may be required to expend significant amounts of money and time in attempting to protect these rights. If we are unable to protect our intellectual property and proprietary rights, our competitive position in the market could suffer.
Our intellectual property consists of patents, copyrights, trade secrets, trade dress and trademarks. Our success depends in part on our ability to obtain patents and maintain adequate protection of our other intellectual property for our technologies, brands and products in the U.S. and in other countries. The laws of some foreign countries do not protect proprietary rights to the same extent as do the laws of the U.S., and many companies have encountered significant problems in protecting their proprietary rights in these foreign countries. These problems may be caused by, among other factors, a lack of rules and methods for defending intellectual property rights.
Our future commercial success requires us not to infringe on patents and proprietary rights of third parties, or breach any licenses or other agreements that we have entered into with respect to our technologies, products and businesses. If we were to be sued for patent infringement, we might be subject to significant damages, enjoined from continuing certain businesses, or required to enter into a license agreement. There is no guarantee that such a license would be available at all or available on reasonable terms. If we were to breach any of our existing license agreements, the licensor might exercise their right to terminate the agreement, and if sued, we might be subject to damages.
The enforceability of patent positions cannot be predicted with certainty. We will apply for patents covering both our technologies and our products, if any, as we deem appropriate. Patents, if issued, may be challenged, invalidated or circumvented. There can be no assurance that no other relevant patents have been issued that could block our ability to obtain patents or to operate as we would like. Others may develop similar technologies or may duplicate technologies developed by us.
We are not currently a party to any litigation with respect to any of our patent positions. However, if we become involved in litigation or interference proceedings declared by the United States Patent and Trademark Office, or other intellectual property proceedings outside of the U.S., we might have to spend significant amounts of money to defend our intellectual property rights. If any of our competitors file patent applications or obtain patents that claim inventions or other rights also claimed by us, we may have to participate in interference proceedings declared by the relevant patent regulatory agency to determine priority of invention and our right to a patent of these inventions in the U.S. Even if the outcome is favorable, such proceedings might result in substantial costs to us, including, significant legal fees and other expenses, diversion of management time and disruption of our business. Even if successful on priority grounds, an interference proceeding may result in loss of claims based on patentability grounds raised in the interference proceeding. Uncertainties resulting from initiation and continuation of any patent or related litigation also might harm our ability to continue our research or to bring products to market.
An adverse ruling arising out of any intellectual property dispute, including an adverse decision as to the priority of our inventions, would undercut or invalidate our intellectual property position. An adverse ruling also could subject us to significant liability for damages, prevent us from using certain processes, products, or brand names, or require us to enter into royalty or licensing agreements with third parties. Furthermore, necessary licenses may not be available to us on satisfactory terms, or at all.
ITEM 2.  
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
We issued the following unregistered securities during the three months ended September 30, 2011:
   
On August 9, 2011, we issued 36,248 shares of common stock valued at $0.1 million to various employees for services rendered.
All of the offerings and sales above were deemed to be exempt under rule 506 of Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended (the “Securities Act”). No advertising or general solicitation was employed in offering the securities. The offerings and sales were made to a limited number of persons, all of whom were accredited investors, our business associates or our executive officers, and transfers of the securities were restricted by us in accordance with the requirements of the Securities Act. In addition to representations by the above-referenced persons, we have made independent determinations that all of the above-referenced persons were accredited or sophisticated investors, were capable of analyzing the merits and risks of their investment, and understood the speculative nature of their investment. Furthermore, all of the above-referenced persons were provided with access to our SEC filings.

 

25


Table of Contents

ITEM 3.  
DEFAULTS UPON SENIOR SECURITIES
Not applicable.
ITEM 4.  
RESERVED
ITEM 5.  
OTHER INFORMATION
None

 

26


Table of Contents

ITEM 6.  
EXHIBITS
         
Exhibit    
Number   Description
       
 
  31.1    
Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
       
 
  31.2    
Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
       
 
  32.1    
Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. ***
       
 
  32.2    
Certification of the Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002***
       
 
  101    
XBRL (Extensible Business Reporting Language) The following materials from Cereplast Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011, formatted in Extensive Business Reporting Language (XBRL), (i) consolidated balance sheets, (ii) consolidated statements of operations and other comprehensive loss, (iii) consolidated statements of cash flows, and (iv) the notes to the consolidated financial statements.
 
     
***  
In accordance with Item 601(b)(32)(ii) of Regulation S-K, this exhibit shall not be deemed “filed” for the purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities or the Exchange Act.

 

27


Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
Date: December 21, 2011  CEREPLAST, INC.
 
 
  By:   /s/ Frederic Scheer    
    Frederic Scheer   
    Chairman, Chief Executive Officer and Director
(Principal Executive Officer) 
 

 

28

EX-31.1 2 c26125exv31w1.htm EXHIBIT 31.1 Exhibit 31.1
Exhibit 31.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, Frederic Scheer, certify that:
1. I have reviewed this quarterly report on Form 10-Q/A of Cereplast, Inc. for the fiscal quarter ended September 30, 2011;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
         
Dated: December 21, 2011  By:   /s/ Frederic Scheer    
    Frederic Scheer,   
    Chief Executive Officer
(Principal Executive Officer) 
 

 

 

EX-31.2 3 c26125exv31w2.htm EXHIBIT 31.2 Exhibit 31.2
Exhibit 31.2
CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, Heather E. Sheehan, certify that:
1. I have reviewed this quarterly report on Form 10-Q/A of Cereplast, Inc. for the fiscal quarter ended September 30, 2011;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
         
Dated: December 21, 2011  By:   /s/ Heather E. Sheehan    
    Heather E. Sheehan, Sr. Vice President & Chief Financial Officer  
    (Principal Financial and Accounting Officer)   

 

 

EX-32.1 4 c26125exv32w1.htm EXHIBIT 32.1 Exhibit 32.1
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of Cereplast, Inc. (the “Company”) on Form 10-Q/A for the three months ended September 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Frederic Scheer, Chief Executive Officer and Principal Executive Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
  (1)  
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
  (2)  
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
     
/s/ Frederic Scheer
 
   
Frederic Scheer
   
Chief Executive Officer
   
(Principal Executive Officer)
   
   
December 21, 2011
   

 

 

EX-32.2 5 c26125exv32w2.htm EXHIBIT 32.2 Exhibit 32.2
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of Cereplast, Inc. (the “Company”) on Form 10-Q/A for the three months ended September 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Heather E. Sheehan, Sr. Vice President & Chief Financial Officer and Principal Financial Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
  (1)  
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
  (2)  
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
     
/s/ Heather E. Sheehan
 
   
Heather E. Sheehan
   
Sr. Vice President & Chief Financial Officer
   
(Principal Financial Officer)
   
     
December 21, 2011
   

 

 

EX-101.INS 6 cerp-20110930.xml EX-101 INSTANCE DOCUMENT 0001324759 2011-09-30 0001324759 2010-12-31 0001324759 2010-01-01 2010-09-30 0001324759 2011-01-01 2011-09-30 0001324759 2010-07-01 2010-09-30 0001324759 2011-07-01 2011-09-30 0001324759 2010-09-30 0001324759 2009-12-31 0001324759 2011-11-11 0001324759 cerp:DirectorAndEmployeeServicesMember 2010-01-01 2010-09-30 0001324759 cerp:PrepaidServicesAndRentMember 2010-01-01 2010-09-30 0001324759 cerp:EarlyTerminationFeesMember 2010-01-01 2010-09-30 0001324759 cerp:BoardMemberServicesMember 2010-01-01 2010-09-30 0001324759 cerp:DirectorAndEmployeeServicesMember 2011-01-01 2011-09-30 0001324759 cerp:ExerciseOfCommonStockWarrantsMember 2011-01-01 2011-09-30 0001324759 cerp:PrepaidServicesMember 2011-01-01 2011-09-30 0001324759 cerp:SettlementAgreementMember 2011-01-01 2011-09-30 0001324759 cerp:SettlementAgreementMember 2010-01-01 2010-09-30 iso4217:USD iso4217:USD xbrli:shares xbrli:shares 4113000 2894000 7007000 28228000 4000 1593000 3486000 19119000 4030000 12984000 6889000 6889000 72000 -42933000 11329000 49737000 13000 6095000 2119000 2119000 3976000 149000 -21000 9000 1251000 2567000 12984000 496000 14000 173000 266000 43000 3351000 -50658000 2213000 5564000 9137000 65000 1392000 5289000 2391000 61992000 16000 34052000 22719000 15877000 59000 12500000 3318000 6842000 -0.23 -0.17 -0.50 -0.49 417000 -93000 11363000 11225000 2500000 4000 96000 13000 1290000 864000 269000 1514000 -35000 2095000 -223000 15609000 64000 57000 -874000 1780000 694000 2000 3314000 1306000 52000 7507000 20000 59000 23000 184000 58000 -315000 -92000 56000 210000 1263000 -15000 -1333000 33000 588000 7507000 11208000 2842642 2596500 <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"> <div align="left">8. SUBSEQUENT EVENTS </div></div> <!-- xbrl,body --> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>Purchase of Manufacturing Facility in Italy</i> </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">Effective October&nbsp;24, 2011, Cereplast Italia S.p.A (&#147;Cereplast Italia&#148;), our wholly owned subsidiary, completed its acquisition of an industrial plant and the real estate on which the industrial plant is located in Cannara, Italy. The Deed of Sale between Cereplast Italia and Societa Regionale Per Lo Sviluppo Economico Dell&#146;Umbria &#151; Sviluppumbria S.p.A, provided for an aggregate purchase price of &#128;4,577,750 ($6,355,748). In connection with the acquisition, Cereplast Italia entered into the following financing transactions: </div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="4%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify">Mortgage loan with Banca Monte Dei Paschi Di Sienna S.p.A for the principal of &#128;3,440,000 ($4,776,096). The loan bears interest of Euribor (6-month) plus 5.7%. The loan is for a term of 15&nbsp;years with interest only payments for the first two years, payable January 1 and July 1 each year and principal and interest payments thereafter according to an amortization schedule. Twenty percent of the principal is guaranteed for 10&nbsp;years by Gepafin, a local government agency; &#128;400,000 ($555,360) of the principal is guaranteed by Eurofidi through December&nbsp;31, 2016.</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="4%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify">Credit facility with Intesa Sanpaolo for up &#128;500,000 ($694,200). The facility is for a term of eight months with a floating interest rate based on Euribor (3&nbsp;month), currently 5.85%. Interest is deferred for the first two months of the term. Cereplast Italia obtained a guarantee of 60% of the amount drawn on the facility from Eurofidi.</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="4%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify">Credit facility with Unicredit Bank for up to &#128;600,000 ($833,040). The facility is for a term of 18&nbsp;months with a floating interest rate based on Euribor (3&nbsp;month), currently 5.93%. Cereplast Italia obtained a guarantee of 60% of the amount drawn on the facility from Eurofidi.</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">We estimate that in addition to the purchase price, Cereplast Italia will incur estimated additional fees of &#128;400,000 ($555,360) in connection with the acquisition. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>Registered Direct Offering</i> </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">On November&nbsp;10, 2011, we entered into a Placement Agent Agreement, relating to a registered direct offering of up to an aggregate of 3,125,000 Units (&#147;Units&#148;), pursuant to which Lazard Capital Markets LLC served as the lead placement agent and Ardour Capital Investments, LLC served as the co-placement agent. Each Unit consists of one share of common stock, par value $0.001 per share, and one warrant to purchase 0.75 of a share of the Company&#146;s common stock. The sale of the Units is being made pursuant to subscription agreements, dated November&nbsp;10, 2011, between the Company and each of the investors in this offering. The investors have agreed to purchase the Units for a negotiated price of $1.60 per Unit, resulting in gross proceeds to the Company of approximately $5,000,000, before deducting the placement agents&#146; fees and estimated offering expenses payable by us. The net offering proceeds to the Company from the sale of the Units, after deducting the placement agents&#146; fees and other estimated offering expenses payable by the Company, are expected to be approximately $4,345,000. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">The per share exercise price of the warrants is $2.20. The warrants are exercisable at any time on or after the date that is 180 days after the initial issuance on the date of closing and will expire on a date that is five years from the date of closing. The closing of the sale and issuance of the Units is expected to take place on or about November&nbsp;16, 2011, subject to the satisfaction of customary closing conditions. </div></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">7. INCOME TAX</div> <!-- xbrl,body --> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">We are subject to U.S. and California income tax. Subject to limited statutory exceptions, we are no longer subject to federal, state and local or non-U.S. income tax examinations by tax authorities for years before 2006. We are not presently liable for any income taxes nor are we undergoing any tax examinations by the Internal Revenue Service. No Deferred Tax Assets or Deferred Tax Liabilities are included in our balance sheets at September&nbsp;30, 2011 or December&nbsp;31, 2010. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">Our policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. </div></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">6. MAJOR CUSTOMERS AND FOREIGN SALES </div> <!-- xbrl,body --> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">The following customers accounted for 10% or more of gross revenue in the periods presented:</div> <div align="center"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"><!-- Begin Table Head --> <tr style="HEIGHT: 0px" valign="bottom"> <td width="44%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="6">Three Months Ended</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="6">Nine Months Ended</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="6">September 30,</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="6">September 30,</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2">2011</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2">2010</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2">2011</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2">2010</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Customer A</div></td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">68.0</td> <td nowrap="nowrap">%</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">27.0</td> <td nowrap="nowrap">%</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Customer B</div></td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">29.2</td> <td nowrap="nowrap">%</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">26.8</td> <td nowrap="nowrap">%</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Customer C</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">26.3</td> <td nowrap="nowrap">%</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td></tr></table></div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">Our gross sales were made up of sales to customers in the following geographic regions (<i>in thousands</i>): </div> <div align="center"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"><!-- Begin Table Head --> <tr style="HEIGHT: 0px" valign="bottom"> <td width="44%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="14"><b>Three Months Ended September 30,</b></td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="6">2011</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="6">2010</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">North America</div></td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">81</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">1.5</td> <td nowrap="nowrap">%</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">440</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">29.0</td> <td nowrap="nowrap">%</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">International</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 45px; TEXT-INDENT: -15px">Italy</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">5,262</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">97.2</td> <td nowrap="nowrap">%</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">1,022</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">67.5</td> <td nowrap="nowrap">%</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 45px; TEXT-INDENT: -15px">Other</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">71</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">1.3</td> <td nowrap="nowrap">%</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">53</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">3.5</td> <td nowrap="nowrap">%</td></tr> <tr style="FONT-SIZE: 1px; HEIGHT: 0px"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">&nbsp;</div></td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td></tr> <tr style="HEIGHT: 0px" valign="bottom"><!-- Blank Space --> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">&nbsp;</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 30px; TEXT-INDENT: -15px">Gross sales</div></td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">5,414</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">100.0</td> <td nowrap="nowrap">%</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">1,515</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">100.0</td> <td nowrap="nowrap">%</td></tr> <tr style="FONT-SIZE: 1px; HEIGHT: 0px"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">&nbsp;</div></td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td></tr></table></div> <div align="center"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"><!-- Begin Table Head --> <tr style="HEIGHT: 0px" valign="bottom"> <td width="44%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="14"><b>Nine Months Ended September 30,</b></td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="6">2011</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="6">2010</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">North America</div></td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">749</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">3.6</td> <td nowrap="nowrap">%</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">1,139</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">45.2</td> <td nowrap="nowrap">%</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">International</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 45px; TEXT-INDENT: -15px">Italy</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">12,470</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">59.8</td> <td nowrap="nowrap">%</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">1,022</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">40.6</td> <td nowrap="nowrap">%</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 45px; TEXT-INDENT: -15px">Germany</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">5,494</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">26.4</td> <td nowrap="nowrap">%</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">210</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">8.3</td> <td nowrap="nowrap">%</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 45px; TEXT-INDENT: -15px">Other</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">2,136</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">10.2</td> <td nowrap="nowrap">%</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">148</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">5.9</td> <td nowrap="nowrap">%</td></tr> <tr style="FONT-SIZE: 1px; HEIGHT: 0px"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">&nbsp;</div></td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td></tr> <tr style="HEIGHT: 0px" valign="bottom"><!-- Blank Space --> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">&nbsp;</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 30px; TEXT-INDENT: -15px">Gross sales</div></td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">20,849</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">100.0</td> <td nowrap="nowrap">%</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">2,519</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">100.0</td> <td nowrap="nowrap">%</td></tr> <tr style="FONT-SIZE: 1px; HEIGHT: 0px"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">&nbsp;</div></td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td></tr></table></div></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"> <div align="left">5. LEASES </div></div> <!-- xbrl,body --> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">We currently operate out of El Segundo, California, Seymour, Indiana and B&#246;nen, Germany. The leases underlying these three facilities are summarized below: </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>California Facility </i>&#151; The El Segundo facility consists of approximately 5,475 square feet of corporate office space. The lease commenced on March&nbsp;1, 2010 and has a term of five years. The lease was subsequently amended on April&nbsp;1, 2011 to add additional office space. The lease term relating to the additional office space expires on May&nbsp;31, 2013. Our current monthly rent is $13,124, with 3% annual escalation. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>Indiana Facility &#151; </i>The Seymour facility consists of approximately 105,000 square feet used as a manufacturing and distribution facility for our products. The lease commenced in January&nbsp;2008, with a ten year term expiring in January&nbsp;2018. Our current monthly rent is $25,000. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>B&#246;nen Facility</i>&#151; The B&#246;nen facility consists of approximately 1,000 square feet of corporate office space. The facility is subject to a lease with monthly rents of approximately $2,000 expiring in December&nbsp;2018. </div></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">4. LOANS PAYABLE AND CONVERTIBLE SUBORDINATED NOTES </div> <!-- xbrl,body --> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>Venture Loan Payable</i> </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">On December&nbsp;21, 2010, we entered into a Venture Loan and Security Agreement (the &#147;Loan Agreement&#148;) with Compass Horizon Funding Company, LLC (the &#147;Lender&#148; or &#147;Horizon&#148;). The Loan Agreement provides for a total loan commitment of $5.0&nbsp;million comprising of Loan A and Loan B, each in the amount of $2.5&nbsp;million. Loan A was funded at closing on December&nbsp;21, 2010 and matures 39&nbsp;months after the date of advance. Loan B was funded on February&nbsp;17, 2011 and also matures 39&nbsp;months after the date of advance. We are obligated to pay interest per annum equal to the greater of (a)&nbsp;12% or (b)&nbsp;12% plus the difference between (i)&nbsp;the one month LIBOR Rate in effect on the date preceding the funding of such loan by five business days and (ii) .30%. We are required to make interest only payments for the first nine months of each loan and equal payments of principal over the final thirty months of each loan. We granted a security interest in all of our assets to the Lender. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">In connection with loan, we issued a seven year warrant to the Lender to purchase 140,000 shares of our common stock at an exercise price of $4.40. The relative fair value of the warrants was $0.2 million and will be recorded as interest expense over the term of the loan. We estimated the fair value of the warrants using the Black-Scholes option pricing model using the following assumptions: </div> <div align="center"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"><!-- Begin Table Head --> <tr style="HEIGHT: 0px" valign="bottom"> <td width="86%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>December 22,</b></td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"><b>Assumptions:</b></td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2"><b>2010</b></td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Expected Life</div></td> <td>&nbsp;</td> <td align="right" colspan="2">7 years</td> <td>&nbsp;</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Expected volatility</div></td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">39.9</td> <td nowrap="nowrap">%</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Dividends</div></td> <td>&nbsp;</td> <td align="right" colspan="2">None</td> <td>&nbsp;</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Risk-free interest rate</div></td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">2.74</td> <td nowrap="nowrap">%</td></tr></table></div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">Also in connection with the Loan Agreement, we incurred $0.4&nbsp;million of debt issue costs which were deferred and are being amortized to interest expense over the term of the loan. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>Promissory Note</i> </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">We signed a promissory note in the amount of $20,359 related to the purchase of an automobile in fiscal year 2010. The note bears interest at 7.69% per annum and is to be repaid over a period of 60&nbsp;months. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>Convertible Subordinated Notes</i> </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">On May&nbsp;24, 2011, we issued $12.5&nbsp;million in aggregate principal amount of 7% Senior Subordinated Convertible Notes due June&nbsp;1, 2016 (the &#147;Notes&#148;). The Notes were issued pursuant to an indenture (the &#147;Indenture&#148;), entered into between us and Wells Fargo Bank, National Association, as trustee, on May&nbsp;24, 2011. In connection with the issuance of the Notes, we entered into a Waiver to our Venture Loan and Security Agreement with Horizon, dated May&nbsp;18, 2011 pursuant to which Horizon provided its consent to the offering of the Notes and waived any restrictions in the Loan Agreement. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">The Notes are senior subordinated unsecured obligations which will rank subordinate in right to payment to all of our existing and future senior secured indebtedness and bear interest at a rate of 7% per annum payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December&nbsp;1, 2011. The Notes mature on June&nbsp;1, 2016, with an early repurchase date of June&nbsp;15, 2014 at the option of the purchaser. The Notes are convertible into shares of our common stock in accordance with the terms of the Notes and the Indenture, at the initial conversion rate of 172.4138 shares of our common stock per $1,000 principal amount of Notes, equivalent to a conversion price of approximately $5.80 per share, subject to adjustment. If the Notes are converted into shares of our common stock prior to June&nbsp;2, 2014, an interest make-whole payment will be due based on the conversion date up until June&nbsp;2, 2014. Upon a non-stock change in control, additional shares of our common stock may need to be issued upon conversion, with a maximum additional shares of 25.606 per $1,000 in principal amount of Notes being issuable thereunder, for a total maximum of 198.0198 shares per $1,000 Note. Certain customary anti-dilution provisions included in the Indenture and/or the Notes could adjust the conversion rate. At September&nbsp;30, 2011, the Notes are convertible into 2,155,173 shares of our common stock. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">The conversion feature within the Notes is not considered to be a beneficial conversion feature within the meaning of Accounting Standards Codification (&#147;ASC&#148;) 470, Debt, and therefore all of the gross proceeds from the Notes have been classified as long term debt. In connection with the issue of the Notes, we incurred approximately $1.3&nbsp;million of debt issue costs which were deferred and are being amortized to interest expense over the term to the early repurchase date of June&nbsp;15, 2014. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">Also in connection with the issuance of the Notes, we entered into a Securities Purchase Agreement dated May&nbsp;18, 2011 pursuant to which we agreed to prepare and file a registration statement with the Securities and Exchange Commission (the &#147;SEC&#148;) registering the resale of the Notes and the shares of common stock underlying the Notes. The registration statement was declared effective on August&nbsp;10, 2011. </div></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"> <div align="left">3. CAPITAL STOCK </div></div> <!-- xbrl,body --> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>Reverse Stock Split</i> </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">On March&nbsp;15, 2010, we implemented a reverse split of our common stock on a 1-for-40 basis. The reverse split was effective at 6:00 a.m. on March&nbsp;15, 2010. All historical and per share amounts have been adjusted to reflect the reverse stock split. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>Capital Stock Issued</i> </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">During the nine months ended September&nbsp;30, 2011, we issued shares of common stock as follows: </div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td width="4%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify">We issued 2,596,500 shares of common stock and 649,128 warrants with an exercise price of $6.35 for gross proceeds of $12.3&nbsp;million pursuant to a securities purchase agreement dated January&nbsp;26, 2011 between us and each of the signatories thereto. We incurred stock issuance costs of $1.1&nbsp;million.</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td width="4%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify">We issued 35,000 shares of common stock pursuant to a warrant exercise for gross proceeds of $0.2&nbsp;million.</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td width="4%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify">We issued 165,796 shares of common stock valued at $0.7&nbsp;million to various employees, directors, and third parties for services rendered during the period.</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td width="4%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify">We issued 4,062 shares of common stock valued at $20,000 pursuant to a settlement agreement.</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>Valuation Assumptions for Stock Options</i> </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">During the nine months ended September&nbsp;30, 2011, we granted options to our employees to purchase an aggregate of 300,000 shares of our common stock, with estimated total grant-date fair values of $0.7&nbsp;million. We estimate that stock-based compensation for awards not expected to be exercised is $0.2&nbsp;million. During the three and nine months ended September&nbsp;30, 2011, we recorded stock-based compensation related to stock options of $23,000 and $0.2&nbsp;million, respectively. The grant date fair value was estimated at the date of grant using the Black-Scholes option pricing model, assuming no dividends and the following assumptions: </div> <div align="center"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"><!-- Begin Table Head --> <tr style="HEIGHT: 0px" valign="bottom"> <td width="86%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2">January 14, 2011</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Average risk-free interest rate</div></td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">2.29</td> <td nowrap="nowrap">%</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Average expected life (in years)</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">6.0</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Volatility</div></td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">41.9</td> <td nowrap="nowrap">%</td></tr></table></div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="4%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify"><i>Expected Volatility: </i>The fair values of stock based payments were valued using a volatility factor based on our historical stock prices.</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="4%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify"><i>Expected Term: </i>We elected to use the &#147;simplified method&#148; as discussed in SAB No.&nbsp;107 to develop the estimate of the expected term.</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="4%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify"><i>Expected Dividend: </i>We have not paid any dividends and do not anticipate paying dividends in the foreseeable future.</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="4%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify"><i>Risk-Free Interest Rate: </i>We base the risk-free interest rate used on the implied yield currently available on U.S. Treasury zero-coupon issues with remaining term equivalent to the expected term of the options.</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>Stock Option Activity</i> </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">Under the 2004 Employee Stock Option Plan adopted by our board of directors (the &#147;Plan&#148;), our board of directors may issue incentive and non-qualified stock options to our employees. Options granted under the Plan generally expire at the end of five or ten years and vest in accordance with a vesting schedule determined by our board of directors, usually over three years from the grant date. As of September&nbsp;30, 2011, we have 34,375 shares available for future grants under the Plan. We settle stock option exercises with newly issued shares of our common stock. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"> <div align="left">The following is a summary of stock option activity (<i>in thousands</i>, <i>except per share data</i>): </div></div> <div align="center"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"><!-- Begin Table Head --> <tr style="HEIGHT: 0px" valign="bottom"> <td width="44%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="6">2011</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="6">2010</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2">Weighted</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2">Weighted</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2">Average</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2">Average</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2">Shares</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2">Exercise Price</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2">Shares</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2">Exercise Price</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Outstanding&#151;January 1</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">73</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">22.40</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">73</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">22.40</td> <td>&nbsp;</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 30px; TEXT-INDENT: -15px">Granted at fair value</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">300</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">5.31</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 30px; TEXT-INDENT: -15px">Exercised</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 30px; TEXT-INDENT: -15px">Canceled/forfeited</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 1px; HEIGHT: 0px"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">&nbsp;</div></td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Outstanding&#151;September&nbsp;30</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">373</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">8.65</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">73</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">22.40</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 1px; HEIGHT: 0px"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">&nbsp;</div></td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Options exercisable at September 30</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">133</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">14.69</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">73</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">22.40</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 1px; HEIGHT: 0px"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">&nbsp;</div></td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td></tr></table></div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">The following table summarizes information about stock options as of September&nbsp;30, 2011 (<i>in thousands, except per share data):</i> </div> <div align="center"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"><!-- Begin Table Head --> <tr style="HEIGHT: 0px" valign="bottom"> <td width="20%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="5%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="5%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="5%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="5%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="5%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="5%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="5%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="5%">&nbsp;</td> <td width="1%">&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="14"><b>Options Outstanding</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="14"><b>Options Exercisable</b></td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Weighted</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Weighted</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2">&nbsp;</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Weighted</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Average</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Weighted</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Average</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2">&nbsp;</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Average</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Remaining</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Aggregate</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Average</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Remaining</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Aggregate</b></td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Exercise</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Contract</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Intrinsic</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Exercise</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Contract</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2"><b>Intrinsic</b></td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="left"><b>Range of Exercise Prices</b></td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2"><b>Shares</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2"><b>Price</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2"><b>Life</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2"><b>Value</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2"><b>Shares</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2"><b>Price</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2"><b>Life</b></td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2"><b>Value</b></td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">$0.0 - $5.31</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">300</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">5.31</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">9.42</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">60</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">5.31</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">9.42</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">&#151;</td> <td>&nbsp;</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">$5.32 - $22.40</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">73</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">22.40</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">3.17</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">73</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">22.40</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">3.17</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">&#151;</td> <td>&nbsp;</td></tr></table></div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">The aggregate intrinsic value in the table above represents the total pretax intrinsic value, based on our closing stock price of $2.80 at September&nbsp;30, 2011 which would have been received by the option holders had all option holders exercised their options as of that date. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>Common Stock Warrants</i> </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">In connection with the issue of 2,596,500 shares of common stock to accredited investors pursuant to a securities purchase agreement entered into on January&nbsp;26, 2011, we issued warrants to purchase 649,128 shares of our common stock. The warrants have an exercise price of $6.35 per share and are exercisable until July&nbsp;31, 2016. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">A summary of warrant activity is as follows (<i>in thousands except per share data</i>):</div> <div align="center"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"><!-- Begin Table Head --> <tr style="HEIGHT: 0px" valign="bottom"> <td width="44%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="3%">&nbsp;</td> <td width="1%">&nbsp;</td> <td width="9%">&nbsp;</td> <td width="1%">&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="6">2011</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="6">2010</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2">Weighted</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2">Weighted</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2">Number of</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2">Average</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2">Number of</td> <td>&nbsp;</td> <td>&nbsp;</td> <td nowrap="nowrap" align="center" colspan="2">Average</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 10pt; HEIGHT: 0px" valign="bottom"> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2">Warrants</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2">Exercise Price</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2">Warrants</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-BOTTOM: #000000 1px solid" nowrap="nowrap" align="center" colspan="2">Exercise Price</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Outstanding&#151; January&nbsp;1,</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">1,273</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">4.44</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">&#151;</td> <td>&nbsp;</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 30px; TEXT-INDENT: -15px">Issued</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">649</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">6.35</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">1,133</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">4.44</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 30px; TEXT-INDENT: -15px">Exercised</div></td> <td>&nbsp;</td> <td nowrap="nowrap" align="left">&nbsp;</td> <td align="right">(35</td> <td nowrap="nowrap">)</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">4.44</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">&#151;</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 1px; HEIGHT: 0px"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">&nbsp;</div></td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 1px solid" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td></tr> <tr style="HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Outstanding&#151;September&nbsp;30</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">1,887</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">5.09</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">1,133</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">4.44</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 1px; HEIGHT: 0px"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">&nbsp;</div></td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td></tr> <tr style="BACKGROUND: #cceeff; HEIGHT: 0px" valign="bottom"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">Warrants exercisable at end of period</div></td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">1,887</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">5.09</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">1,133</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="left">$</td> <td align="right">4.44</td> <td>&nbsp;</td></tr> <tr style="FONT-SIZE: 1px; HEIGHT: 0px"> <td> <div style="MARGIN-LEFT: 15px; TEXT-INDENT: -15px">&nbsp;</div></td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td style="BORDER-TOP: #000000 3px double" nowrap="nowrap" align="right" colspan="2">&nbsp;</td> <td>&nbsp;</td></tr></table></div></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Basis of Presentation and Consolidation</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (&#147;GAAP&#148;).&nbsp; The unaudited consolidated financial statements include the financial condition and results of operations of our wholly-owned subsidiary, Cereplast International, S.A., a Luxembourg company organized during the year ended December&nbsp;31, 2008, for the purpose of conducting sales operations in Europe.&nbsp; Intercompany balances and transactions have been eliminated in consolidation.&nbsp; The results of operations for interim periods are not necessarily indicative of the results that may be expected for a full year.&nbsp; These financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2010.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Use of Estimates</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements.&nbsp; Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, the allowance for doubtful accounts and the fair value of stock options.&nbsp; Actual results could differ from those estimates.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Cash and Cash Equivalents</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents. At various times throughout the year, we may have exceeded federally insured limits.&nbsp; At September&nbsp;30, 2011 and December&nbsp;31, 2010, balances in our cash accounts exceeded federally insured limits of $0.25 million by approximately, $4.0 million and $2.3 million, respectively.&nbsp; We have not experienced any losses in such accounts and we do not believe we are exposed to any significant credit risk on cash and cash equivalents.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Concentration of Credit Risk</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">We had unrestricted cash, cash equivalents, and short-term investments totaling $4.0 million and $2.4 million at September&nbsp;30, 2011 and December&nbsp;31, 2010, respectively.&nbsp; The unrestricted cash and cash equivalents are held for working capital purposes.&nbsp;&nbsp; We do not enter into investments for trading or speculative purposes.&nbsp; Some of the securities in which we invest, however, may be subject to market risk.&nbsp; This means that a change in prevailing interest rates may cause the principal amount of the investment to fluctuate.&nbsp; To minimize this risk, we intend to maintain our portfolio of cash equivalents and short-term investments in a variety of securities, including commercial paper, money market funds, debt securities and certificates of deposit.&nbsp; Due to the short-term nature of these investments, we believe that we do not have any material exposure to changes in the fair value of our investment portfolio as a result of changes in interest rates.&nbsp; We actively monitor changes in interest rates.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Concentration of credit risk with respect to accounts receivable is limited to certain European customers to whom we make substantial sales.&nbsp; As of September&nbsp;30, 2011 we had one large European customer that accounted for $6.9 million, or 33% of our accounts receivable balance, which is past due.&nbsp; We have another large European customer with $6.1 million, or 29% of our receivable balance, which is expected to be paid as current invoices come due, during the period December, 2011 through February&nbsp;2012, in accordance with agreed payment terms.&nbsp; Agreed upon payment terms for both of these customers are 90 days from receipt of goods.&nbsp; These customers have acknowledged to us their agreement with the amounts owing and no amounts recognized in revenue or recorded in accounts receivable from these customers are in dispute.&nbsp;&nbsp;&nbsp; To reduce risk, we routinely assess the financial strength of our most significant customers, using standard credit risk evaluation methods with reference to publicly available and customer supplied information, and monitor the amounts owed to us, taking appropriate action when necessary.&nbsp; As a result of the recent deterioration in the general economic conditions in Europe and the slow payment by some of our European customers, we have increased our allowance for doubtful accounts by $1.7 million to reflect management&#146;s assessment of credit risk associated with these customer balances.&nbsp; We are working with all customers to mitigate credit risk and ensure collection of all outstanding amounts.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Other Concentration</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">During the nine months ended months ended September&nbsp;30, 2011, we had two significant suppliers that accounted for 34.0% and 27.6% of total cost of goods sold, respectively.&nbsp; During the same period in the prior year, we had two significant suppliers that accounted for 25.7% and 24.7% of total cost of goods sold, respectively.&nbsp; No other suppliers accounted for more than 10% of cost of goods sold during these periods.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Restricted Cash</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">We had restricted cash in the amount of approximately $43,000 on September&nbsp;30, 2011 and December&nbsp;31, 2010. The restricted cash amount consists of a &#147;Certificate of Deposit&#148; which supports a &#147;Letter of Credit&#148; for a leased facility.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Fair Value of Financial Instruments</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The carrying amounts of our financial instruments as of September&nbsp;30, 2011, which include cash equivalents, accounts receivable, accounts payable, accrued expenses, loans payable and convertible subordinated notes approximate their fair values due to the short-term nature of these instruments.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Accounts Receivable</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">We maintain an allowance for doubtful accounts for estimated losses that may arise if any of our customers are unable to make required payments. Management performs a review of the receivables past due from customers on a monthly basis and reserves against uncollectible items for each customer after all reasonable means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was approximately $1.8 million and $66,000 as of September&nbsp;30, 2011 and December&nbsp;31, 2010, respectively.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Inventory</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Inventories are stated at the lower of cost (first-in, first-out basis) or market and consist primarily of raw materials used in the manufacturing of bioplastic resins, finished bioplastic resins and finished goods. Inventories are reviewed for excess and obsolescence and a reserve is established accordingly. Inventories consisted of the following (<i>in thousands</i>):</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="bottom" width="63%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman" size="1">September&nbsp;30,&nbsp;2011</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman" size="1">December&nbsp;31,&nbsp;2010</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="bottom" width="63%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman" size="1">(Unaudited)</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Raw Materials</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.3%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 13.36%; PADDING-TOP: 0in" valign="bottom" width="13%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">2,029</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.3%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 13.36%; PADDING-TOP: 0in" valign="bottom" width="13%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">936</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Bioplastic Resins</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 14.66%; PADDING-TOP: 0in" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">1,542</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 14.66%; PADDING-TOP: 0in" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">318</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Finished Goods</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 14.66%; PADDING-TOP: 0in" valign="bottom" width="14%" bgcolor="#CCEEFF" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">41</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 14.66%; PADDING-TOP: 0in" valign="bottom" width="14%" bgcolor="#CCEEFF" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">44</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Packaging Materials</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 14.66%; PADDING-TOP: 0in" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">66</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 14.66%; PADDING-TOP: 0in" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">53</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">WIP</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 14.66%; PADDING-TOP: 0in" valign="bottom" width="14%" bgcolor="#CCEEFF" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&#151;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 14.66%; PADDING-TOP: 0in" valign="bottom" width="14%" bgcolor="#CCEEFF" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">41</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Obsolescence Reserve</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">(192</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0.375pt; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">)</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&#151;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt 20pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Inventory, Net</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.3%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.36%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="13%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">3,486</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.3%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.36%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="13%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">1,392</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Property and Equipment</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Property and equipment are stated at cost and depreciation is computed on the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are between five and seven years. Repairs and maintenance expenditures are charged to expense as incurred. Property and equipment consist of the following (<i>in thousands</i>):</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="bottom" width="63%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman" size="1">September&nbsp;30,&nbsp;2011</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman" size="1">December&nbsp;31,&nbsp;2010</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="bottom" width="63%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman" size="1">(Unaudited)</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Equipment</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.3%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 13.36%; PADDING-TOP: 0in" valign="bottom" width="13%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">5,506</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.3%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 13.36%; PADDING-TOP: 0in" valign="bottom" width="13%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">5,074</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Construction in Progress</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 14.66%; PADDING-TOP: 0in" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">952</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 14.66%; PADDING-TOP: 0in" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">135</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Furniture&nbsp;&amp; Fixtures</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 14.66%; PADDING-TOP: 0in" valign="bottom" width="14%" bgcolor="#CCEEFF" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">296</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 14.66%; PADDING-TOP: 0in" valign="bottom" width="14%" bgcolor="#CCEEFF" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">279</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Automobile</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 14.66%; PADDING-TOP: 0in" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">25</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 14.66%; PADDING-TOP: 0in" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">25</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Leasehold Improvements </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="14%" bgcolor="#CCEEFF" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">228</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="14%" bgcolor="#CCEEFF" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">51</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="bottom" width="63%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">7,007</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">5,564</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Less Accumulated Depreciation </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="14%" bgcolor="#CCEEFF" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">(2,894</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0.375pt; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">)</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="14%" bgcolor="#CCEEFF" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">(2,213</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0.375pt; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">)</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%"> <p style="MARGIN: 0in 0in 0pt 20pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Property and Equipment, Net </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.3%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.36%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="13%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">4,113</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.3%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.36%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="13%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">3,351</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Intangible Assets</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Intangible assets are stated at cost and consist primarily of patents and trademarks. Amortization is computed on the straight-line method over the estimated life of these assets, estimated to be between five and fifteen years. Intangible assets consist of the following (<i>in thousands</i>):</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="bottom" width="63%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman" size="1">September&nbsp;30,&nbsp;2011</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman" size="1">December&nbsp;31,&nbsp;2010</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="bottom" width="63%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman" size="1">(Unaudited)</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1">&nbsp;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Intangible Assets</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.3%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 13.36%; PADDING-TOP: 0in" valign="bottom" width="13%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">196</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.3%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 13.36%; PADDING-TOP: 0in" valign="bottom" width="13%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">206</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Less Accumulated Amortization </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">(36</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0.375pt; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">)</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 14.66%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="14%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">(33</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0.375pt; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">)</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 63.38%; PADDING-TOP: 0in" valign="top" width="63%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt 20pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Intangible Assets, Net </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.3%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.36%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="13%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">160</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 3.06%; PADDING-TOP: 0in" valign="bottom" width="3%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.3%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 13.36%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="13%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">173</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.18%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt 3.5in; TEXT-INDENT: 0.5in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Deferred Income Taxes</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences.&nbsp; Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.&nbsp; Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.&nbsp; Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any.&nbsp; Tax positions taken are not offset or aggregated with other positions.&nbsp; Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority.&nbsp; The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Interest and penalties associated with unrecognized tax benefits are classified as additional income taxes in the statement of income.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Revenue Recognition</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">We recognize revenue at the time of shipment of products, when the following fundamental criteria are met: (i)&nbsp;persuasive evidence of an arrangement exists; (ii)&nbsp;delivery has occurred; (iii)&nbsp;the price to the customer is fixed or determinable; and (iv)&nbsp;collection of the sales price is probable.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Certain of our product sales are made to distributors under agreements with generally the same terms of sale and credit as all other customer agreements. Revenue from product sales to our customers, including our customers who are distributors, is recognized upon shipment provided the above noted fundamental criteria of revenue recognition are met. The sale of products to our customers who are distributors is not contingent upon the distributor selling the product to the end-user, and our current agreements with distributors do not have any rights of return.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Marketing and Advertising</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">We expense marketing and advertising costs as incurred. Marketing and advertising costs for the three months ended September&nbsp;30, 2011 and 2010 were approximately $0.1 million and $0.2 million, respectively.&nbsp; Marketing and advertising costs for the nine months ended September&nbsp;30, 2011 and 2010 were approximately $0.3 million and $0.5 million, respectively.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Stock-Based Compensation</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Compensation cost for all stock-based awards is measured at fair value on the date of grant and recognized over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes valuation model.&nbsp; Such value is recognized as expense over the service period, net of estimated forfeitures, using the straight-line method. Adjustments to this expense are made periodically to recognize actual rates of forfeiture which vary significantly from estimates.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Loss Per Share Calculations</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Basic loss per share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares available. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Our diluted loss per share is the same as the basic loss per share for the three months and nine months ended September&nbsp;30, 2011 and 2010 as inclusion of any potential shares would have had an anti-dilutive effect due to our generation of a net loss.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Legal Proceedings</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">From time to time, we may become involved in various lawsuits and other legal proceedings, which arise in the ordinary course of business. Legal proceedings are subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Comparative Figures</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">&nbsp;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Certain of the prior year figures have been reclassified to conform to the presentation adopted in the current year.</font></p></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"> <div align="left">1. ORGANIZATION AND LINE OF BUSINESS </div></div> <!-- xbrl,body --> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>Organization</i> </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">We were incorporated on September&nbsp;29, 2001 in the State of Nevada under the name Biocorp North America Inc. On March&nbsp;18, 2005, we filed an amendment to our articles of incorporation to change our name to Cereplast, Inc. (the &#147;Company&#148;).</div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify"><i>Line of Business</i> </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">We have developed and are commercializing proprietary bio-based resins through two complementary product families: (1)&nbsp;Cereplast Compostables<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top">&#174;</sup> resins which are renewable, ecologically sound substitutes for traditional petroleum-based non-compostable plastics and (2)&nbsp;Cereplast Sustainables<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top">&#174;</sup> resins, which replace up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources. Our resins aim to be competitively priced compared to fully petroleum-based plastic resins and can be converted into finished products using conventional manufacturing equipment without significant additional capital investment by downstream converters. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">The demand for non-petroleum based, clean and renewable sources for materials, such as bioplastics, and the demand for compostable/biodegradable products is each being driven globally by a variety of factors, including environmental concerns, new stringent regulations on compostable material, fossil fuel price volatility, and energy security. These factors have led to increased spending on clean and sustainable products by corporations and individuals as well as legislative initiatives at the local and state level. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">We are a full-service resin solution provider uniquely positioned to capitalize on the rapidly increasing demand for sustainable and environmentally friendly alternatives to traditional plastic products. </div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">We primarily conduct our operations through two product families: </div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="4%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify">Cereplast Compostables<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top">&#174;</sup> resins<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top"> </sup>are compostable and bio-based, ecologically sound substitutes for petroleum-based plastics targeting primarily compostable bags, single-use food service products and packaging applications. We offer 13 commercial grades of Compostables resins in this product line. These resins are compatible with existing manufacturing processes and equipment making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Compostables line in November&nbsp;2006.</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="4%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify">Cereplast Sustainables<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top">&#174;</sup> resins<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top"> </sup>are partially or fully bio-based, ecologically sound substitutes for fully petroleum-based plastics targeting primarily durable goods, packaging applications and applications other than single-use food service items. We offer six commercial grades of Sustainables resins in this product line. These resins are compatible with existing manufacturing processes and equipment, making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Sustainables line in late 2007 under the name &#147;Cereplast Hybrid Resins<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top">&#174;</sup>.&#148;</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="12%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify">Cereplast Hybrid Resins<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top">&#174;</sup> replace up to 50% of the petroleum content in conventional plastics with bio-based materials such as industrial starches sourced from plants. The Hybrid resins line is designed to offer similar properties to traditional polyolefins such as impact strength and heat deflection temperature, and is compatible with existing converter processes and equipment. Cereplast Hybrid Resins<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top">&#174;</sup> provide a viable alternative for brand owners and converters looking to partially replace petroleum-based resins in durable goods applications. Hybrid resins address this need in a wide range of markets, including automotive, consumer goods, consumer electronics, medical, packaging, and construction. We commercially introduced our first grade of Hybrid resin, Hybrid 150, at the end of 2007. We currently offer three commercial grades in this product line.</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt"> <table style="FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr style="FONT-SIZE: 10pt; BACKGROUND: none transparent scroll repeat 0% 0%; COLOR: #000000; HEIGHT: 0px" valign="top"> <td style="BACKGROUND: none transparent scroll repeat 0% 0%" width="12%">&nbsp;</td> <td nowrap="nowrap" align="left" width="3%"><b>&#149;</b></td> <td width="1%">&nbsp;</td> <td> <div style="TEXT-ALIGN: justify">Cereplast Algae Plastic<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top">&#174;</sup> resins. In October of 2009 we announced that we have been developing a new technology to transform algae into bioplastics and intend to launch a new resin family containing algae-based materials that will complement our existing line of resins. The first commercial product with Cereplast Algae Plastic<sup style="FONT-SIZE: 85%; VERTICAL-ALIGN: text-top">&#174;</sup> resin is now being produced and sold as part of our Sustainables resin family. We believe that it is important to enhance research on non-food crops as we expect a surge in demand in bioplastics in future years, thus potentially creating pressure on food crops. Algae is the first non-food crop project that we have introduced and our R&amp;D department is contemplating the development of additional non-food crop based materials in future years.</div></td></tr></table></div> <div style="MARGIN-TOP: 10pt; FONT-SIZE: 10pt" align="justify">Our patent portfolio is currently comprised of five U.S. patents, one Mexican patent, and eight pending patent applications in the U.S. and abroad. Our trademark portfolio is currently comprised of approximately 41 registered marks and 11 pending applications in the U.S. and abroad. </div></td></tr></table> 15793553 Cereplast Inc 0001324759 10-Q 2011-09-30 true --12-31 Yes Smaller Reporting Company Q3 2011 1504000 36000 2095000 0.001 0.001 3207000 0.001 0.001 12992195 15793553 12992195 15793553 495000000 495000000 0 0 11333000 34052000 5000000 5000000 1711000 49000 160000 1459000 43000 15778000 15778000 12925000 12925000 15470000 15470000 11400000 11400000 5414000 1515000 20849000 2519000 45000 2000 628000 70000 5369000 1513000 20221000 2449000 4475000 1132000 17701000 1778000 894000 381000 2520000 671000 280000 106000 789000 302000 3689000 2233000 8457000 5432000 -3075000 -1958000 -6726000 -5063000 275000 586000 -513000 -999000 -513000 -274000 -999000 -586000 -3588000 -2232000 -7725000 -5649000 -54000 52000 -93000 52000 -3642000 -2180000 -7818000 -5597000 31250 125000 12500 50000 151302 770000 78605 301000 153796 657000 35000 155000 12000 59000 4062 20000 -22153000 -5305000 -1290000 -184000 25175000 7445000 0 157000 1639000 2008000 0 0 43000 -3588000 -2232000 -7725000 -5649000 1000 20162 75000 Cereplast, Inc. is filing this Amendment No. 1 (the ?Amendment?) to its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2011, filed with the Securities and Exchange Commission on November 14, 2011 (the ?Form 10-Q?), to revise the disclosure in ?Concentration of Credit Risk? and ?Revenue Recognition? in Note 2 of the notes to the financial statements contained in the Form 10-Q. </R> <R> No other changes have been made to the Form 10-Q. This Amendment speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q. EX-101.SCH 7 cerp-20110930.xsd EX-101 SCHEMA DOCUMENT 0010 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 0030 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1010 - Disclosure - ORGANIZATION AND LINE OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 1020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 1030 - Disclosure - CAPITAL STOCK link:presentationLink link:calculationLink link:definitionLink 1040 - Disclosure - LOANS PAYABLE AND CONVERTIBLE SUBORDINATED NOTES link:presentationLink link:calculationLink link:definitionLink 8000 - Disclosure - CONVERTIBLE SENIOR NOTES link:presentationLink link:calculationLink link:definitionLink 1050 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 1060 - Disclosure - MAJOR CUSTOMERS AND FOREIGN SALES link:presentationLink link:calculationLink link:definitionLink 1070 - Disclosure - INCOME TAX link:presentationLink link:calculationLink link:definitionLink 8010 - Disclosure - COMMON STOCK WARRANTS link:presentationLink link:calculationLink link:definitionLink 1080 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 9999 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0035 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 cerp-20110930_cal.xml EX-101 CALCULATION LINKBASE DOCUMENT EX-101.LAB 9 cerp-20110930_lab.xml EX-101 LABELS LINKBASE DOCUMENT Common Stock Issued for Services, Salaries, and Wages Common Stock Issued for Services, Salaries and Wages Represents the stock issued by the entity during the reporting period for services, salaries and wages. Proceeds from Convertible Subordinated Notes, Net of Issuance Costs Proceeds from Issuance of Convertible Subordinated Long-term Debt The cash inflow from a borrowing where a lender is placed in a lien position behind debt having a higher priority of repayment (senior) in liquidation of the entity's assets or underlying collateral and can be exchanged for a specified amount of another security at the option of the issuer or the holder. Cash Paid During the Year For: Cash Paid During the Year For [Abstract] Represents the number of shares issued by the entity under private placements during the reporting period. Shares issued under a private placement, shares Issuance of Stock, Shares, Under Private Placements ORGANIZATION AND LINE OF BUSINESS CONVERTIBLE SENIOR NOTES Convertible Senior Notes Disclosure [Text Block] CONVERTIBLE SENIOR NOTES The entire disclosure for convertible senior notes. MAJOR CUSTOMERS AND FOREIGN SALES Revenue by Major Customers and Geographic Region Disclosure [Text Block] MAJOR CUSTOMERS AND FOREIGN SALES Disclosure of the entities revenues from major customers and by geographic region. COMMON STOCK WARRANTS Common Stock Warrants Disclosure[Text Block] COMMON STOCK WARRANTS Entire disclosure for common stock warrants. Document and Entity Information Director and Employee Services Services provided by directors and employees during the reporting period. Director and Employee Services [Member] Prepaid Services Prepaid services received by the entity during the reporting period. Prepaid Services [Member] Settlement Agreement Costs associated with a settlement agreement during the reporting period. Settlement Agreement [Member] Early Termination Fees Fees associated with early lease termination during the reporting period. Early Termination Fees [Member] Board Member Services Services provided by board members during the reporting period. Board Member Services [Member] Exercise of Common Stock Warrants Represents common stock warrants exercised during the reporting period. Exercise of Common Stock Warrants [Member] Prepaid Services and Rent Prepaid services and rent received by the entity during the reporting period. Prepaid Services and Rent [Member] CONSOLIDATED BALANCE SHEETS Statement [Table] Statement, Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Statement Statement [Line Items] ASSETS Assets [Abstract] Current Assets Assets, Current [Abstract] Inventory, Net Inventory, Net Prepaid Expense and Other Assets, Current Prepaid Expenses and Other Current Assets Assets, Current Total Current Assets Cash and Cash Equivalents, at Carrying Value CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS, END OF PERIOD Cash Accounts Receivable, Net Accounts Receivable, Net, Current Property, Plant and Equipment, Net [Abstract] Property and Equipment Accumulated Depreciation and Amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated Depreciation and Amortization Property, Plant and Equipment, Gross Property and Equipment Property, Plant and Equipment, Net Property and Equipment, Net Property and Equipment, Net Assets Total Assets Other Assets, Noncurrent [Abstract] Other Assets Restricted Cash and Cash Equivalents, Noncurrent Restricted Cash Deposits Assets, Noncurrent Deposits Total Other Assets Other Assets, Noncurrent Deferred Loan Costs Deferred Finance Costs, Noncurrent, Net Intangible Assets, Net Intangible Assets, Net (Excluding Goodwill) Liabilities and Equity [Abstract] LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities, Noncurrent [Abstract] Long-Term Liabilities Loans Payable, Noncurrent Loan Payable Liabilities, Noncurrent Total Long-Term Liabilities Convertible Subordinated Notes Convertible Subordinated Debt, Noncurrent Capital Lease Obligations, Noncurrent Capital Leases, Long-Term Liabilities Total Liabilities Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Equity Stockholders' Equity Attributable to Parent [Abstract] Shareholders' Equity Preferred Stock, Value, Issued Preferred Stock, $0.001 par value; 5,000,000 shares authorized and none outstanding Common Stock, Value, Issued Common Stock, $0.001 par value; 495,000,000 shares authorized; 15,757,305 and 12,992,195 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively Common Stock, $0.001 par value; 495,000,000 shares authorized; 15,793,553 and 12,992,195 shares issued and outstanding at September 30, 2011 and December 31, 2010, respectively Additional Paid in Capital Additional Paid in Capital, Common Stock Retained Earnings (Accumulated Deficit) Accumulated Deficit Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income Common Stock, Share Subscribed but Unissued, Subscriptions Receivable Common Stock Subscribed, not issued Stockholders' Equity Attributable to Parent Total Shareholders' Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total Equity Stockholders' Equity Attributable to Noncontrolling Interest Noncontrolling Interests Liabilities and Equity Total Liabilities and Shareholders' Equity Liabilities, Current [Abstract] Current Liabilities Accounts Payable, Current Accounts Payable Accrued Liabilities, Current Accrued Expenses Capital Lease Obligations, Current Capital Leases, Current Portion Loans Payable, Current Loan Payable, Current Portion Liabilities, Current Total Current Liabilities Preferred Stock, Par or Stated Value Per Share Preferred Stock, par value (in dollars per share) Preferred Stock, Shares Authorized Preferred Stock, shares authorized Preferred Stock, Shares Outstanding Preferred Stock, shares outstanding Common Stock, Par or Stated Value Per Share Common Stock, par value (in dollars per share) Common Stock, Shares Authorized Common Stock, shares authorized Common Stock, Shares, Issued Common Stock, shares issued Common Stock, Shares, Outstanding Common Stock, shares outstanding Sales Revenue, Goods, Gross GROSS SALES Sales Discounts, Returns and Allowances, Goods Sales Discounts, Returns and Allowances Sales Discounts, Returns and Allowances Sales Revenue, Goods, Net NET SALES Cost of Goods Sold COST OF SALES Gross Profit GROSS PROFIT Research and Development Expense Research and Development Selling, General and Administrative Expense Selling, General and Administrative Selling, General and Administrative Operating Income (Loss) LOSS FROM OPERATIONS BEFORE OTHER EXPENSES OTHER EXPENSES Nonoperating Income (Expense) [Abstract] Interest Income (Expense), Nonoperating, Net Interest Expense, Net Nonoperating Income (Expense) TOTAL OTHER EXPENSE, NET Restructuring Costs Restructuring Charges Weighted Average Number of Shares Outstanding, Basic WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, BASIC (in shares) Provision for Income Taxes Income Tax Expense (Benefit) Provision for Income Taxes Weighted Average Number of Shares Outstanding, Diluted WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, DILUTED (in shares) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract] OTHER COMPREHENSIVE INCOME Gain (Loss) on Foreign Currency Translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax TOTAL COMPREHENSIVE LOSS Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest BASIC AND DILUTED LOSS PER SHARE (in dollars per share) Earnings Per Share, Basic and Diluted Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest NET LOSS BEFORE PROVISION FOR INCOME TAXES CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME Adjustment to Reconcile Net Loss to Net Cash Used in Operating Activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Provision for Doubtful Accounts Allowance for Doubtful Accounts Changes in Operating Assets and Liabilities Increase (Decrease) in Operating Capital [Abstract] Increase (Decrease) in Accounts Receivable Accounts Receivable Deferred Loan Costs Increase (Decrease) in Deferred Charges Increase (Decrease) in Inventories Inventory Increase (Decrease) in Prepaid Expense Prepaid Expenses and Other Current Assets Intangibles Increase (Decrease) in Intangible Assets, Current Increase (Decrease) in Accounts Payable Accounts Payable Accrued Expenses Increase (Decrease) in Accrued Liabilities Deposits Increase (Decrease) in Deposit Assets Deposits Amortization of Loan Discount Amortization of Debt Discount (Premium) Loss on Disposal of Leasehold Improvements Gain (Loss) on Disposition of Assets Depreciation and Amortization Depreciation, Depletion and Amortization Impairment of Intangible Assets Impairment of Intangible Assets (Excluding Goodwill) Purchase of Property and Equipment, and Intangibles Payments to Acquire Productive Assets Payments on Capital Leases Repayments of Long-term Capital Lease Obligations Proceeds from Issuance of Common Stock and Subscriptions, Net of Issuance Costs Proceeds from Issuance of Common Stock Payments made on Notes Payable Repayments of Long-term Debt Proceeds from Loan Payable, Net of Loan Costs Proceeds from Debt, Net of Issuance Costs Proceeds from Long-term Capital Lease Obligations Proceeds from Capital Leases Proceeds from Noncontrolling Interests Noncontrolling Interest Activities SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Supplemental Cash Flow Information [Abstract] Interest Interest Paid Income Taxes Income Taxes Paid FOREIGN CURRENCY TRANSLATION Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations Shares issued under a private placement Proceeds from Issuance of Private Placement CONSOLIDATED STATEMENTS OF CASH FLOWS ORGANIZATION AND LINE OF BUSINESS Nature of Operations [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] CAPITAL STOCK CAPITAL STOCK Stockholders' Equity Note Disclosure [Text Block] LOANS PAYABLE AND CONVERTIBLE SUBORDINATED NOTES LOANS PAYABLE AND CONVERTIBLE SUBORDINATED NOTES Debt Disclosure [Text Block] LEASES LEASES Leases of Lessee Disclosure [Text Block] INCOME TAX INCOME TAX Income Tax Disclosure [Text Block] SUBSEQUENT EVENTS SUBSEQUENT EVENTS Subsequent Events [Text Block] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Amendment Description Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Award Type and Plan Name [Axis] Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain] Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award Stock Issued During Period, Value, Other Dollar value of shares issued Stock Issued During Period, Shares, Other Number of shares issued Expense related to vesting of employee stock options Stock or Unit Option Plan Expense Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES: CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] NET CASH USED IN OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities, Continuing Operations NET CASH USED IN INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net Cash Provided by (Used in) Financing Activities, Continuing Operations NET CASH PROVIDED BY FINANCING ACTIVITIES NET LOSS Net Loss Net Income (Loss) Available to Common Stockholders, Basic NET INCREASE IN CASH Net Cash Provided by (Used in) Continuing Operations Increase (Decrease) in Restricted Cash for Operating Activities Restricted Cash NET LOSS Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net Loss EX-101.PRE 10 cerp-20110930_pre.xml EX-101 PRESENTATION LINKBASE DOCUMENT EX-101.DEF 11 cerp-20110930_def.xml EX-101 DEFINITION LINKBASE DOCUMENT XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
LOANS PAYABLE AND CONVERTIBLE SUBORDINATED NOTES
9 Months Ended
Sep. 30, 2011
LOANS PAYABLE AND CONVERTIBLE SUBORDINATED NOTES  
LOANS PAYABLE AND CONVERTIBLE SUBORDINATED NOTES
4. LOANS PAYABLE AND CONVERTIBLE SUBORDINATED NOTES
Venture Loan Payable
On December 21, 2010, we entered into a Venture Loan and Security Agreement (the “Loan Agreement”) with Compass Horizon Funding Company, LLC (the “Lender” or “Horizon”). The Loan Agreement provides for a total loan commitment of $5.0 million comprising of Loan A and Loan B, each in the amount of $2.5 million. Loan A was funded at closing on December 21, 2010 and matures 39 months after the date of advance. Loan B was funded on February 17, 2011 and also matures 39 months after the date of advance. We are obligated to pay interest per annum equal to the greater of (a) 12% or (b) 12% plus the difference between (i) the one month LIBOR Rate in effect on the date preceding the funding of such loan by five business days and (ii) .30%. We are required to make interest only payments for the first nine months of each loan and equal payments of principal over the final thirty months of each loan. We granted a security interest in all of our assets to the Lender.
In connection with loan, we issued a seven year warrant to the Lender to purchase 140,000 shares of our common stock at an exercise price of $4.40. The relative fair value of the warrants was $0.2 million and will be recorded as interest expense over the term of the loan. We estimated the fair value of the warrants using the Black-Scholes option pricing model using the following assumptions:
         
    December 22,  
Assumptions:   2010  
Expected Life
  7 years  
Expected volatility
    39.9 %
Dividends
  None  
Risk-free interest rate
    2.74 %
Also in connection with the Loan Agreement, we incurred $0.4 million of debt issue costs which were deferred and are being amortized to interest expense over the term of the loan.
Promissory Note
We signed a promissory note in the amount of $20,359 related to the purchase of an automobile in fiscal year 2010. The note bears interest at 7.69% per annum and is to be repaid over a period of 60 months.
Convertible Subordinated Notes
On May 24, 2011, we issued $12.5 million in aggregate principal amount of 7% Senior Subordinated Convertible Notes due June 1, 2016 (the “Notes”). The Notes were issued pursuant to an indenture (the “Indenture”), entered into between us and Wells Fargo Bank, National Association, as trustee, on May 24, 2011. In connection with the issuance of the Notes, we entered into a Waiver to our Venture Loan and Security Agreement with Horizon, dated May 18, 2011 pursuant to which Horizon provided its consent to the offering of the Notes and waived any restrictions in the Loan Agreement.
The Notes are senior subordinated unsecured obligations which will rank subordinate in right to payment to all of our existing and future senior secured indebtedness and bear interest at a rate of 7% per annum payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2011. The Notes mature on June 1, 2016, with an early repurchase date of June 15, 2014 at the option of the purchaser. The Notes are convertible into shares of our common stock in accordance with the terms of the Notes and the Indenture, at the initial conversion rate of 172.4138 shares of our common stock per $1,000 principal amount of Notes, equivalent to a conversion price of approximately $5.80 per share, subject to adjustment. If the Notes are converted into shares of our common stock prior to June 2, 2014, an interest make-whole payment will be due based on the conversion date up until June 2, 2014. Upon a non-stock change in control, additional shares of our common stock may need to be issued upon conversion, with a maximum additional shares of 25.606 per $1,000 in principal amount of Notes being issuable thereunder, for a total maximum of 198.0198 shares per $1,000 Note. Certain customary anti-dilution provisions included in the Indenture and/or the Notes could adjust the conversion rate. At September 30, 2011, the Notes are convertible into 2,155,173 shares of our common stock.
The conversion feature within the Notes is not considered to be a beneficial conversion feature within the meaning of Accounting Standards Codification (“ASC”) 470, Debt, and therefore all of the gross proceeds from the Notes have been classified as long term debt. In connection with the issue of the Notes, we incurred approximately $1.3 million of debt issue costs which were deferred and are being amortized to interest expense over the term to the early repurchase date of June 15, 2014.
Also in connection with the issuance of the Notes, we entered into a Securities Purchase Agreement dated May 18, 2011 pursuant to which we agreed to prepare and file a registration statement with the Securities and Exchange Commission (the “SEC”) registering the resale of the Notes and the shares of common stock underlying the Notes. The registration statement was declared effective on August 10, 2011.
EXCEL 14 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\V8SDY8V-F-%]E,S1F7S0U93!?8C,V-U]D.&8Y M9C8S.3(X8C@B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-534U!4EE?3T9?4TE'3DE&24-!3E1?04-#3U5. M5#PO>#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I7 M;W)K#I7;W)K#I3='EL97-H M965T($A2968],T0B5V]R:W-H965T3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V8SDY8V-F-%]E,S1F7S0U93!? M8C,V-U]D.&8Y9C8S.3(X8C@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-F,Y.6-C9C1?93,T9E\T-64P7V(S-C=?9#AF.68V,SDR.&(X+U=O'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQAF5D M(&%N9"!N;VYE(&]U='-T86YD:6YG/"]T9#X-"B`@("`@("`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`@("`\=&%B;&4@ M8VQA&-E<'0@4VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$F%T M:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV.30\'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'!E;G-E'!E;G-E6UE;G1S(&]N($-A<&ET86P@ M3&5A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$6%B;&4\+W1D/@T*("`@("`@("`\ M=&0@8VQA6%B M;&4L($YE="!O9B!,;V%N($-O'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&-E<'0@4VAA6UE;G0@07=A M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!3:&%R92UB87-E9"!087EM96YT($%W M87)D/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\ M&5R8VES92!O9B!#;VUM;VX@4W1O8VL@5V%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$6UE;G0@07=A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G0@07=A6UE M;G0@07=A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$2!3:&%R92UB87-E9"!087EM96YT($%W87)D M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\V8SDY8V-F-%]E,S1F7S0U93!?8C,V-U]D.&8Y M9C8S.3(X8C@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F,Y.6-C M9C1?93,T9E\T-64P7V(S-C=?9#AF.68V,SDR.&(X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2`M+3X-"CQD:78@F%T:6]N/"]I/B`\+V1I=CX-"CQD:78@3X\:3Y,:6YE(&]F($)U'0M=&]P)SXF(S$W-#L\+W-U M<#X@2!P971R;VQE=6TM8F%S960@<&QA2!D;W=N3Y4:&4@9&5M86YD(&9O3Y792!A6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0G/@T*/'1A M8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<@8V5L;'-P86-I;F<],T0P M(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@8F]R9&5R/3-$,#X-"CQT MF4Z(#$P<'0[(&)A8VMG2<^0V5R97!L87-T($-O;7!O&ES=&EN9R!M86YU9F%C='5R:6YG M('!R;V-E6QE/3-$)V9O;G0M'0M=&]P)SXF(S$W-#L\+W-U<#X@'0M=&]P)SX@ M/"]S=7`^87)E('!A2!O2!B:6\M8F%S960L(&5C;VQO M9VEC86QL>2!S;W5N9"!S=6)S=&ET=71E"!C;VUM97)C:6%L(&=R861E&ES=&EN9R!M86YU9F%C='5R:6YG('!R;V-E M2!I;G1R;V1U8V5D(&]U6QE/3-$)T9/3E0M4TE:13H@.#4E M.R!615)424-!3"U!3$E'3CH@=&5X="UT;W`G/B8C,36QE/3-$)V9O;G0M2<^0V5R M97!L87-T($AY8G)I9"!297-I;G,\6QE/3-$)T9/3E0M4TE:13H@ M.#4E.R!615)424-!3"U!3$E'3CH@=&5X="UT;W`G/B8C,36]L M969I;G,@&ES M=&EN9R!C;VYV97)T97(@<')O8V5S'0M=&]P)SXF(S$W-#L\+W-U<#X@<')O M=FED92!A('9I86)L92!A;'1E6)R:60@,34P+"!A="!T:&4@96YD(&]F(#(P,#2!O M9F9E6QE/3-$)V9O;G0M M2<^ M0V5R97!L87-T($%L9V%E(%!L87-T:6,\6QE/3-$)T9/3E0M4TE: M13H@.#4E.R!615)424-!3"U!3$E'3CH@=&5X="UT;W`G/B8C,32!C;VYT86EN:6YG(&%L9V%E M+6)A3Y/=7(@<&%T96YT('!O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\V8SDY8V-F-%]E,S1F7S0U93!?8C,V-U]D.&8Y9C8S.3(X8C@- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F,Y.6-C9C1?93,T9E\T M-64P7V(S-C=?9#AF.68V,SDR.&(X+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F4Z,3!P M=#L@9F]N="UF86UI;'DZ)U1I;65S($YE=R!2;VUA;B6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;B<@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0G/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U35%E,13H@:71A;&EC.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY"87-I6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6EN9R!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@:&%V M92!B965N('!R97!A2P@0V5R97!L87-T M($EN=&5R;F%T:6]N86PL(%,N02XL(&$@3'5X96UB;W5R9R!C;VUP86YY(&]R M9V%N:7IE9"!D=7)I;F<@=&AE('EE87(@96YD960@1&5C96UB97(F;F)S<#LS M,2P@,C`P."P@9F]R('1H92!P=7)P;W-E(&]F(&-O;F1U8W1I;F<@2!B86QA M;F-E65AF4],T0R/B9N8G-P.SPO M9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\ M:3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z M(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6EN9R!F:6YA;F-I86P@2!A;F0@97%U M:7!M96YT+"!T:&4@9&5F97)R960@=&%X('9A;'5A=&EO;B!A;&QO=V%N8V4L M('1H92!A;&QO=V%N8V4@9F]R(&1O=6)T9G5L(&%C8V]U;G1S(&%N9"!T:&4@ M9F%I6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQI/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U35%E,13H@:71A;&EC.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY#87-H(&%N9"!#87-H M($5Q=6EV86QE;G1S/"]F;VYT/CPO:3X\+W`^#0H\<"!S='EL93TS1"=-05)' M24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B9N M8G-P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@ M,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/E=E(&-O;G-I9&5R(&%L M;"!H:6=H;'D@;&EQ=6ED(&EN=F5S=&UE;G1S('=I=&@@86X@;W)I9VEN86P@ M;6%T=7)I='D@;V8@=&AR964@;6]N=&AS(&]R(&QE&-E961E9"!F961E&-E961E9"!F961E2!A<'!R;WAI;6%T96QY+"`D-"XP(&UI;&QI;VX@ M86YD("0R+C,@;6EL;&EO;BP@F4],T0R/B9N8G-P.SPO9F]N M=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\:3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET M86QI8SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@2!M87)K970@9G5N9',L(&1E8G0@F4] M,T0R/B9N8G-P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I M;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D-O;F-E;G1R M871I;VX@;V8@8W)E9&ET(')I'!E8W1E9"!T;R!B92!P86ED(&%S(&-U6UE;G0@=&5R;7,N)FYB6UE;G0@ M=&5R;7,@9F]R(&)O=&@@;V8@=&AEF4],T0R/B9N8G-P.SPO9F]N M=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\:3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET M86QI8SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@2XF;F)S<#L@1'5R M:6YG('1H92!S86UE('!E65A2XF;F)S<#L@3F\@;W1H97(@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U35%E,13H@:71A;&EC.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY297-T6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;B<@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@&EM871E;'D@)#0S+#`P,"!O;B!397!T96UB97(F;F)S<#LS,"P@,C`Q M,2!A;F0@1&5C96UB97(F;F)S<#LS,2P@,C`Q,"X@5&AE(')E6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQI/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U35%E,13H@:71A;&EC.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY&86ER(%9A;'5E(&]F M($9I;F%N8VEA;"!);G-T6%B;&4L(&%C8W)U960@97AP96YS97,L(&QO86YS('!A>6%B;&4@ M86YD(&-O;G9EF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ M(#!I;B`P:6X@,'!T)SX\:3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;B<@2!O9B!O=7(@8W5S=&]M97)S(&%R92!U;F%B;&4@=&\@;6%K M92!R97%U:7)E9"!P87EM96YT2!I&EM871E;'D@)#$N."!M:6QL:6]N(&%N9"`D-C8L M,#`P(&%S(&]F(%-E<'1E;6)E6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;B<@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0G/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U35%E,13H@:71A;&EC.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY);G9E;G1O6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;B<@6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@2!O9B!R87<@;6%T97)I86QS('5S960@:6X@ M=&AE(&UA;G5F86-T=7)I;F<@;V8@8FEO<&QA&-E6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@F4],T0Q/B9N8G-P M.SPO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/ M4D1%4BU224=(5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q-"4@8V]L6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-) M6D4Z(#AP=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU224=(5#H@;65D M:75M(&YO;F4[(%!!1$1)3D'0@ M,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q-"4@8V]L6QE M/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#AP=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@F4],T0Q/B9N8G-P.SPO9F]N=#X\+V(^/"]P/CPO=&0^/"]T MF4],T0Q M/B9N8G-P.SPO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)T)/4D1%4BU224=(5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z M(#AP=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD M.R!&3TY4+5-)6D4Z(#%P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;B<@F4] M,T0Q/B9N8G-P.SPO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(&-E;G1EF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3DF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/B0\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S M<#L\+V9O;G0^/"]P/CPO=&0^/"]TF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/C$L-30R/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ M(')I9VAT)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)U!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/C0T/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/C8V/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!A M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO M=&0^/"]T6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T* M/'1R/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0@,3!P=#L@5$58 M5"U)3D1%3E0Z("TQ,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D]B M6QE M/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU224=(5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q-"4@8V]LF4],T0R/B@Q.3(\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@F4],T0R/BD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!A;&EG;CTS1')I M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`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`@F4] M,T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B;&4^#0H\<"!S M='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)' M24XZ(#!I;B`P:6X@,'!T)SX\:3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;B<@2!A;F0@97%U:7!M96YT(&%R92!S M=&%T960@870@8V]S="!A;F0@9&5P65A'!E;G-E(&%S(&EN8W5R2!A;F0@97%U:7!M96YT(&-O;G-I6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@F4],T0Q/B9N M8G-P.SPO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T)/4D1%4BU224=(5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q-"4@8V]L6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4 M+5-)6D4Z(#AP=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU224=(5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q-"4@8V]L M6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#AP=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@F4],T0Q/B9N8G-P.SPO9F]N=#X\+V(^/"]P/CPO=&0^ M/"]TF4] M,T0Q/B9N8G-P.SPO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU224=(5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-) M6D4Z(#AP=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE M/3-$)U!!1$1)3D6QE/3-$)T9/3E0M5T5)1TA4.B!B M;VQD.R!&3TY4+5-)6D4Z(#%P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;B<@F4],T0Q/B9N8G-P.SPO9F]N=#X\+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;B<@F4],T0R/C4L-3`V/"]F;VYT/CPO<#X\ M+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@F4],T0R/C4L,#6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!A;&EG;CTS1')I9VAT M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1%6%0M M04Q)1TXZ(')I9VAT)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)U!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,7!T M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;F)S M<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!A;&EG;CTS1')I9VAT M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B9N8G-P M.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R/@T*/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0@,3!P=#L@5$585"U)3D1%3E0Z("TQ,'!T)SX\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DQE87-E:&]L9"!);7!R;W9E;65N=',@/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU224=(5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q-"4@8F=C M;VQOF4],T0R/C(R.#PO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"="3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+5))1TA4 M.B`P:6X[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4Q%1E0Z M(#!I;CL@0D%#2T=23U5.1#H@(V-C965F9CL@4$%$1$E.1RU"3U143TTZ(#!I M;CL@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!724142#H@,30N-C8E.R!0 M041$24Y'+51/4#H@,&EN.R!"3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P M="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,30E(&)G8V]L;W(] M,T0C0T-%149&(&-O;'-P86X],T0R/@T*/'`@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`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`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;B<@F4],T0R/BD\+V9O;G0^/"]P/CPO=&0^/"]T2!A M;F0@17%U:7!M96YT+"!.970@/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU224=(5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T)/4D1%4BU224=(5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,BXR-7!T(&1O M=6)L92<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3,E/@T*/'`@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+5))1TA4.B`P:6X[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE M.R!0041$24Y'+4Q%1E0Z(#!I;CL@4$%$1$E.1RU"3U143TTZ(#!I;CL@0D]2 M1$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!724142#H@,2XS)3L@4$%$1$E.1RU4 M3U`Z(#!I;CL@0D]21$52+4)/5%1/33H@=VEN9&]W=&5X="`R+C(U<'0@9&]U M8FQE)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"CQP('-T>6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@'0@,7!T('-O;&ED.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M4$%$1$E.1RU"3U143TTZ(#!I;CL@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!724142#H@,3,N,S8E.R!0041$24Y'+51/4#H@,&EN.R!"3U)$15(M0D]4 M5$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$S)3X-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^/"]TF4],T0R/DEN=&%N9VEB;&4@07-S971S/"]F M;VYT/CPO:3X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T M)SX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^ M#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN=&%N9VEB;&4@87-S971S(&%R92!S=&%T960@ M870@8V]S="!A;F0@8V]N6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;B<@F4],T0Q/B9N8G-P.SPO9F]N=#X\+V(^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T)/4D1%4BU224=(5#H@;65D:75M(&YO;F4[ M(%!!1$1)3D'0@,7!T('-O;&ED M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q-"4@8V]L6QE/3-$)T9/3E0M M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#AP=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)T)/4D1%4BU224=(5#H@;65D:75M(&YO;F4[(%!!1$1)3D'0@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q-"4@8V]L6QE/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!& M3TY4+5-)6D4Z(#AP=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@ MF4],T0Q/B9N8G-P.SPO M9F]N=#X\+V(^/"]P/CPO=&0^/"]TF4],T0Q/B9N8G-P.SPO9F]N=#X\+V(^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU224=(5#H@;65D:75M M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M5T5) M1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#AP=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;B<@6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#%P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@F4],T0Q/B9N8G-P.SPO9F]N=#X\+V(^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1%6%0M M04Q)1TXZ(')I9VAT)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;B<@F4],T0R/C(P-CPO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[ M(%!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X\+W1R M/@T*/'1R/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0@,3!P=#L@ M5$585"U)3D1%3E0Z("TQ,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/DQEF%T:6]N(#PO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"="3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+5)) M1TA4.B`P:6X[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4Q% M1E0Z(#!I;CL@4$%$1$E.1RU"3U143TTZ(#!I;CL@0D]21$52+4Q%1E0Z(&UE M9&EU;2!N;VYE.R!724142#H@,30N-C8E.R!0041$24Y'+51/4#H@,&EN.R!" M3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,30E(&-O;'-P86X],T0R/@T*/'`@F4],T0R/BD\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(')I9VAT M)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,7!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF;F)S<#L\+V9O;G0^/"]P/CPO=&0^#0H\=&0@'0@,BXR-7!T(&1O M=6)L92<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@8F=C;VQOF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ MF4],T0R/C$V,#PO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3DF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"="3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+5))1TA4 M.B`P:6X[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4Q%1E0Z M(#!I;CL@0D%#2T=23U5.1#H@(V-C965F9CL@4$%$1$E.1RU"3U143TTZ(#!I M;CL@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!724142#H@,2XS)3L@4$%$ M1$E.1RU43U`Z(#!I;CL@0D]21$52+4)/5%1/33H@=VEN9&]W=&5X="`R+C(U M<'0@9&]U8FQE)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!B9V-O;&]R M/3-$(T-#145&1CX-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;B<@'0@,7!T('-O M;&ED.R!0041$24Y'+4Q%1E0Z(#!I;CL@0D%#2T=23U5.1#H@(V-C965F9CL@ M4$%$1$E.1RU"3U143TTZ(#!I;CL@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE M.R!724142#H@,3,N,S8E.R!0041$24Y'+51/4#H@,&EN.R!"3U)$15(M0D]4 M5$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$S)2!B9V-O;&]R/3-$(T-#145&1CX-"CQP('-T>6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0@,RXU M:6X[(%1%6%0M24Y$14Y4.B`P+C5I;B<^/&9O;G0@F4],T0R/D1E9F5R&%B;&4@=&5M<&]R87)Y(&1I M9F9E"!B87-E2!A('9A M;'5A=&EO;B!A;&QO=V%N8V4@=VAE;BP@:6X@=&AE(&]P:6YI;VX@;V8@;6%N M86=E;65N="P@:70@:7,@;6]R92!L:6ME;'D@=&AA;B!N;W0@=&AA="!S;VUE M('!OF5D+B9N8G-P.R!$969E"!L87=S(&%N9"!R871E6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@&%M:6YA=&EO;BP@:6YC M;'5D:6YG('1H92!R97-O;'5T:6]N(&]F(&%P<&5A;',@;W(@;&ET:6=A=&EO M;B!P2XF;F)S<#L@5&%X('!O2XF;F)S<#L@5&AE('!O6%B;&4@=&\@=&AE('1A>&EN M9R!A=71H;W)I=&EEF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=- M05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/DEN=&5R97-T(&%N9"!P96YA;'1I97,@87-S;V-I871E9"!W:71H('5N6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQI/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U35%E,13H@:71A;&EC.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY2979E;G5E M(%)E8V]G;FET:6]N/"]F;VYT/CPO:3X\+W`^#0H\<"!S='EL93TS1"=-05)' M24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B9N M8G-P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@ M,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/E=E(')E8V]G;FEZ92!R M979E;G5E(&%T('1H92!T:6UE(&]F('-H:7!M96YT(&]F('!R;V1U8W1S+"!W M:&5N('1H92!F;VQL;W=I;F<@9G5N9&%M96YT86P@8W)I=&5R:6$@87)E(&UE M=#H@*&DI)FYB2!H87,@;V-C=7)R960[ M("AI:6DI)FYB6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;B<@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@2!T:&4@ M6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M=#L@1D].5"U35%E,13H@:71A;&EC.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY-87)K971I;F<@86YD($%D=F5R=&ES:6YG/"]F M;VYT/CPO:3X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T M)SX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B9N8G-P.SPO9F]N=#X\+W`^ M#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E=E(&5X<&5N&EM871E M;'D@)#`N,2!M:6QL:6]N(&%N9"`D,"XR(&UI;&QI;VXL(')E2XF;F)S<#L@36%R:V5T:6YG(&%N9"!A9'9E2`D,"XS(&UI;&QI;VX@86YD M("0P+C4@;6EL;&EO;BP@F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)' M24XZ(#!I;B`P:6X@,'!T)SX\:3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;B<@F4],T0R/B9N8G-P.SPO9F]N=#X\ M+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D-O;7!E;G-A=&EO;B!C;W-T(&9O'!E8W1E9"!T;R!V97-T+B!4 M:&4@9F%I6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;B<@6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0G/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U35%E,13H@:71A;&EC.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY,;W-S(%!E6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;B<@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQI/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U35%E,13H@:71A;&EC.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY,96=A;"!0F4],T0R/B9N8G-P.SPO9F]N=#X\+W`^#0H\<"!S M='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\:3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;B<@'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^ M/'1A8FQE('-T>6QE/3-$)V9O;G0M3HG M5&EM97,@3F5W(%)O;6%N)RQT:6UE3X-"CQD:78@86QI9VX],T1L969T/C,N($-! M4$E404P@4U1/0TL@/"]D:78^/"]D:78^#0H\(2TM('AB2`M+3X- M"CQD:78@6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0[($9/ M3E0M4TE:13H@,3!P="<@86QI9VX],T1J=7-T:69Y/D]N($UA6QE/3-$)TU!4D=) M3BU43U`Z(#$P<'0[($9/3E0M4TE:13H@,3!P="<@86QI9VX],T1J=7-T:69Y M/CQI/D-A<&ET86P@4W1O8VL@27-S=65D/"]I/B`\+V1I=CX-"CQD:78@6QE/3-$)TU! M4D=)3BU43U`Z(#$P<'0G/@T*/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS M1#$P,"4@8F]R9&5R/3-$,#X-"CQTF4Z(#$P M<'0[(&)A8VMG6QE/3-$ M)U1%6%0M04Q)1TXZ(&IU6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0G/@T*/'1A8FQE M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<@8V5L;'-P86-I;F<],T0P(&-E M;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@8F]R9&5R/3-$,#X-"CQT6QE/3-$)U1%6%0M04Q)1TXZ(&IU65E6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0G/@T* M/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<@8V5L;'-P86-I;F<] M,T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@8F]R9&5R/3-$,#X- M"CQTF4Z(#$P<'0[(&)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0[($9/3E0M4TE:13H@,3!P="<@86QI M9VX],T1J=7-T:69Y/CQI/E9A;'5A=&EO;B!!6QE/3-$)TU!4D=)3BU4 M3U`Z(#$P<'0[($9/3E0M4TE:13H@,3!P="<@86QI9VX],T1J=7-T:69Y/D1U M&5R8VES960@:7,@)#`N,B9N8G-P.VUI M;&QI;VXN($1UF4Z(#$P<'0[)R!V86QI9VX],T1B;W1T;VT^#0H\=&0^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED)R!N;W=R87`],T1N;W=R87`@86QI9VX],T1C M96YT97(@8V]L2`Q-"P@,C`Q,3PO=&0^#0H\=&0^ M)FYB6QE/3-$)V)A8VMG6QE/3-$ M)TU!4D=)3BU,1494.B`Q-7!X.R!415A4+4E.1$5.5#H@+3$U<'@G/D%V97)A M9V4@#L@ M5$585"U)3D1%3E0Z("TQ-7!X)SY!=F5R86=E(&5X<&5C=&5D(&QI9F4@*&EN M('EE87)S*3PO9&EV/CPO=&0^#0H\=&0^)FYB"<^5F]L871I;&ET M>3PO9&EV/CPO=&0^#0H\=&0^)FYB6QE/3-$)T)! M0TM'4D]53D0Z(&YO;F4@=')A;G-P87)E;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)TU!4D=)3BU43U`Z M(#$P<'0G/@T*/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<@8V5L M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@8F]R M9&5R/3-$,#X-"CQTF4Z(#$P<'0[(&)A8VMG M2<^/&D^17AP96-T960@5&5R;3H@ M/"]I/E=E(&5L96-T960@=&\@=7-E('1H92`F(S$T-SMS:6UP;&EF:65D(&UE M=&AO9"8C,30X.R!A6QE/3-$)V9O;G0M'!E M8W1E9"!$:79I9&5N9#H@/"]I/E=E(&AA=F4@;F]T('!A:60@86YY(&1I=FED M96YD6QE/3-$)T)!0TM'4D]5 M3D0Z(&YO;F4@=')A;G-P87)E;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&IUF5R;RUC;W5P;VX@:7-S=65S('=I=&@@2!O=7(@8F]A M65A&5R8VES97,@=VET:"!N97=L>2!I3X-"CQD:78@86QI9VX],T1L969T/E1H92!F;VQL;W=I;F<@:7,@ M82!S=6UM87)Y(&]F('-T;V-K(&]P=&EO;B!A8W1I=FET>2`H/&D^:6X@=&AO M=7-A;F1S/"]I/BP@/&D^97AC97!T('!E6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M"!S;VQI9"<@;F]W"<^3W5T"<^1W)A;G1E9"!A="!F86ER('9A M;'5E/"]D:78^/"]T9#X-"CQT9#XF;F)S<#L\+W1D/@T*/'1D/B9N8G-P.SPO M=&0^#0H\=&0@86QI9VX],T1R:6=H=#XS,#`\+W1D/@T*/'1D/B9N8G-P.SPO M=&0^#0H\=&0^)FYB"<^17AE6QE/3-$)TU! M4D=)3BU,1494.B`S,'!X.R!415A4+4E.1$5.5#H@+3$U<'@G/D-A;F-E;&5D M+V9O"<^)FYB M6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)R!N;W=R87`],T1N;W=R M87`@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,CXF;F)S<#L\+W1D/@T*/'1D M/B9N8G-P.SPO=&0^#0H\=&0^)FYB6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)R!N;W=R87`],T1N;W=R87`@86QI M9VX],T1R:6=H="!C;VQS<&%N/3-$,CXF;F)S<#L\+W1D/@T*/'1D/B9N8G-P M.SPO=&0^/"]T#L@5$585"U)3D1%3E0Z("TQ-7!X)SY/=71S=&%N9&EN M9R8C,34Q.U-E<'1E;6)E6QE/3-$)V9O;G0M6QE/3-$)TU!4D=)3BU,1494.B`Q-7!X.R!415A4+4E.1$5.5#H@+3$U<'@G M/B9N8G-P.SPO9&EV/CPO=&0^#0H\=&0^)FYB6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<@;F]W"<^3W!T:6]N&5R8VES86)L92!A="!397!T96UB97(@ M,S`\+V1I=CX\+W1D/@T*/'1D/B9N8G-P.SPO=&0^#0H\=&0^)FYB#L@5$585"U)3D1%3E0Z("TQ-7!X)SXF;F)S M<#L\+V1I=CX\+W1D/@T*/'1D/B9N8G-P.SPO=&0^#0H\=&0@"!D;W5B;&4G(&YO=W)A<#TS1&YO=W)A M<"!A;&EG;CTS1')I9VAT(&-O;'-P86X],T0R/B9N8G-P.SPO=&0^#0H\=&0^ M)FYB6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<@;F]W3Y4:&4@9F]L;&]W:6YG('1A8FQE('-U;6UA&-E<'0@<&5R('-H87)E(&1A M=&$I.CPO:3X@/"]D:78^#0H\9&EV(&%L:6=N/3-$8V5N=&5R/@T*/'1A8FQE M('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<@8V5L;'-P86-I;F<],T0P(&-E M;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@8F]R9&5R/3-$,#X\(2TM($)E M9VEN(%1A8FQE($AE860@+2T^#0H\='(@=F%L:6=N/3-$8F]T=&]M/@T*/'1D M('=I9'1H/3-$,C`E/B9N8G-P.SPO=&0^#0H\=&0@=VED=&@],T0S)3XF;F)S M<#L\+W1D/@T*/'1D('=I9'1H/3-$,24^)FYB6QE/3-$)V9O;G0M M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#$P<'0[)R!V86QI9VX],T1B;W1T;VT^#0H\=&0^)FYB6QE/3-$)V9O;G0M&5R8VES92!06QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED)R!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED)R!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@ M8V]L6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!N;W=R87`],T1N;W=R87`@ M86QI9VX],T1C96YT97(@8V]L#L@5$585"U)3D1%3E0Z("TQ-7!X)SXD,"XP("T@)#4N,S$\ M+V1I=CX\+W1D/@T*/'1D/B9N8G-P.SPO=&0^#0H\=&0^)FYB"<^)#4N,S(@+2`D,C(N-#`\+V1I=CX\+W1D/@T*/'1D/B9N8G-P.SPO M=&0^#0H\=&0^)FYB3Y4:&4@86=G6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0[($9/3E0M4TE:13H@,3!P M="<@86QI9VX],T1J=7-T:69Y/CQI/D-O;6UO;B!3=&]C:R!787)R86YT6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0[($9/ M3E0M4TE:13H@,3!P="<@86QI9VX],T1J=7-T:69Y/DEN(&-O;FYE8W1I;VX@ M=VET:"!T:&4@:7-S=64@;V8@,BPU.38L-3`P('-H87)E29N8G-P M.S,Q+"`R,#$V+B`\+V1I=CX-"CQD:78@6QE/3-$)V9O;G0MF4Z(#$P<'0[)R!V86QI9VX],T1B;W1T;VT^#0H\=&0^ M)FYB6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!N;W=R87`],T1N;W=R M87`@86QI9VX],T1C96YT97(@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED)R!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L#L@5$585"U)3D1%3E0Z("TQ-7!X)SY/=71S=&%N9&EN9R8C,34Q.R!*86YU M87)Y)FYB6QE/3-$)TU!4D=)3BU,1494.B`S,'!X.R!415A4+4E.1$5.5#H@+3$U<'@G M/DES6QE/3-$)V)A M8VMG6QE/3-$)TU!4D=)3BU,1494.B`S,'!X.R!415A4+4E.1$5.5#H@ M+3$U<'@G/D5X97)C:7-E9#PO9&EV/CPO=&0^#0H\=&0^)FYBF4Z(#%P>#LG/@T*/'1D/@T*/&1I=B!S='EL93TS1"=- M05)'24XM3$5&5#H@,35P>#L@5$585"U)3D1%3E0Z("TQ-7!X)SXF;F)S<#L\ M+V1I=CX\+W1D/@T*/'1D/B9N8G-P.SPO=&0^#0H\=&0@6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)R!N;W=R87`],T1N;W=R87`@86QI M9VX],T1R:6=H="!C;VQS<&%N/3-$,CXF;F)S<#L\+W1D/@T*/'1D/B9N8G-P M.SPO=&0^#0H\=&0^)FYB"<^ M3W5TF4Z M(#%P>#LG/@T*/'1D/@T*/&1I=B!S='EL93TS1"=-05)'24XM3$5&5#H@,35P M>#L@5$585"U)3D1%3E0Z("TQ-7!X)SXF;F)S<#L\+V1I=CX\+W1D/@T*/'1D M/B9N8G-P.SPO=&0^#0H\=&0@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,W!X(&1O=6)L92<@;F]W#L@ M5$585"U)3D1%3E0Z("TQ-7!X)SY787)R86YT&5R8VES86)L92!A="!E M;F0@;V8@<&5R:6]D/"]D:78^/"]T9#X-"CQT9#XF;F)S<#L\+W1D/@T*/'1D M/B9N8G-P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H=#XQ+#@X-SPO=&0^#0H\ M=&0^)FYB"<^)FYB6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<@ M;F]W6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<@;F]W M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A&)R;"QB;V1Y("TM M/@T*/&1I=B!S='EL93TS1"=-05)'24XM5$]0.B`Q,'!T.R!&3TY4+5-)6D4Z M(#$P<'0G(&%L:6=N/3-$:G5S=&EF>3X\:3Y696YT=7)E($QO86X@4&%Y86)L M93PO:3X@/"]D:78^#0H\9&EV('-T>6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0[ M($9/3E0M4TE:13H@,3!P="<@86QI9VX],T1J=7-T:69Y/D]N($1E8V5M8F5R M)FYBF]N($9U;F1I;F<@0V]M M<&%N>2P@3$Q#("AT:&4@)B,Q-#<[3&5N9&5R)B,Q-#@[(&]R("8C,30W.TAO M2!I;G1E M6UE;G1S M(&9O2!I;G1EF4Z(#$P M<'0[)R!V86QI9VX],T1B;W1T;VT^#0H\=&0^)FYB6QE/3-$)V)A8VMG6QE/3-$)TU!4D=)3BU,1494.B`Q-7!X M.R!415A4+4E.1$5.5#H@+3$U<'@G/D5X<&5C=&5D($QI9F4\+V1I=CX\+W1D M/@T*/'1D/B9N8G-P.SPO=&0^#0H\=&0@86QI9VX],T1R:6=H="!C;VQS<&%N M/3-$,CXW('EE87)S/"]T9#X-"CQT9#XF;F)S<#L\+W1D/CPO='(^#0H\='(@ M=F%L:6=N/3-$8F]T=&]M/@T*/'1D/@T*/&1I=B!S='EL93TS1"=-05)'24XM M3$5&5#H@,35P>#L@5$585"U)3D1%3E0Z("TQ-7!X)SY%>'!E8W1E9"!V;VQA M=&EL:71Y/"]D:78^/"]T9#X-"CQT9#XF;F)S<#L\+W1D/@T*/'1D(&YO=W)A M<#TS1&YO=W)A<"!A;&EG;CTS1&QE9G0^)FYB6QE/3-$)V)A8VMG6QE/3-$)TU!4D=)3BU, M1494.B`Q-7!X.R!415A4+4E.1$5.5#H@+3$U<'@G/D1I=FED96YD6QE/3-$)TU!4D=) M3BU,1494.B`Q-7!X.R!415A4+4E.1$5.5#H@+3$U<'@G/E)I6QE/3-$)TU! M4D=)3BU43U`Z(#$P<'0[($9/3E0M4TE:13H@,3!P="<@86QI9VX],T1J=7-T M:69Y/D%LF5D('1O(&EN=&5R97-T(&5X<&5N6QE/3-$)TU!4D=)3BU43U`Z(#$P M<'0[($9/3E0M4TE:13H@,3!P="<@86QI9VX],T1J=7-T:69Y/CQI/E!R;VUI M6QE/3-$)TU!4D=)3BU4 M3U`Z(#$P<'0[($9/3E0M4TE:13H@,3!P="<@86QI9VX],T1J=7-T:69Y/E=E M('-I9VYE9"!A('!R;VUI65A29N8G-P.S(T+"`R,#$Q+B!);B!C;VYN96-T:6]N('=I=&@@=&AE M(&ES2!R97-T M65A&EM=6T@861D:71I;VYA;"!S:&%R97,@;V8@,C4N-C`V('!EF5D('1O(&EN=&5R97-T(&5X<&5N6QE/3-$)TU!4D=) M3BU43U`Z(#$P<'0[($9/3E0M4TE:13H@,3!P="<@86QI9VX],T1J=7-T:69Y M/D%L29N8G-P.S$X+"`R,#$Q('!U&-H M86YG92!#;VUM:7-S:6]N("AT:&4@)B,Q-#<[4T5#)B,Q-#@[*2!R96=I6EN9R!T:&4@3F]T97,N(%1H92!R96=I M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V M8SDY8V-F-%]E,S1F7S0U93!?8C,V-U]D.&8Y9C8S.3(X8C@-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F,Y.6-C9C1?93,T9E\T-64P7V(S-C=? M9#AF.68V,SDR.&(X+U=O'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ MF4Z,3!P=#L@9F]N="UF86UI;'DZ)U1I;65S($YE=R!2 M;VUA;B2`M+3X-"CQD:78@6UO=7(L($EN9&EA;F$@86YD($(F(S(T-CMN96XL($=E M6EN9R!T:&5S92!T:')E92!F86-I M;&ET:65S(&%R92!S=6UM87)I>F5D(&)E;&]W.B`\+V1I=CX-"CQD:78@2`\+VD^)B,Q-3$[ M(%1H92!%;"!396=U;F1O(&9A8VEL:71Y(&-O;G-I&EM M871E;'D@-2PT-S4@2!R96YT(&ES("0Q,RPQ,C0L('=I=&@@,R4@86YN=6%L(&5S8V%L871I;VXN M(#PO9&EV/@T*/&1I=B!S='EL93TS1"=-05)'24XM5$]0.B`Q,'!T.R!&3TY4 M+5-)6D4Z(#$P<'0G(&%L:6=N/3-$:G5S=&EF>3X\:3Y);F1I86YA($9A8VEL M:71Y("8C,34Q.R`\+VD^5&AE(%-E>6UO=7(@9F%C:6QI='D@8V]N2`Q,#4L,#`P('-Q=6%R92!F965T('5S960@87,@ M82!M86YU9F%C='5R:6YG(&%N9"!D:7-T29N8G-P.S(P,3@N($]U3PO:3XF(S$U,3L@5&AE($(F(S(T-CMN96X@9F%C M:6QI='D@8V]N2`Q+#`P,"!S<75A2!R96YT'!I3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V8SDY8V-F-%]E,S1F7S0U M93!?8C,V-U]D.&8Y9C8S.3(X8C@-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-F,Y.6-C9C1?93,T9E\T-64P7V(S-C=?9#AF.68V,SDR.&(X+U=O M'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0[($9/3E0M4TE: M13H@,3!P="<@86QI9VX],T1J=7-T:69Y/E1H92!F;VQL;W=I;F<@8W5S=&]M M97)S(&%C8V]U;G1E9"!F;W(@,3`E(&]R(&UO6QE/3-$)T9/3E0M4TE:13H@,3!P="<@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4@ M8F]R9&5R/3-$,#X\(2TM($)E9VEN(%1A8FQE($AE860@+2T^#0H\='(@=F%L M:6=N/3-$8F]T=&]M/@T*/'1D('=I9'1H/3-$-#0E/B9N8G-P.SPO=&0^#0H\ M=&0@=VED=&@],T0S)3XF;F)S<#L\+W1D/@T*/'1D('=I9'1H/3-$,24^)FYB M"!S;VQI9"<@;F]WF4Z(#$P<'0[)R!V M86QI9VX],T1B;W1T;VT^#0H\=&0^)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED)R!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED)R!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED)R!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED)R!N;W=R87`],T1N;W=R87`@86QI9VX],T1C96YT97(@8V]L6QE/3-$)V)A8VMG6QE/3-$)TU!4D=)3BU,1494.B`Q-7!X.R!415A4 M+4E.1$5.5#H@+3$U<'@G/D-U6QE/3-$)TU!4D=) M3BU,1494.B`Q-7!X.R!415A4+4E.1$5.5#H@+3$U<'@G/D-U#L@5$585"U)3D1%3E0Z("TQ-7!X)SY#=7-T;VUE M6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0[($9/3E0M4TE:13H@,3!P="<@ M86QI9VX],T1J=7-T:69Y/D]U6QE/3-$)T9/3E0M4TE: M13H@,3!P="<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T M:#TS1#$P,"4@8F]R9&5R/3-$,#X\(2TM($)E9VEN(%1A8FQE($AE860@+2T^ M#0H\='(@=F%L:6=N/3-$8F]T=&]M/@T*/'1D('=I9'1H/3-$-#0E/B9N8G-P M.SPO=&0^#0H\=&0@=VED=&@],T0S)3XF;F)S<#L\+W1D/@T*/'1D('=I9'1H M/3-$,24^)FYBF4Z(#$P<'0[)R!V86QI9VX],T1B;W1T;VT^#0H\=&0^)FYB6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED)R!N;W=R87`],T1N;W=R87`@86QI9VX] M,T1C96YT97(@8V]L6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED)R!N;W=R87`],T1N;W=R87`@86QI9VX] M,T1C96YT97(@8V]L6QE/3-$)V)A8VMG6QE/3-$)TU!4D=)3BU, M1494.B`Q-7!X.R!415A4+4E.1$5.5#H@+3$U<'@G/DYO"<^26YT97)N871I;VYA;#PO9&EV/CPO=&0^#0H\=&0^ M)FYB6QE/3-$)V)A8VMG6QE/3-$)TU!4D=)3BU,1494.B`T M-7!X.R!415A4+4E.1$5.5#H@+3$U<'@G/DET86QY/"]D:78^/"]T9#X-"CQT M9#XF;F)S<#L\+W1D/@T*/'1D/B9N8G-P.SPO=&0^#0H\=&0@86QI9VX],T1R M:6=H=#XU+#(V,CPO=&0^#0H\=&0^)FYB"<^3W1H97(\+V1I M=CX\+W1D/@T*/'1D/B9N8G-P.SPO=&0^#0H\=&0^)FYB6QE/3-$)V9O;G0M6QE/3-$)TU!4D=)3BU,1494.B`Q-7!X.R!415A4+4E.1$5.5#H@+3$U M<'@G/B9N8G-P.SPO9&EV/CPO=&0^#0H\=&0^)FYB6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)R!N;W=R87`],T1N M;W=R87`@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,CXF;F)S<#L\+W1D/@T* M/'1D/B9N8G-P.SPO=&0^#0H\=&0^)FYB6QE/3-$)TU!4D=)3BU, M1494.B`Q-7!X.R!415A4+4E.1$5.5#H@+3$U<'@G/B9N8G-P.SPO9&EV/CPO M=&0^#0H\=&0^)FYB6QE/3-$)V)A8VMG6QE/3-$)TU!4D=) M3BU,1494.B`S,'!X.R!415A4+4E.1$5.5#H@+3$U<'@G/D=R;W-S('-A;&5S M/"]D:78^/"]T9#X-"CQT9#XF;F)S<#L\+W1D/@T*/'1D(&%L:6=N/3-$;&5F M=#XD/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT/C4L-#$T/"]T9#X-"CQT9#XF M;F)S<#L\+W1D/@T*/'1D/B9N8G-P.SPO=&0^#0H\=&0@;F]W6QE/3-$ M)V9O;G0M6QE/3-$)TU!4D=) M3BU,1494.B`Q-7!X.R!415A4+4E.1$5.5#H@+3$U<'@G/B9N8G-P.SPO9&EV M/CPO=&0^#0H\=&0^)FYB6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`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`Z M(",P,#`P,#`@,7!X('-O;&ED)R!N;W=R87`],T1N;W=R87`@86QI9VX],T1R M:6=H="!C;VQS<&%N/3-$,CXF;F)S<#L\+W1D/@T*/'1D/B9N8G-P.SPO=&0^ M#0H\=&0^)FYB#L@5$585"U) M3D1%3E0Z("TQ-7!X)SXF;F)S<#L\+V1I=CX\+W1D/@T*/'1D/B9N8G-P.SPO M=&0^#0H\=&0^)FYB6QE/3-$)TU!4D=)3BU, M1494.B`S,'!X.R!415A4+4E.1$5.5#H@+3$U<'@G/D=R;W-S('-A;&5S/"]D M:78^/"]T9#X-"CQT9#XF;F)S<#L\+W1D/@T*/'1D(&%L:6=N/3-$;&5F=#XD M/"]T9#X-"CQT9"!A;&EG;CTS1')I9VAT/C(P+#@T.3PO=&0^#0H\=&0^)FYB MF4Z(#%P>#LG/@T*/'1D/@T*/&1I=B!S='EL93TS1"=-05)'24XM M3$5&5#H@,35P>#L@5$585"U)3D1%3E0Z("TQ-7!X)SXF;F)S<#L\+V1I=CX\ M+W1D/@T*/'1D/B9N8G-P.SPO=&0^#0H\=&0@"!D;W5B;&4G(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS M1')I9VAT(&-O;'-P86X],T0R/B9N8G-P.SPO=&0^#0H\=&0^)FYB6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,W!X(&1O=6)L92<@;F]W3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V8SDY8V-F-%]E M,S1F7S0U93!?8C,V-U]D.&8Y9C8S.3(X8C@-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-F,Y.6-C9C1?93,T9E\T-64P7V(S-C=?9#AF.68V,SDR M.&(X+U=O'0O:'1M;#L@8VAA6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0[($9/3E0M M4TE:13H@,3!P="<@86QI9VX],T1J=7-T:69Y/E=E(&%R92!S=6)J96-T('1O M(%4N4RX@86YD($-A;&EF;W)N:6$@:6YC;VUE('1A>"X@4W5B:F5C="!T;R!L M:6UI=&5D('-T871U=&]R>2!E>&-E<'1I;VYS+"!W92!A"!A=71H;W)I=&EE M65A"!E>&%M:6YA=&EO;G,@8GD@=&AE($EN=&5R;F%L(%)E M=F5N=64@4V5R=FEC92X@3F\@1&5F97)R960@5&%X($%S2!IF4@:6YT97)E'!E M;G-E'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'1A8FQE('-T>6QE/3-$)V9O;G0M3HG5&EM97,@3F5W(%)O;6%N)RQT:6UE3X-"CQD:78@86QI9VX],T1L969T M/C@N(%-50E-%455%3E0@159%3E13(#PO9&EV/CPO9&EV/@T*/"$M+2!X8G)L M+&)O9'D@+2T^#0H\9&EV('-T>6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0[($9/ M3E0M4TE:13H@,3!P="<@86QI9VX],T1J=7-T:69Y/CQI/E!U3Y%9F9E8W1I=F4@3V-T;V)E2!O=VYE9"!S=6)S:61I87)Y M+"!C;VUP;&5T960@:71S(&%C<75I6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0G/@T*/'1A8FQE('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<@8V5L;'-P86-I;F<],T0P(&-E;&QP M861D:6YG/3-$,"!W:61T:#TS1#$P,"4@8F]R9&5R/3-$,#X-"CQTF4Z(#$P<'0[(&)A8VMG2<^36]R=&=A9V4@;&]A;B!W:71H($)A;F-A($UO;G1E($1E:2!0 M87-C:&D@1&D@4VEE;FYA(%,N<"Y!(&9O2!P87EM96YT3L@ M)B,Q,C@[-#`P+#`P,"`H)#4U-2PS-C`I(&]F('1H92!P2!%=7)O9FED:2!T:')O=6=H($1E8V5M8F5R)FYB6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0G/@T*/'1A8FQE('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3!P="<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG M/3-$,"!W:61T:#TS1#$P,"4@8F]R9&5R/3-$,#X-"CQTF4Z(#$P<'0[(&)A8VMG2<^0W)E9&ET(&9A8VEL:71Y('=I=&@@26YT97-A(%-A;G!A;VQO(&9O2!I6QE/3-$)V9O;G0M6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0[($9/3E0M4TE:13H@,3!P="<@86QI M9VX],T1J=7-T:69Y/E=E(&5S=&EM871E('1H870@:6X@861D:71I;VX@=&\@ M=&AE('!U6QE/3-$)TU!4D=)3BU43U`Z(#$P<'0[($9/ M3E0M4TE:13H@,3!P="<@86QI9VX],T1J=7-T:69Y/CQI/E)E9VES=&5R960@ M1&ER96-T($]F9F5R:6YG/"]I/B`\+V1I=CX-"CQD:78@F%R9"!#87!I=&%L($UA28C,30V.W,@8V]M;6]N('-T;V-K+B!4:&4@2!A;F0@96%C:"!O9B!T:&4@:6YV97-T M;W)S(&EN('1H:7,@;V9F97)I;F2!O9B!A<'!R;WAI;6%T96QY("0U+#`P,"PP M,#`L(&)E9F]R92!D961U8W1I;F<@=&AE('!L86-E;65N="!A9V5N=',F(S$T M-CL@9F5E6%B M;&4@8GD@=7,N(%1H92!N970@;V9F97)I;F<@<')O8V5E9',@=&\@=&AE($-O M;7!A;GD@9G)O;2!T:&4@2!T:&4@ M0V]M<&%N>2P@87)E(&5X<&5C=&5D('1O(&)E(&%P<')O>&EM871E;'D@)#0L M,S0U+#`P,"X@/"]D:78^#0H\9&EV('-T>6QE/3-$)TU!4D=)3BU43U`Z(#$P M<'0[($9/3E0M4TE:13H@,3!P="<@86QI9VX],T1J=7-T:69Y/E1H92!P97(@ M2!T:6UE(&]N M(&]R(&%F=&5R('1H92!D871E('1H870@:7,@,3@P(&1A>7,@869T97(@=&AE M(&EN:71I86P@:7-S=6%N8V4@;VX@=&AE(&1A=&4@;V8@8VQO'!I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!296=I2!#96YT3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,#`P,3,R-#'0^,3`M M43QS<&%N/CPO'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&-H86YG92!#;VUM:7-S:6]N(&]N($YO=F5M8F5R(#$T+"`R,#$Q M("AT:&4@/T9O'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^4VUA;&QE3QS<&%N/CPO'0^,C`Q M,3QS<&%N/CPO'0^43,\&UL/@T*+2TM+2TM/5].97AT4&%R=%\V8SDY8V-F-%]E,S1F7S0U 893!?8C,V-U]D.&8Y9C8S.3(X8C@M+0T* ` end XML 15 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
CAPITAL STOCK
9 Months Ended
Sep. 30, 2011
CAPITAL STOCK  
CAPITAL STOCK
3. CAPITAL STOCK
Reverse Stock Split
On March 15, 2010, we implemented a reverse split of our common stock on a 1-for-40 basis. The reverse split was effective at 6:00 a.m. on March 15, 2010. All historical and per share amounts have been adjusted to reflect the reverse stock split.
Capital Stock Issued
During the nine months ended September 30, 2011, we issued shares of common stock as follows:
   
We issued 2,596,500 shares of common stock and 649,128 warrants with an exercise price of $6.35 for gross proceeds of $12.3 million pursuant to a securities purchase agreement dated January 26, 2011 between us and each of the signatories thereto. We incurred stock issuance costs of $1.1 million.
   
We issued 35,000 shares of common stock pursuant to a warrant exercise for gross proceeds of $0.2 million.
   
We issued 165,796 shares of common stock valued at $0.7 million to various employees, directors, and third parties for services rendered during the period.
   
We issued 4,062 shares of common stock valued at $20,000 pursuant to a settlement agreement.
Valuation Assumptions for Stock Options
During the nine months ended September 30, 2011, we granted options to our employees to purchase an aggregate of 300,000 shares of our common stock, with estimated total grant-date fair values of $0.7 million. We estimate that stock-based compensation for awards not expected to be exercised is $0.2 million. During the three and nine months ended September 30, 2011, we recorded stock-based compensation related to stock options of $23,000 and $0.2 million, respectively. The grant date fair value was estimated at the date of grant using the Black-Scholes option pricing model, assuming no dividends and the following assumptions:
         
    January 14, 2011  
Average risk-free interest rate
    2.29 %
Average expected life (in years)
    6.0  
Volatility
    41.9 %
   
Expected Volatility: The fair values of stock based payments were valued using a volatility factor based on our historical stock prices.
   
Expected Term: We elected to use the “simplified method” as discussed in SAB No. 107 to develop the estimate of the expected term.
   
Expected Dividend: We have not paid any dividends and do not anticipate paying dividends in the foreseeable future.
   
Risk-Free Interest Rate: We base the risk-free interest rate used on the implied yield currently available on U.S. Treasury zero-coupon issues with remaining term equivalent to the expected term of the options.
Stock Option Activity
Under the 2004 Employee Stock Option Plan adopted by our board of directors (the “Plan”), our board of directors may issue incentive and non-qualified stock options to our employees. Options granted under the Plan generally expire at the end of five or ten years and vest in accordance with a vesting schedule determined by our board of directors, usually over three years from the grant date. As of September 30, 2011, we have 34,375 shares available for future grants under the Plan. We settle stock option exercises with newly issued shares of our common stock.
The following is a summary of stock option activity (in thousands, except per share data):
                                 
    2011     2010  
            Weighted             Weighted  
            Average             Average  
    Shares     Exercise Price     Shares     Exercise Price  
Outstanding—January 1
    73     $ 22.40       73     $ 22.40  
Granted at fair value
    300       5.31              
Exercised
                       
Canceled/forfeited
                       
 
                       
Outstanding—September 30
    373       8.65       73       22.40  
 
                       
Options exercisable at September 30
    133     $ 14.69       73     $ 22.40  
 
                       
The following table summarizes information about stock options as of September 30, 2011 (in thousands, except per share data):
                                                                 
    Options Outstanding     Options Exercisable  
                    Weighted                             Weighted        
            Weighted     Average                     Weighted     Average        
            Average     Remaining     Aggregate             Average     Remaining     Aggregate  
            Exercise     Contract     Intrinsic             Exercise     Contract     Intrinsic  
Range of Exercise Prices   Shares     Price     Life     Value     Shares     Price     Life     Value  
$0.0 - $5.31
    300     $ 5.31       9.42     $       60     $ 5.31       9.42     $  
$5.32 - $22.40
    73     $ 22.40       3.17     $       73     $ 22.40       3.17     $  
The aggregate intrinsic value in the table above represents the total pretax intrinsic value, based on our closing stock price of $2.80 at September 30, 2011 which would have been received by the option holders had all option holders exercised their options as of that date.
Common Stock Warrants
In connection with the issue of 2,596,500 shares of common stock to accredited investors pursuant to a securities purchase agreement entered into on January 26, 2011, we issued warrants to purchase 649,128 shares of our common stock. The warrants have an exercise price of $6.35 per share and are exercisable until July 31, 2016.
A summary of warrant activity is as follows (in thousands except per share data):
                                 
    2011     2010  
            Weighted             Weighted  
    Number of     Average     Number of     Average  
    Warrants     Exercise Price     Warrants     Exercise Price  
Outstanding— January 1,
    1,273     $ 4.44           $  
Issued
    649       6.35       1,133       4.44  
Exercised
    (35 )     4.44              
 
                       
Outstanding—September 30
    1,887     $ 5.09       1,133       4.44  
 
                       
Warrants exercisable at end of period
    1,887     $ 5.09       1,133     $ 4.44  
 
                       
XML 16 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
Sep. 30, 2011
Dec. 31, 2010
CONSOLIDATED BALANCE SHEETS    
Preferred Stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred Stock, shares authorized 5,000,000 5,000,000
Preferred Stock, shares outstanding 0 0
Common Stock, par value (in dollars per share) $ 0.001 $ 0.001
Common Stock, shares authorized 495,000,000 495,000,000
Common Stock, shares issued 15,793,553 12,992,195
Common Stock, shares outstanding 15,793,553 12,992,195
XML 17 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
ORGANIZATION AND LINE OF BUSINESS
9 Months Ended
Sep. 30, 2011
ORGANIZATION AND LINE OF BUSINESS  
ORGANIZATION AND LINE OF BUSINESS
1. ORGANIZATION AND LINE OF BUSINESS
Organization
We were incorporated on September 29, 2001 in the State of Nevada under the name Biocorp North America Inc. On March 18, 2005, we filed an amendment to our articles of incorporation to change our name to Cereplast, Inc. (the “Company”).
Line of Business
We have developed and are commercializing proprietary bio-based resins through two complementary product families: (1) Cereplast Compostables® resins which are renewable, ecologically sound substitutes for traditional petroleum-based non-compostable plastics and (2) Cereplast Sustainables® resins, which replace up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources. Our resins aim to be competitively priced compared to fully petroleum-based plastic resins and can be converted into finished products using conventional manufacturing equipment without significant additional capital investment by downstream converters.
The demand for non-petroleum based, clean and renewable sources for materials, such as bioplastics, and the demand for compostable/biodegradable products is each being driven globally by a variety of factors, including environmental concerns, new stringent regulations on compostable material, fossil fuel price volatility, and energy security. These factors have led to increased spending on clean and sustainable products by corporations and individuals as well as legislative initiatives at the local and state level.
We are a full-service resin solution provider uniquely positioned to capitalize on the rapidly increasing demand for sustainable and environmentally friendly alternatives to traditional plastic products.
We primarily conduct our operations through two product families:
   
Cereplast Compostables® resins are compostable and bio-based, ecologically sound substitutes for petroleum-based plastics targeting primarily compostable bags, single-use food service products and packaging applications. We offer 13 commercial grades of Compostables resins in this product line. These resins are compatible with existing manufacturing processes and equipment making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Compostables line in November 2006.
   
Cereplast Sustainables® resins are partially or fully bio-based, ecologically sound substitutes for fully petroleum-based plastics targeting primarily durable goods, packaging applications and applications other than single-use food service items. We offer six commercial grades of Sustainables resins in this product line. These resins are compatible with existing manufacturing processes and equipment, making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Sustainables line in late 2007 under the name “Cereplast Hybrid Resins®.”
   
Cereplast Hybrid Resins® replace up to 50% of the petroleum content in conventional plastics with bio-based materials such as industrial starches sourced from plants. The Hybrid resins line is designed to offer similar properties to traditional polyolefins such as impact strength and heat deflection temperature, and is compatible with existing converter processes and equipment. Cereplast Hybrid Resins® provide a viable alternative for brand owners and converters looking to partially replace petroleum-based resins in durable goods applications. Hybrid resins address this need in a wide range of markets, including automotive, consumer goods, consumer electronics, medical, packaging, and construction. We commercially introduced our first grade of Hybrid resin, Hybrid 150, at the end of 2007. We currently offer three commercial grades in this product line.
   
Cereplast Algae Plastic® resins. In October of 2009 we announced that we have been developing a new technology to transform algae into bioplastics and intend to launch a new resin family containing algae-based materials that will complement our existing line of resins. The first commercial product with Cereplast Algae Plastic® resin is now being produced and sold as part of our Sustainables resin family. We believe that it is important to enhance research on non-food crops as we expect a surge in demand in bioplastics in future years, thus potentially creating pressure on food crops. Algae is the first non-food crop project that we have introduced and our R&D department is contemplating the development of additional non-food crop based materials in future years.
Our patent portfolio is currently comprised of five U.S. patents, one Mexican patent, and eight pending patent applications in the U.S. and abroad. Our trademark portfolio is currently comprised of approximately 41 registered marks and 11 pending applications in the U.S. and abroad.
ZIP 18 0000950123-11-103695-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950123-11-103695-xbrl.zip M4$L#!!0````(`$1&E3\4%>IJ9%D``+MW`P`1`!P`8V5R<"TR,#$Q,#DS,"YX M;6Q55`D``P_D\4X/Y/%.=7@+``$$)0X```0Y`0``[%UK<]M&LOV>JOR'6<;. MQE4DA0>?DNTMO:PH*XN**&]R[Y=;0V!(30P"7#PD,;_^=@_>+X*$1%NR6978 M-#"8/M/3?::[9T"^_=?#W"!WS':X9;YKR&VI09BI63HW9^\:G\:MP_'Q^7GC M7^]__.'M/UHM.3<=*$#E\X8^?,/:NKD2))[$FFU M\*F'B6WP??R3@"C3V=>8O7C7N'7=Q?[>WOW]?1LNL(5!';>M6?,]19)E::@" M#K^YP;85=NR9]!24O?P]H0Z+&SN.:T9I;&`*74FHG5P0_3?DN26*H>/ M8(PG*OABWEO3\_7HRU6S:G+6Z",DR-)07P%6/(MN>. MU5'D_JHG_!;A`SK+P'>8UIY9=WMPHVC`.9T&XY"'P^&>N-N`J2/D+7[<=\2H MKMF4B%O[[G+!WC4WX_OA%H%AC*@TNX M_JYQCLU^5WTY40MFNMQ=!M>BJUS'ZU/.;"*PL!3V<*S'Y_]NO)=@)E2ET^\. MW^YE'PY%[17("B0MF,TM/2=?S(_[WM?DL*5*4>?!G73/B5["2\'05VE#>FFZ MD%JR`E;UU+HXP:Y_5__GYN1%*`0&;;LG0(F^2B3TM;"7^%[F(6;JB4>2%A7> M>0HMRB]4B_+F6I2WIT7IA;!4UA#[S\H07YX*Y9\ M9/,)L[^"RF*B8;,YB\8;W=`!QL/"X!IW?8Q$Y]#.S\V"!&8?DPS=,]AH.KZE M-CN"Y$<_MN8+:$==:'EHV]2<,>S_:!DWN:)+O'1X3VU=_'$#83PHY\J@YB6= ML\,'[C3>8P2_7ZFZMWN%:.-1[A4-\YN*K0(KNX+4E7(]5`]H[!J&MS.PU0:V M2FL[VPIMZY3:QO*&V7-N"KU_8#OJJK*LNI7W^@^(4N#L[JUH>G,\8V+961-:&U92%<4])L2=,-,2Y8)5`H/YP7$XZTC,=QK>38R[ M4GM";T[)U%1!RO<>>MF5;8&!N$MT#Q>3CO]Z?(%&?'9U*#Z$SCD0 M%_X.GPTF'-_4#^>6[?*_Q?72CD/X<@WXRF#82<%_*E!K:O_,MAPG'(!28P!] M2>JOIW\A*C,#CL-OJ`2PLN%2/WEMF%.NC6@")WAUE/J)27!GANWL$URUXF?+)7 M`XG:&?122)(=YWS0\B`3O&8:XW=T8C!HDE%&OXXRAK(\S#I6J:0TIF/JW(*V M\"\TWCMJ0!/GT#V&K'7)S=E_J.&Q$-R@EM'@1"6PK24Q#?*"TPDWN,O%5H;( MJF\M0V>V@SVXRQ#?L`J?E%.=,ARDS;I*5AI9_OZYJ1D>GNZ\0N("#G-=FT\\ M%R?AQKJT3,1D6X8!3;).*5"L.;L`M@4+'TUOZ$,$K9);<]#Z2MGRM([@-.IKYE)N,OV4VB8H MUDFM=5.,?R.@E5R<`]KJ*$,U38#5\M:>TUJ$#.G+AM.JZQS-D1I70-SGYC%= M<)<:BJ:R/9=R721RF0H*%^$DKJSX2F?,FULG._I<[T]"L$J=<*FER$_'L8$/ M7T!2QD83@\]$FI";PG2]IB^PIXJ@ZB"(*6;4UJQD.)XL\2R M-F<5I=OK%\:9*ZU+Q.!1PK,YH^1C-+_+M)A$O)_G,;4R72U80=(^7-A_&@+D MK9;#(98M0[%YL"2G!UXF(9O:N-2<<9B0H!US3Q^"&/#,LO1[;A@1ILWI5>ZK MF82G6EQ645,&N/4/W,37N@ZF; MT[FB9`+"KUD&4S=?!;K=7F<]^UBW"M;9?%$8RMGXOKS4LT$MJK/Y0M'K2D]> MB.K46"G4H2(]71VJL_FZT%4&7Z0*U:FQ**A#^;%%J/7SU4Z=!+HG#S,3^%09 M:Z=.G"[WZN6L*^MSG3H%1+4C=96R=&J-$EU!0MVI)+VBLKO2+\]L-\BINW5V M?N3NH-_?-*TNR5L*(-79S>FNE2258K.`GF!)`U(8>Q/+UG$O#]>_B5N`K\YF M#61-4J;RO([,]2L3W3J;-ZHJ#YZL-M&MLXO3&W1*W:F0G,/0*MQG/J(.U\#Q M3KCAX1<5A%6J=)E*28,Y*0(3[URWI+:BQI`J1-;#ERYF%>"35N*3^]O&)U?K M#U\W+H?8E;8-4:E6X6J(G6%-B.'.!*Z%,9Z5"TJ9SG`CO9]-8:/.,YJ93IGF MCJ:0T=[BR9AK8(R161P^`+^XW/1@2*,%'H=`_HMW(U9R6#G45F:C\[&`)@BITZOQOA7[E#"ZME^A"#4X_%;0N)/*12)/08 M]\I@;!5N1?$C^\W6'>PKAGV)VH3,?"585LY\-RR5RVS'&.XR2_\,PBR M8H1UO:\47I&XF`KB!Z&Q59.&?GW-&TW4QKTZ)5YAM MMK2TMNB,GH/';JQ##0C%9C!ZW=-L(70-FLF@>8ZS)5$IO6(TQ*;$*8+J$$>.KZ>YR M5ZY28EIB%;Z@"IXHK,08:[IZ2^U60,P+K8(9%F"2=K@Z^5LQQ]G]W)7BJA7H MU\2/@69G270K\\`5VE.4[)9`AMZRBQV`S0.9BIC2P% M*VAFVZ-TBT5>G2B6(\YRSR;",[6K1/EX-,4@X(0[8JC@>7/NS6.L-4FHFZG& M5@E,Q'B)R`^C$J9_L**70,?4H+9?Y_F#IDRU9G34&O0[<52WB>A<''+'\6P] M/'%B>1-WZAFA]<0@5VYRK##5_B`7PI5*R^U!5FX@Q/AJ,GIOF-N6K!2Z1C;7 MJZ2?HO02R7&]7&ZC*K/Q5QD3E;O6(-+(H]4AEYOW*6*AD MYH>5*4X^\:Z3@_4KU^T2Q7WQ'*Q?TXGDS,&:;:9@_9J>DMGPWV8&UJ]<#XLA MME2Y*CI_FA1L4'.%;.7VAK>6@0TJP_.2:GRKQ79S:"N M)RN]JA2L*KDYH]S$LY8C$V)UH6L1O&?GMZ8;MS(NLE+:8[.#0#&LN@&JNGKZ-Y&!8DVNZ@\$CDX/B4.C*!J-UV95!-99Z$W%8TZ77#,&R M8NT,\SE47#F+..[28.\:4VC8TCDWEOO_O.%S(+Y+=D^N MK3DU_]ET\4+383:?'C1^GKD'/_X@>K03G_7XL\[O0CD?#Z_/SB];-Z.K?>)+ M^C"ZO&F-S__WU+_0(!1"5?-=XR_/`]:8X/D9[\;_`D$?*NZ.;'T)6FUGA`G=L+QPY5G0XX(494U M)1^IZ4VIYGHV9(/D`]4P@EP2;I)S",^7`J!XB.2Q/AJ1G[-";$U&FFM-F/TS MG2\.S(FS.%`Z38(FT23'X8\W"$2WEF$LB75O,ITX8)M-L$"\2<&Q`8_.!#%D-]?AU$U%)8"4_?P:#(U MR`+/=A+\[0F(OPA$%`9AC@L^0*#U_2W7;L6-W!/<(6#XX@;"@,C)A[CUC9G[4*'EL:9RYE%RSF3@6Q\@5L\F%1<9WW/`6 M"XN<@D]9]IMKM-ON=P9LV.3?1Q4V< M8M01=WT5)=1<,+M,5*]06:XEFD]A[JQ[M,ZI.,&.GUR;F@X5_3K[FUEFDA&2 M').S5PT4Z"RH)GZG1/+_O:"Z'O[[GNON[;L&A,6O&P2WOIF-UY.$4]+W`3DZ M//[WV?7HT^7)/C$MD_D#6E!QMLG1\%U4,+$%HRZ17L-_!^1X=#&ZWB<_B:UM MZ8#\>GI^]NO-/I$6#PUR%_B6:RV2\O50_J;BHL%U7OO,$;FE4'62/4&(:=W; M^'LH_M^-%`N&':FO(PJ:1#V"90[]'B<1&6;Z#I6\!H["V;\Y_?.F=7AQ?G:Y M3Y+,\Q%"KQG^G(QAT<`TC\"V*/F(:Q(X#R=7U-%N.3GA9,P9>&W`.^@9:);@ M!V"+"_#SE"^HS4Y':L(4@2]TFOU^KRD->V]\1Q>R)HSB"8+PQ6=X^!2X%^R' M_-)K0;#MWKX!YO`>`QX13DG@P3D^)G=C=2Q%IV(8<<\F4%Y8>(E@ M3[D-]]Q[BXAGFMA"N,%OL!``)Q)9,,UOGH$?&05:PX;B8CQD_%_%4<".OW;\M9*_ MCF&)Y"Z9AO&:<'W<^'&`IZBYH)9A"7_Q%@G+[T:6WQMVFHHD!<04=9,C&<9G MMRX1M!3P"R53X",773MB`/R]+H*_D:5C,!3QF1J/UR)O@'`@:?&WR`O(*D`0^"FB:^=#!VOBOPH%&"/GQ4=Z8!3!D\!#'MB,;M-[ M$[&ZR=%/(9.,''WGQ3LO_BI>_,GDFG\=(I+/H1/#,AK[<2_RXX&J-J5.M1_+ M@XPO/KDW#]77+]LEUTM9_V"8]O$YZLB]!5.%I(X&[RF1(&-)YTH%.8Y_.`9? MN(@ZTZ->(/J8,N9D4JQ\S,(KLZOV-G+VJ(J`2:CCYVK^UTN3$:3S6$;8;M%@ M9))+"._2L96">Y9.(2F)BY"',__/X&L9FT`WAF_\HJ$=CTCW1V0%(\+) M\)TPE13#5;4I*UTQ->"W$`,GRA+B0JH6`8:!!347._)+!A?T;VKK)-@-)1^I M_1GW&BXNCHG#[#LT"Q%7$X-1'2L*P4BH&`F&X8>VCB6.L`?(Z^DMB3) M&+_[;9L"$CYZ[W_I,XXT<@>IW>^*PDK<,6+";[R@YC(N5C@I>3ZU.5CM"![P M-0T<-V$X-W.JLY1JL<*CV7PA'(.&LPWZT(6CK;*>L/R2P"6&)!*A0#P7*K9$ M%@<7N!.9B0\UOG]+[Y@/0$\I(AZ$S](FFUDN%^"B\LHKN=V3A&:Q)9JJXQD! M49.9>(-Y$53`0]X)`:.*%W#S03`+L/,K8:'B?Q@AR&00:XEM;31]9*RT33CQ M7/A<)%00,57D%NPTU8[0Y5:H%=46N1(@\;]+/38)!!OXE3#_5TI; MD7QM1Y<33XHQ4F0)&">?BT(EFIO0*_:EQXN8`Q&"!!>63N(^AXG@(AGVMP'" MU5D/N$\S+`<5BUH72QHHC]NB&4UW/L4:KY^N1U.>Z<4?1]AE,%IA%J+8$$'( M4$!ROESZ.3"1<*@3RW.+_+T7^CM0Q5](](%=XG<`.U._L"BPP>Q8RN";V4OI0T9X M>3SZ>$IN#O_\HKLC$-BA[R0,XE-[W!;&=PS-@31-B-RXF`^PM(#A5PZ`76I,+$"."$FP:Q/:6>8,'3Q^4B4OO`:]=Q;?&L(CWG@@A+4Q7RBQ]^8;I,_0@@NT`ES_*`= M0E$T#+_6OTQ(@7Y,O`A/`'8/-_QFEN_IRV(4X#LBD\?H]9J!14-P$!P4:(,# MDO#T.\&OSPH.5("$U.7DF2D4S<77-OK[)ACB3*@A*,"Y9?@X,,L85)PMP@5+ MN=][28EN._0]`HP+R^":R+]@;B&$M&8FN%J<6U'_J)8?>/JLY9E1.UTH=\), M-A7T9L8/!HN77X=EH&;_:!EHQC_!F5C?'D=,JQ@GL3$=3/+1\B/]R[*/!4\R M&P^#G#%K!ADXA+?^-M5*YAI^,\P%3O;Q\+?1-3G^-+X!`KL>D\/+$WCT^A3R M?C(^O#@=%UC=%AGM)K5YIH53)&KSD'%'!?77Z"MSRP_(_`269@*)H)A?,5-**C*N@!66JR:6"XI)5ZS" MPM-:E:=,<6F=MNM4DL*VPRWUN\/[?>--K`:5E>)U'6>M\FBM.F[`*;!:(%?` MA5[`<9!<0J"BUQ'ZU*@NN5D?U#.=E["(/[H^.;UN'8UN8)&+=@*( MO'@@#L0^>F-#544A'('(;3MS]]R0?R\3K`B$&-&]D'F-`$LO#?"WK>$5#I/< M4_Q)TQB;3C=SFK)8^^+T`_0@=QPJ467O-W[X*(FAR6Y%N/ M7EZB@Z2KGPY:V[A7[^]0OS7O\#]N M\8`-5M'](B1N_CGDGMG,W^+W%EB@]*^Z5J*@&50IXUKG+"I!BS,=N$GQ"X(3 M9U)$:\MSJ*D[`K^X^J;L-8)=3?,9U[!V>'=XO\?2BMQ)'V3-ET%)OCQ5=KSU MN]=F[Z6542+`WT(9Y=*RW5MR""LYU^ACP]QI[.E>NG3I_MU:CHKW.8+>4APLL8_'/Y8#]DU^"X:?#VR[ZPTY>A+!;YL M+:/;5'I%M;[GQU+#_K,K2LI-27D9RNOU:ZV07X3B5_J%^%*OK^`7_9<2^#RW M0EJW"-#S4YSZU/Z03/S0GI/^\80A3V:8C\D(TMF7J$:NGWKYFLQN8&^[\+V# M_%U!?L3R@ZU%L=C`=X7'"WSW)54G?CZ.N&OP73188 M4>J52;K-CMQY$4&#+$G;/?U24X-RLRL7A3/?C@:_E\!+A?55M[R)P5Y.3+## M_$UB3KB<_W'UV8;=<8`UV^ZVJW=XOS;>-9?3%[^!G3T.D'O_:'<:8'<:X-GD M:<_^-$"_,WP168;Z_^U]:W/C-K+H]U3E/_#.9FHG5;*BM^V9S6YI;,^LSW%L MK^TDE?OE%D1"%G8H4N'#'N77W^X&0((4)4NR)5$>;FT262*!1J/?:'37>VOX M&)OWTIKM_A&@N^2,UJ8NC[\PZH[6 MRJ@HJ1+95?9,"TS=(NE2ONUN-LJ75=8ITFKE0UVW7N3-5">`9Q+P\R98\6Z;5J!WM21BVK.DRK5JW^;HQ^*T8654:1P5S M26`V6$Y^+$J76>9YK#G]_$K2V6KY%]CG/;P:7O`PY'Q!X>E6H_%J"D^GP^2E M<+=N79SU;\]VV'/X=VXTB9*ERKF%31FP[Z5KW?+[V'/\FE%BOP9?3L=^'-2L M<\\1S).M;S\2-?ZMU>E]\+A7LU1X5#7(I'V7A>K=J6H60GU6L"R":B:ER\J' M\7C,`JJV/N"N_[AB_]@5NR09O0.2YLHTGTA83/;CQ76D&$D[8)D]>;+=2+JU MSF'7"O^,<55#3OU6X/%@XDLL#X?8-P33SKB!)NJMPSU;=O?ZA07V*&5T51Z? M,#YBH=%`+.W@88[U",^$22<+@(G!T(X9$^R$B?9FKG,FWM^F0V:V9XG&-CL[V?T$&&:&Q'5)JX* MYORA19.:&S#;)D/NP#H:?6E-G%7CKCN@E*_ZE[?6=?^/_L>+ M,^H2<7)U^=O9S=TY_GW[*YIYYY?]N[-3Z_+J;MMM(Q(&^`TH"';#NL#VT]>R M9U9*_1MJ[5=`C$HI%;7VRX"(,NR6@\Q`#DF:_%GO4&TH7NT-.[TL9L?=?Y&*2NHI1_UA>O6C1;80-0NBFMX!M2M;ITEAR:$T,>/ M-=G`3A7*4QTW<;!6O3LS6%V_C]I]&),^9U':FFO1)M&<(&IBU,7M8V-LF8V: M:SZ&XLEYP*X^:M*/YJ2(?CX(LMJA>:@,"9R)N:&_YG2J(Y(_`#+4K7@F;&JT M-<]I?'?NSJW'0E(M&(@"F+1B)`+RGQK'81#;4_)V`A_U7792;=-N`;4FU=N4]ER4/7SG`A"'FFX_NLS^=2K+F:4I?=,*WO=0JM#J]4JT=V*9U\T M2*/Y>J%]@^W66^B+`??4GB37(5YR+W9Y,>),-SJ]$$/^[,.&A9'A0QGH>2&D M;1L_#SYJP,15+U&_@?;Q2Z<2[9(@3P7Z*[J(]L:(\1)LXOVBQ!L1?CD88N0Y ML9\PGE,V:FS5#]=)GIT;_MF`D=U']T[,6MK1C/LL[6Z/`H8.&K>=61\9K%"' M#R)IGL.8&)-['`EP-*C&O*-[T9)C&7#571Z%%%HU-K=8[/!+740U5X.NN`>=BSVQ_Y` MN#3"4&"87?I)LCLO-9#'\0?4RCAMGQM9A_7>\5O#.9?=P56[]H!/F'#DKC#5 MMA2G[#7RH8'-[L^)[P$(D4`?X#9&/P&[)0,Z<+?"S6[75>X$!(\U9+/SU#7] MH5D4^"%?^AY8ZEX&&+2SGN[NX5OKEGO"#[*K,I=+*[0OG8 MF41(/C8F!R&V5!`#`6$'>!GO1D@=%?K+C7>N?S#&K&7#ACKZ$LM8R._H\EF? M6'#O6Q^9]Z5F7:J;==BHVK<%_55#?S@*`,^OIP46 M131_9^)!!@;0^U\FODESJ"!CC6)#3A:XYI&*F)DXE()/1SE5\!&@`)F(!Q8\ M#57X&+92L:4$=!DR0%@=:@J.W`E>NVP(KH1"5D)OA.%26J&374F:H4F:L4G% M#JZ6"$E&=Q09Z9<#$P3<1=L0)L04"P)BB!<;XU7$6PFWH3(.9^E5=JE7\J&F MP1*>B`0PNYPW1!#USC0/6_5.LWVT"`3/&*9+F$)'#%'6#U@H`_8(B[$XHHQX`FP(+EGQ/'7KUPG&($'A>P<2,"`, M[YXKRR\*?+=FGOLO6-&8@5W"I=DQ2'1'/*$3$@U4XS:JC6[W5KSL+U@HS:F#(S%#+F49[C9"BT2:K`6 MP;:4Y_(.#Q)J8?`OCP^%G9,&!0.-.?.42NR#_$'JAK]N(\`V"YP0#")'P$"D M;:QWJ772OSTQ3QP[AX!4//NN:?D4<*`6KI6-/&_"5&S8:_#N8>0A&.#&6D8, MSW?0FK%=%H8PJ8S*1Z3*LU$\\L*DL_@>=LO`7$/;.7/"+W/#&68VRYST ME&P.RRVN!10DK"4\`W4?37$A"[-:6J\FJV5^$FH;%%G_^ORN?V'=WEV=_._N M@VW!ZN-Z4>:G`@C4/^B>$7"=CQ687.+= MQ`I59H^I=Z0E(>4/:"^73%03%@*9(-IPS(5-!)I8QHG4,Q,A M>+;B6I$)E49BYHA$3(*AT^ZYY]MS(-_&2?>31Y3FL82'.2T@PKT051,([]`& M@]Y%/0YVE=5X"___8)U<75S=).=_<\XP(G]2>#2^5`G+1='S_+&Y/D34>N[X MP\*CQ%5.T@LWD0X2^A?GGR_?6[G(JR*35JU[W*MU,^DA68(!-NUUCFO-UI&1 MZ*$=]MF,D5Z]W27/)&=?XF_-5I&=EXG`Z40XSE;)C9S-Z>LF-R(3B* M6RB+`4/-#(4/#Z5!'/F47)+8I,KSU\:6-#@)['IS-I=M5;5?,5O%;.UN+A$K M&S7)\('.ZTI8;`Y/8?V-BC@KXGPV<39[W=KA<6\>=5+"'>7K`LD=SDIQ(-H' M%@@?)"\'L].?8'H0Y$B`"L/A:0?!]27#MX`-41XK4"&3-Q4N-' MGK-5U%Q1\\K4W*DU>JTE:+DE>TKV-6Y9"(Z,AG,S#P^ALUL-Y[*:%:A>"-QF*+D-.L!A??2 M+&*M1V>%6B;Y&!8*!$.C'\A3";P;P;U0;@0%XQ\I2(M!8*ZSQF0(6&MQ2BDH MUMF6@4]YOQ0EYNJ83?*LYX)JI%`HOU]M`J59M`FU.'$V7CBB&WW@EY M-2C\\;F(7@.7O<)Z._M&P+^5-M6[TWQNJG?E*RWG*Q60X3+3O7GU3E;BA20W M(U)V>9^K*I&SLJ6Y*4W2Y/XFG>8KETP:A,RX:X&U"2*PK9-$(#3UC6.D)./( MYF$5*:BH?_O4?\>#L4GWZ#.ZB?,74[D@,\\AQ&-9F5`SYM'(=XP+_IA_($([ M#D.9%_^1*:O:`=5'72DKB<`5K%$Q1+;9PE]A2O' M%G2XC]$1NDR!Z=U9-][QZ5?,1L1DR(A20E$AI(^I/#E,9@LY)YJ3B=(5H5>$ MOC5"IYMXG]"Q/=>.+5;4R)'[@"G9/\)PLCZ.^YQP.Z`R(KW.D`+4C9I"P?YG>K.B-20#_HPBBYNQ&, M?D&*"^T1=V(7TW.1N(2W"$$UX`!Y#T7EY2*+R-F2=.0TMERW^N1$/!4`)RW3 M[M3:6,10GA"D3(1A>G6SYE[5#,G@A4+^\OPG@^$D@J]XS../[G0VUVHK^>CS M7X9%7*:>I]J?4PQ4W6NX3;2+?Z<R-J# M;6'IDS^^?R('\S5&WJL^QQ6\KQ9>0^F_ZI.8JC7O#K>S#`^L>&;W.\>`O$H# M+]]J]@(?%3&^$/+5*6!)%[,/Z"@G*6XJX>"6O)4]4702Y#.=!'V-YSQ[!?HW MA>T%C+3+X_RK.`KQ"C5XBRK^TFVF>3<$]':S)`Z+>J2^W$2K]G-JU3N;:2[[ M[:%F`0=LK<6:JFD<&:?O.Z#Q=J,T--6MMS?CV*T!2RJ`]ANBW8GZA=2O=9>S M`XI_+5M;0;0/"MX-PWODL;OWF>_-3N)JAO@!^UEFA%-A&.P MKN5=HC6=I9[S>FLJ)U%4#RA"6K-Y;29/>W-T7CU0G@=*3BJK@O?2$I! MZ@^M[!W7\'F;LJF+N`G8QB7B?8I.YU:17B?>XT5K^&WY$KH'B^BXHG2 M+.(;YXD%NF^7-S5^:-0;UH'U0W+[^77<_UXS)[1,=\"/ZYU6F7!#8Y;JAF*O MHIU733L+1.:VI"-L:@O%8YHL7M6`*0F-M^O-PS(AIWSRL2*>5TX\AH"4'S>< M'I_VUQ0Z$*3:.*J."S+UG`W\!VPQ.<'V"U@]FWZBWIKP5<2^YE^O91OWV*Y/ M'7Z,KCVRZV3]J)&YXI4B)4FR?QP)>V0]^K'KR!K?`^ST'G";BP=993PM8V^- M?-?A00@/XI:X^:_3?ISPC@ARJ?[4Z5.6'-\`NG$02OX_D87"967YWV6_[PWW M;#WWP`'R/&S?"3-3)7-J/D#5YF'EK5KWN%?KSF]2COUQ;3O@#A8<@.`T%-GM,FKKJ3KD6>&+V-5>L]2U5B2[>\U3/*N:L:ZZH?>K8Q;*]S M7&NVCA868$?J3EXFNF%I-7>#!'OU=M>XJ8'E[O&_YAW$V(N$:_U/[!JPMIL$ M:V\CI-(WR[?KCO!)Y79!]"HOMH1S[J`47T%)B4Q=1GGU-U"J,NT5O*\6W@7> MU*O*X*_*M%?)!U69]NWBHYS$N.+"+V,J&^$/R[`+FZS7_HWAI:3$N:&SJHR+ M6'[EM_>EV[\Q?"]@IM(5G)N-&31K!/^62P+56N6*Q';JGV!K`K,KVNQ/UVRG>_G1"Z&KX?5=( M=_E9\+RSHMP;1`JYX557@JM++%<@E`'DK-M7^UK)NUHZ.2I7(T*TW M2F,)OE;KZU7IF:H*9@5S26!>P'*[C&WI"&.^TC7W',SXF/!`^+OP^2O=LQ/= MLZ6@7Z5_*KE8P5R^:M?+//_]=__X*0X/[AF;O*?$4971>O9G+*+II1_Q4Q%B MEFT<\#O^-?KHPC/__/X[R_J'?NTJN&>>^(OJ79_X'CE\]$??37\ M)#SFV8*YM_`-Y6Z&Z>CP]"W@20R%#2JL;]L^ID=Z]]?G-W?] MSZU&&['I1?###1_^_.84,WG^T_[C[O3-/PE_9F[A$!X\",5?_+T\OJ6_AVPL MW.G[O]^),0^M2_YHW?ACYOV]%N$7M1#TY?"#*:B"_.[(SY.LR`+Y)CSYSR2] M,(XSSCU-IB\^]7\YO_CCO94#YXV%<&N":=6MVU]_@8G^L*X^6;?GGR_//YV? M]"_OK/[)"9@==^>7GZWKJXOSD_.S6]ILG#C9^#^R4%`"L$G!E,2;(?'9Q8C7A.D7`HDN!`!#CT'N33%=WTYPR!UK MJ*4"S*3%@I&0/PGXA,GT;AHD<+!1I#YCK3O$7C+,X](@4')B+#>-. M7"K)3WGIOWJ49D[B!S.<99"F<_CA<[]_K?\Z^O!C/44BY7O''HMEAOK3D,.< M;NQPFB]]`-Z#`30-`4W%;B03S,$H9_*R@$HW?P01[$X/_$#;4V[G@U.4@-XXJH&(#.CQ21Q,_)#+W'W/B6W";L@0L0;X@..S M.(`O3.P1I!J8`7-Q[T+"002>2LAL^6ZZW=P58\":O`U@H!L>R^]*,181:H&S MBK%R>$)*O/?\R/)@M6'(`A#Z\(P#FB82#UQ>T4C'H^L:8P;P8KK^A-NTUS`L MLX:QZQ+ZP38K>'&%^`A%.'`9V*UX=0=&9O?R>A#PR9A] M`5;66R'OXH1A/%:WM(CAV7`(G$ZLP<:H0D*\EP9\)-DKRNNP(KA,J6`8L\;4 M8^;0%3BY2"60YTD/4Y7H(1`E<&&)C@^S5ZS^%# M'J#ZQ,MT>(5.63)XR0>%L7PJ^9/$`SHR$'\R;:6MCKKUO M1RB'M$"U20@Z`C`<6,/`'^-]HM#8D4K,K"MF3E@XDF8I?D"O#7:'ZR3#2MX\ M`=+O4O<*<'GI6N<(?'2P#5P!B-37$24ODHQA()'`C0=>=8&3([R3.)760\"Y M-0:81L"0@066$5TL!+UOX[[P=%_J5C\"#@*[)(9'"#9XVX_O1]@H2BMFNJF( M)@@91GCGCJ.B'L*_I;TK//29'0NMI:SM8N29@!B:0(2ZBNQN@MV[`^=>B/Y&>'YH55OZR]J*#70Y@+A MYD[-A<%>$3;0D$.S+!`<``5)#I:EZX>AA#F,[5%6;@$F'9_>&H!QR6$$^$9> MQ42SUJ$KIC!&:`AL>2/5"D3X! MR:XE91?>1H\]8)@H$.2E('W69JBT1K0+OD@0'8!C-,X(-KIMCX9($5MVTB^> M)U;F,;7TKG,K*&0U8MD1=Z4K]N@'7RB2P":"J@5(']64A%G1H40`);G+F^(F M$L@I"AAF;J#\1EAC5SJ'!2-;M_XX\1J-N^FPSZJH`%>CUZR1_P@B!P2ZY.BE,%2E!U-Z$T' MR>Y_3E$RQ6J(*Q$!12]XL2SRK(0B=D9)F78!681*KJDZ%MIMQ!(B=/@`[$-V MD;0RD"!9$B8#8]*.P84:8P$1^/5Q!(X1F7U?2$Q@*EE$'B%&VC(FWI,-1!^E M;@!&L5P6@.R8F5+)%@FSBF_]T*L?IW88?-%NO]746;0Z92O6E-2#Q4XP.NG$ MO,AN8\`C(YAX'D"$3P"AF0&A=9R`L'#F)%`GS>X)$^CCP^C@_`(M`'/Y6)@7 MQ0E'"&MF0%3&"1,%II"H['+K$Q\$N8(BC6:K5A20IJ(D#LP^E3(6I$EVY^3O M\03(*?,0X7\`"$JE3DHKY1DC$]N]E0%E@L9P'[J$$H\W!^AM) MF#Y/*\KMGUT8/.^( MO40J4M#8!_+,V/D:E!J@1!82@@6SP,EP.D_C)F,>C3"BK)A_")(4-Y^*R`S` M!$9(4$/+S!M40IJ\PW@R`;7AF.V!I6&F9706^7JC:E;$R-0A+PH4.P:!F`H@ MC[B7!+6G.1%AZ@T9WD99!EH0E9.O9)K21NH@Q8)-]/RQL-/S"B.NGT2!0M=_ M3,@7_+M0F4.(XEG95I/2Z`&W&K`JRS?%P9,Q)QCXAV;],+%`(]S^H8O2-HWN MZ4.;WH=0D0`!E1/5\(MO"XJN:S(WZ##Q>?-*%*A3VYF2NUTW*[)!L@LJ. M7,G3H,P?"XR,FK8RHD<_(U25I`O"(ANC#5[F6^*1UF&]1[I=UGNS439KA8;7 M!ISY7J,!?\C&B?Y6PFR"XBT-HZT,8JM;/U0@=O#36B!>@CM$Y)E.E9UE[`?D M07BP>V_EV6I^=,-$"?4B*W&QMKBX2:,,&"VO1,4*4:9\A$:?B"71A4R,U_JA MTZYA6AR6(UP[:E37I_S9V)"* MWB6+KQAV78;MZ]V]2;:\8M`E]6<2+6?>DTXO?JO3(AQ]K)DDI+$`*_&((469 M=77:3#0E]HBU=,Z+RH=)(E)AW?HES8P!BQ)#$3)4\"!@`4:H0&YR&M*3$9QT M-CP3DKZ"BYE]F"ZK4AMY@'DI[)XAYP%$V@NF@"A(';5*!C(F<<'9,%)'\!@A M\.4JY"$(F<:)'VUD"GX=,7B=3H!E7&(",D.&3(K:ZD-^C@".?:S$ M?+=$VLLC"_.&3;-^E#TDZ_7(TGE2K*YX1%86^MTW074.^L2+_&!:B:=5T$5G M9@&7V6<.GO8B0P%W2'N8?--W0Q&$T8'P:I;\A!DKQ/D_8@18'<@IK8[&.7KB M8YEM"V,$[#$Y&0LQARUQV`&J&&SJ2'J[\.A`^)3H+&SD"A`C.*,GPA'69<__ M1C,F/\MXN)5?EY1ORO7&+)90ON_GIW?_QJD:;S]8ZE;4 MR=7%1?_Z%B!`H]%E1R,WY.[6=?]T]/SR\\'-^HQX7VP]'?R(F'F M*UTFC[Y4R^FUZ^VCM^DS=,\+'IBYN*OA[JEZSBMLVF#N[OVN%CCP72=;U'W9 M_6P^N9^#[,[2I^*K;B^`SG:]T5L%FTLC4]T&[5^J0'D8YD1-&]WZKVB[4M>U<.!O'/\1[R+ MAYC395_F['&S\W;F(N3.-_QHM0TO-O4R9\3-BO4JUJM8[\59K]"+RG!>8\>< MUZPW5S(AFM\2Y\F/3Q;JJLR[RKS;/E5JY9WO^JKWC]6C%4Q5L58 MY=KGRC3;=].LL#S>\^RUR)]DC#5K<`_,X@<_O_G;RB5"] MNEV\A]Q?]MACWI8MF>7Z,4V^N*'DBXW1[TY"(_NGEA9R])P8Q$;C#%L0F\U: MM].J"*\BO&T37KMYM!M\;BID]:H5<15IBCY\TFF1GS$MLCS&9N5JOJCIOI:\ MG<'G'DC@3D%*547#%0WO%0UW2H3URNFOG/ZG4'W-["_L'N\S;/[0JO*^*N]K M#EI[FPN65E174=TV?NUT"[+Z7?-XBYD% M]?9A%^';.;FOB*6"JU$5F>\3F6_!O*Z"&]]2<*.U)=,DJ>Y5@R>B\MC5WZ9O MN$&AOOP./"WI"Q/Q%\GY5KT%>IGJ`;H+;F7N=<;^,_:N2"-N?!/G7`1X@6W< MIQL#[5KGJ$1W!BJQ5XF]2NQ58F_S&?_M#?KE513U*8]&?J2BWSMA]'TK0GQM M-F0_TPW99V&O*A(_@;NDF7VN.#'5(\8''#X).+;VHF9FU-X/6\EAZT/9%R`* M&$JD`Y?Z'%'W-@O+@M.O::7U..18^=L5#[)7*#4W"4..%=/OEGR28!SPZ!&K MDP_%@RPH'&*//.I&!$/=\`D3@2P]3&7AN4?EQZE%@B.P<8$%1/T.G;LW!DBZ\7%4BKBH15Z7JJHI:Z^.["MCO;L.K2L05ZU6LMP^L M5U4BWFO.V_RA767>53JFC/C>7QVSMP53JTK$%6-5C/5:]KDRS?;=-"MS/M6V M4KT7G$U4.06OXII-587T!9#XJJN0=FO=1I535/%_Q?_?*O\W#JN21*_NNL#+ M6K(ELUM/?"^,@EBVA(>YKP/_/N!A59>HJA"S_2KNW:H8<45VV\^);7=W@\_J M\EX5;%JO&'$<>)3B:&P-?L)_K$_B*V4_EL<0K1S1%S7KOYEZ+ZWC*II2$?&^ M$_%AB1J352&!*B3P)*K[,9"`/Q!N5:NH\L:V+R]WXXQ55%=1714"V`_M6X4` MH@\7G(5\Y+N.=3Z>!/X#Q]R3T"J/J?EM^DM[4M%B<]=0]M)%:VVN&UW%-Q7? MO%:^Z5;UF%^=;?4\,VKM:U;KVTU[Y3Y]"UYF=6^C!*+YL-9H'%8D7I'XZR7Q M;JW;VURV916UJ:(VFXC:A*'5M^UX'+M4`^O4K+I5'FNZ\7F#*?*T2V;H[NY6NR[$1PEK;R^YNYLM,AZ235II];?<"R\GWJ9#_+-A5HX:%:#/Z'Q3T M:-!-"2:!&+-`N%-L3S"!QS#U#Q^(`N9P^.E+6+?Z8S^(Q%_/;NC@BB%7;1!" M#6#-^#WRK4%!MX:A&$8\[=;* MO%<=%BK6JUBOZK!0E?$M7QG?RKRK=$P9\;V_.F9O"\%7'18JQJH8Z[7LW]F]OTQRQL:(N4H>W=<`Q]9/I[9QY:B].;']U-6BW5'[7M^_JZA\ M#2K?XF6`YU^@*RV5?]M!M6W=JIL)JFWX0EWE7.]:I+_DE>K-78798Y]^&Y=C M7G(3-WIC9F]B"LU>0?93)?0JH5<)O4KHO5JA=[CK"B#?,J'/`BX8YU[MC_FUAW[6M3_KKI[N`!U0J(N0M31_4/L M*B`<^"4.\58>WM%S!1L(5T13?5WP<<0#/IA:CAX%7C?O,`;<]N\]F,ZQAGX` MCSG8:1B]S8B/)W[``GA7#.%E[ME87.GKZ?[8]T5PP MRO2'"3H\)PL0_/ MXN)PJ]FC'`?(A2LR-<;KTTO%9"]K\;X=5=CP\%7<1EA-B)'PI] M:]C@'T530^$!H0GF6G1#6?8=4;\!ZPH0"TX<(/\^CH0]JA%MTZUC)"/VP(1+ M+,A1N@#%U@S2!%A`H!:U]` M`B`-(X#^<`@T3HQS?Q_P>SKQ>Q31R/)A[B!];\&`N,8QYW*AB(8#B88#1,,! MSJ)VAD"-1K`@Z@:#,(PY"V/D-Q9*L[(D#"2 M)ZSY&XYL9+OP MO!@*12R.0P0('8QA[#L,G@>1!C@)'":;T M2_3>>B=^3!$`ZB*,68BU/[1:)[V*.C%`HXTFY%]%&(4?X%7S70=4_@,'0WL$ M7.;;=HRF(CUD/D7Z/A!V(B)MT/7`9`%*]:'XBA8&.A@`)4I(D*4?B/G?B0=C M%*RN`>+?4#HA?>%0#KA`9I9B$(_#C01*502@3"']LF! M_08%'$=^``K,N6%AS#P!_GX`)P$%C]6FA:A)D?@!5\6H4)?2UG"TOS1W-2XBJ3 MD4"V!EAHZ,@4L1"L3+.F:<,ISJJ3:41+-QAT!OQ"*!%(-`UMV&=8%X)&@$J7 M-7D.[#;7U9:PQI)B*^XY!W'(@YKTQ6E*8$@8*;]SF8D=GR8>,:K^,Y7!RU`N M-8J#5VJM;$,7_L*"+YS"(;@A?0=$920P(E-IQ"4U(O\*%F"(4LG$)$LQ206V MT#I$D4#JIV[]\L3#.D2!GA"-!V'M#N M/$#+0@C[QO>WD6]_.?A(L9,3\#J!A%EE""]MHA@8D_7SABJ.&1)>94R*R2`R M!C^2L`$\R41`H56N2^7IF.(]V++2IS1,@:1D'FC-!S0C51",)I03H`2R5:V\ M!W!+I8XWYQE*N"Q_(H,<(DQLV4P$_J/+`/I;>^2C39/&?\<^F-&F5+B-[9$: M/&NYL#`1B',@KUD>)^\@K?$':QER`8H<@V$I-$4E!.N@HS",*RT%LBI$.F5B M'.W,:=`S"S`W8/.CU&]8U<8KYE M#%BW3H5+$R^`*12@NUE`E3R+X,'S%'OB/",$;I!K)9 MO3)W3K)H'$0+F"AUZPI\'&6$W/M/$I?.SGT2.BODI=KRTM^#QMRC0=%',FU MDI)+@?0)U37%(]$^@/_6@"G!+I@"+U-H77@/OOL@SQQ!W0L_#NFX-Q;JZ%C& M@%Q"_R1%?TV9"/!*R)-#\`!^0YO!!B8(R=@:H`W#@?*MB_P0LO9R//@OET$1 MX6&.`T92/%O&O?`H089'D.?0WPKI0#%V(S4E3A(H&,$BB5"$X^HD6,/\ZM5I M'\,0:#`F5DT!_%T:32H*`[8.QEG0KN1:,H1HZLV@`B&P72;&6LAR?;@JCTM1 M<&`,C+113&88BG-UT*7/+6&=N`*,6[G)6I5D03%B@%HS3H9MWY/"E_"0)'1( M)%7R9FUY@VX-0V3"+GX2]VB/5Q)GQ9"U.DD`PL32Y$"TA$;#_`!7)#WY(X/, M`P4_UA'2"3R-$5T9M'7`8TMS(W2L%$>>1^7TZHS]6T;C\N!*:]A M/!LDVAW_&GUTP0?]Y_??6=8_].R7##VOJ^'51)D.8)HX/[^YZW]N-3IO*-(, M+][PX<]O3M&(^4_[C[O3-__$Y62JGB,>#G!'WLNMH[^'#`S/Z?N_Y[;N[S64 MBF$-W%(Q_&!>\3*O@QG)J2##LK0DLT=-CDNH)LFH12=5#*=OLL.H'UT^E#38 M!`/QYG/_\OS_]N_.KRZM_N6I=7%^>69=?;(^_GH+GVYOY74I>#O92/59#OM_ M#@ZLKX/`K0U\9VH='+P@W(G<,8DD%0+6+##/GO)W+@UH/.,.,$5.M10H,&Q; MQVC8-IJ:.X@LD04O^0-SF#H1(D\!+>R/PLA<+G4QD#T#AW)*).7!9&P71E(2"&FE!E?Y9/1S_JW9.93RUYOJ+XX^_%C?`(J37;U`]P$@_ZA4[,9WEH2@ M`S:""TI;>E-D?(#_Q`.4+.(OU.-@9H`$Y1$:50/AJV@:R")!J4N!']^/K.B1 M?-F)3!#"1_51$[$]B)SWUKNF<3B;X)[BG7Y(\H/6',:3`AUPU'W[P?KM[.;N M_*1_H;/F41H=X#7,1!']K7G8D5P)PQ#N%*#:5$3CS>./.%O-XIA0?J_B4B'( M2`>-04!2%&,\BCR]@"6>Y81'@>_R>*QPX/G>@9U";]%ZA"V-UG>MPM7>RJRU MS:Y66\8TJHL3H2@<<\M190-?$0PXV4K2I2 MK?=$[0B]E&Q<3;H/+$1&UIM;T]G)YCP&6?\$SSK\'LA"$KG&,09Z&8PFQ'/O002^IT_,?72YD'9A"1AL5F?:X)KH MJ*1%X?V4W_2ZP!GQP81S@8ZXJ]([P*6$ES#;3ZX/HR'WP.0JBA-X(;2EODQ'_'>AS`6(W*\F85>D.F#`I M_HR)@55VIC*8)8-@,%\=H`3PC0//*3P2=:2496)/;HQ!!13=%X!T^,!R^ADXOJ#.T'/S6/3?TWJ_%6`LHT?4UC>@;4%^P5-.-D MF1>Y\!(=8MT+45"C9V:#W'%1JW"@5=`FV-3HY.KBZN:]];<&_>^#9=9KR)1* M,*WYY";ABM,EB^N\+7(^3#9,9UJP#`6B'+&Y9C.!*/Y3GK,J24T90"ZJ]8JV6116F+P'1684)48B"%F+)+F` M(*5B8I^,V1=U`CL&20T"U9D:J'O21I6`T`K3A9%PC@AL+O.^,NNC`UY8W:7_ MD'?R&HU>Q@E:)KY12<%*"JXM!;?B+[VH%)Q@&$*'V*5GLYH@7.@-%8M#)PZ( M6>Y!\H$L+!9STL,WOY"'%G0-:)[X%!$?FP(R%%^+):2Y45N5D+4MBWC#!20LO_G@X"X5@WSZ:Y8F*NIY&J2D27140W6Z]?1F^8KG-A MK&Y!&"L)8`DO&_7)1K#2\&4:R](1$7#68XPZR*NN@0U"2@51''7#P&5T[0`C M,FK%2H9)84!7$&';I%NLI:5,ML$8*F;J%GBROCN%)0QQG`04$(=XE2$"ZKJG M.X:.-4+2VF"BA@>$A(5R%U M]$E6#P(Z]'_T\"1==4)6(3;+]7TIZWU#SVKZ*!;L2!,9_9BS_;-[">(IP/J] MI+<\+D_[&#(1!C;H!&&HDLLSP2P61_[8QS74J-EQC+=5E#I._N:X>X'O4=0- M2]78&+Q*M'4MZ?LDL>38 M2::!)%B9U#2KX`LU>:5E*BVS/2W3=^\9MZZE0-^8*X#-RZTK._)5,B-PRC&> M.C+/\S$IR$D2;-(<`G6&1F*`HM<1MT<>VOE3)>Z]D)(*&"V!SBR,`+R*%4?( MF_"+RV">D1I)!F/ET3DI.;!`:1X<:4:72=`PX2<]BR,QD6@"5QTRZL52:CK) M$(/G-9.3$MGR!LA;;8_J5&&B91V%PZGD04B"7U]'G/4Z%+)(NND<*%GU@`H? M"*ST$C%Y:,R]$=WJQ\0*5/D8P<83%O*`@-TF*FZOQZ00$/+1*`[3;$[<0W!/E/,&:@:?A#G3^>H*RRH956Y-!B3$B4Q7 M,^G04`OZ*M\-H1G_.05H$6E$#F0G>&@^N!(0>?)#%*QO"AOG7]FY\P276^]F M-<)R47L\@00KB&YJPDX/?5?XM.A$TR%O8&X>:<(A6AV_UF_KZB78,Q2\OP#' MX&&C_%(=(6$^MJ6/A-0<&7]:I3[0<.1L#P*?.?)4%(T^CH;#4F!E[V!UFG@, M!BS,`T)_\$4*C68S`6VV M__'3O,SFU+A=^[9YKS9L68P`3L:,/?<<_C7_^73 M=*K#^5.!M=!LMSJ'W>/,^K(CI1.=^G:,['HWG1A+.9H_?K-Q\!\YLOGJ[(#7 M=%?GS'-.,;21C'P\?V3\>-`X/F@WLN-G1DHGZNNTG4\N2^FBV9@_`5C#7`Z= M>3<=\D0RT2<1@D']!TBB//C-YOS1#PZ:K8-V4TXP;Z29'9;/W5`),*`US':* MTVRY9FO^?'_P,+/#A2/EY_LD7!Z<`"#W?I#24[,]?YI;X#!XQTH&ME0^DSEY M9MA96I!HD/OX";XS%K@@'?`_[2P=S(PR;R+$=VZ:[F*R*YHH&26;VWCA@Q5V M+2OO*)RGT_1,H730+I1)AD3Z]189JMOH`-.F$K)@ABP()_*H_`*3"ZX&KBH] M%!I;%4V7!ZMLV,)ASD19HFX'H:`V(0&9T,S#-G2>'I52D7[/@ M*J!$0N;^7G0ME]PC]>!=RG[J]59 M":>)[=4Z/@9NZQ92X1S+:S6XEK(+%UJ%+P#9N;Q8F`#5VQ2RY$0K0G.X.10M M!4]?5JC[RX3I:"T,=4@U9#76_-G6`.MIO5",JN<`EN79^:3>?EH9%.&L,4\Z M/$'D2X/57!-GZP)&SZA+SV=_QF".GNMP^K4L%MF/9-$A5"AW_J7O(4`8!85' MDJI_"?RM=8RX9KO=SFSWRT"54\"R#&X":7L=A=MI=%M9C4NC/KW9!?S17D\+ MS/#&XNG6`VU=1?`LX*XP$T(B%#HY'IU]58SPV?<="C,G8*WC(#1[V?U:9L8\NN0&R[MP M_`1+(*7KP=Y6"8#'ZP#8Z>8Q]\1\6?!N.!XH8RV8$Q:.^A[]!V7*`W,QU%BP MOYW&.ON;E6#+3YL%]W=5<*(OZTU<4D&'J^&,%)=E+^9#>;K($#D\RL"ZTIQ+ M@:M*8,SJN8T"/&_6S6&X40QPZ[C5+2>&GPGP]C&L`DU%5-$Y;)03R<^'>2>4 M/`?F9J=14CP_'^;E\'R+Y4Q5H5/4@>'G`*O1K"++2$5T.\ULL+)XX!>8O%$4 M*6UVMS/Y#/FK2.11S@3:Y.J+`.@VUYP?K_136.V&*JN&H,W[NOM'2&^N3@N= M@LUX>IY-`%=`*ZVRP%9,2KW645D`+":UG)!?'SZ3.M&27EWDM'M/$/V,P;S& MQ,7BIKWYB>>)FE:KN955%TW>>4K,SZ MHKUMMEN;FJYX1YN'AXWF!E=8/.71\C.2ZK@.?&SOLO+V'1UGS0)CL'5G*=BU M]E'SI6>9PWX4(GOQ]10I@L,EEW2CU@.^(KIK=O)*<5UX+O2A?MD6\V+M=S, M@W8C9PX4#/O<>0LHZ*!YW#W:]+S%Q''0.VSUMK#DHJF[C5Y[M:DI-ARK&Y4G M(^H5MP;#YC:Y:-27F+>(UH]FM,X34^LC.8D21?N7OI=4JES+NSG(.QG+3+,) MP(KHXOCX^)FPF3]FWGH!3,T=^V5`*!(/K9`ROI/G@'_G0#[A\CIHRGWT%A:,+\I[C1?(Y1_AKZ)GNT5&.Q#<& M7EGP4$C8K9SJ_P;P,(>[#@]S!TG?`"KFL7BODU<`6T(%Y3A@HGG`1R!#P-B4 M0WZ"P<6])[-"[>D=7HECMBIL2W_)&F^?F?`0S'Y`78U.2:W+U''045=#;)R[ MA@;*2O\M`%DVK!3(CEPVT3>(E'EJNOVM(V:.Z;UC@BF82S^X5N+@&E9'KY./ M/K\H2+M<;Z%UTN=9$4?-?.S]U2QYGK70/3[H*TC+:33`.3[FEP-9!M=SMNR3`&P(R1]]%C@2Q%M9$6P^C@GFG>-X&8BE.FN4`L/7`9\P MX6A804?><"^:CV2,IK1VCN4EH99G,_F M1;*645]WI9^+W4ZCMT/EN`+`2;+C^@@&FQQO=ES+>GK.Q^FO(7?.O>0,L(]M MN>4]^X*`WWKN4:L%XCE[?/`L*+:XHGG>3[O1W?:"SJF9R(:VJ-DZ;BRSH"6! MV.*"YNQ0\ZBS[?6HYFH;V:!6MWFX%,4M"<06%S0GY;C3V=QZLIO:8C<4C&N.:9+@")75%K>.O7>8]YT2Z M662RS@R]%(&]&'LT>^WC9:AI;59X,;H'[7WT,I`F^ZTP_I%[?*UTWB(:RH[Y M0A,O2;]/S$UMEDZY_.^YE[VX^LD/"G3N6CO5R:?JK#-S7H9@JN^Z67+Y[(5T MM#5G62HWX-FS+'OR_A++6>I<>]Y$+Y!:59CQ_+RDJA>+9*WB$<%;NW2)5H!8 M&A-K>?.9VH"G/+0#05IL;O&X?.M/$6)?44'E4.%S,I9UZ=>MINP,^J_DVW_] M2'WBHM#Z3\RP,+D[577VL)KK)RSUB^469><)>///Y*D)@?_]=S`0=](VJE:[ M@1U.F\V::F]*I7>IC:IL6"=4Q?:SKZJ/*<9'1!A2U^VT4X_5[,AQ%,0)*/_Z ML88@!_Q!A/S[[ZCF:](M&.N%_NL$^^]YD6J8BBV/P$`"57`CPB__HKG_I6X2 MP5)M_]ZC"K'_DGV"L`F&+LKO^9$J?*9!JL\$\LYHJ= MB<5[_#?\^?\!4$L#!!0````(`$1&E3]>?\.7"`T``!6S```5`!P`8V5R<"TR M,#$Q,#DS,%]C86PN>&UL550)``,/Y/%.#^3Q3G5X"P`!!"4.```$.0$``-U= M67/;.!)^WZK]#UK/LR([GIG=I.*=4GRD5.6)75:R,V];%`E9V*$(#0#:\OSZ M!2A2X@&`38DTVWJ)([*[T<='H'%_^F6]#`=/A`O*HHN3LW>G)P,2^2R@T>/% MR??I<#R]G$Q.?OGWW__VZ1_#X>`+B0CW)`D&LY?!3?P_*D4\F$12"9#>(QG\ M_IL7!8//IV<_GPZ&0\T5TNB/C_J?F2?(0)46B8]K02].%E*N/HY&S\_/[Y[/ MWS'^.'I_>GHV^OW7VZF_($MO2",E,_+)R4#1?Q3)PUOF>S)1-<>^GO$P$W`^ MVI9EI="_AAG94#\:GKT?GI^]6XO@)%51OP84DI&O*_2I36T>;D_C38O3Y3C!H.-ZS@+R0.9#_3?[P^30AD^X605>D*^\]ERI"E&G[U0 M^VRZ($2J$A,1\F5%+DX$7:Y"DCU;<#*_.%$"5LH!9V>G'\Y/M?D_%/A'^^LQ ME0HE2Q+)N_E$X6E)]E&F*N0`C2X]L;@)V;/81Y,=:M^%^22 MM2110(),LM:A4?"247-/S!)8Q6+XZ'FKD39G1$(I MLB>)@J_E7@6*XB48B3BY3*1-J0*RAG_G+-EQ:G,K75. MLX^##>%`LD&)A?&`\+0B?R;T<2$W/WH+DOYRQE&@_US_&=,G+U1ZBK&\]#A_ M4:W,?[PP)J7@->))W0/CZ3O8Y="R_8PU8"&5K"$!E(@.*F/?9['2]('X1&D] M"\E7(BV?-X`T^]I=I`CQT,`T-PS<@M+HOT<3_4GTI!1C_.4K*4?;]"IU0>$5 MPF@Z5'='K\B81NL<3;3N5?+BT>!ZO2*1(*JVN9,+PETM<@..U$$0#H0A;VZH M&PD@>2E`?D0$$+8B7+[BJ;ZNZ7S@3Y>X$C+@NYAOB_J(.BK$+"R9K"VAPE>#$2"H98XH7+[5Y)+@B M*TY\FEBJ_A^2)&91,%XR+NE?R7.K?=5TL%6QN]2Q';'X,=J1!QNAN3T=3+7C ML%?@Y]KLKRSRC1F2DR9UJ)D&4\L'L<+2Y%E8T26_#T1(3GV%4W-7VQKAYHRI MPQHP]H<%=^39`>87\&(L1L.GB7AT+>,5F1.E6W!#(ST&?,E$7N%JT@RF3UU8 M3X\8.$V-A>$%(!5=FCV)I!<]TEE(4HN(O%[[8:PG[+XP%CS3,*R,GL!9MJ,J M`!;$>-G#9!AD8(+1-5@JA6*"2E&3@-21;:L2"QEB1`!-@U8<-F'HAF%NJ3>C M(964"-4@3B7S_UBP4"DI=,,H7TH(@)*G[JHEQV"WW42[-3U"&1P"YK*E`.0Z MD1K3!5'HLJ.<=N;193M!-;C]CQV;XL8`1MBB6@H@WMG@;$[JWGO1$U+NR3TS M46E:KT2$(J:.63VG3;;P&B;URG(P1IK')*C]<&OI=O&VT"$..<@R6-1MHM#U M4"Z]%95>>$L\0>YF(7U,++-$'T:\7>+A),:*@T8V`L!0)P]=[^.6>9&[QG=0 M9,VW@0)KP.NM`439*`1S]\+:JW325+,S%/W)^@0-UH6TYVB&7B.>.OR618_? M"%_F05CY9.TDVV_60((BIN8Q`H!)MN`6QP?,@M"E:)B)!`#8Q^C84@!2D9705AR$#MLH/3N5.^-P*6AL4"HU$M% ME_E5AYHF43I:?J\G\E6TI.1T%DM=17YCVA@6214"I#291FI[E-"\/=(,9LA'O>@:L"&AL*P`3 M$)GH$N`'(CT:D>#:XY%JC$1AB>N<^K2Z0A#*L%T96,N`%26-;06@!"(3W2AJ M3LEDS8G"](J3!8D$?2*;G>^W3.C%1G?S;]ZZ.H.V#W=UC3N(&RN8#O,"I/YI M6D`*LY_0P.Q7&C&>I,_&?K7M=>JBRFM,2#BT1U)C>T?]D6JI[C3GTZCLZEOU MN\,#*:H'_MNQ+:V%(J2/IN\2]5>G];F(Q6'/#N,)JM)FF]%^^<2\2 MGI]NV4E^;3#Y137-NHX<L<3\!IN.2^ROYNP*Z*R/ M4!5JY98MVVY'ZMHB=!W;>\[F5-X:-^V67NPVZ&8OCA+95L.[!F"^X%BH`MEJ MTP-&.+:URX!O5#PNE4$TBI4]=RM]8)R>J?I,YNK#V=`IIQ!QO9;) MBJ@`-=:O4-)V&TQW)?6Z);@,9_::7BWO"4Z5V6ROZ5`)[%]0:J16.?-".1NR M4V39BX&B/Z2]!J88Q"T%R'6H59(UF+3!CKWDO(C-MUC"G.%-ZM3\FQYW?CF" MSUSJ%[=Z5:7H6!:XL<=PZH5$/)`G$L5$[T44U4W#+I)LZME$TE]X3?%C($,* M\QO+L"FHW7<1+8@]WV4CC.>IGC7'IUCDF@,?2KI303_BHKL3#\9 M\TBOK1F'(7O6V]=%8HT)#7"N/#P`7,CQTMAN.(`@HLV(0G0FC3[PX&Z>:#ME M85""CN7M=DRS^!9="^%6W]4X5#C1!_*!"*)4Y)T4C9G]X>ZJ@J6-*)":F.?B!DGS9BRA@/& MA!8Y>QD-@1!4L!E+YWBPI/J]K&BB&3ZU=*GS['1'/VP!==%K#EXX=`)4A9T(&V*-K:7;R#H!&J2GA4)T`![1I0X0-\1 M>]\ MG`@1DT"I-27\B?I$3+W0XYN-XK]YU4[[/JS5'9/UK,>`MP-\U3+^FFEBQN./ M>(87\K7UW5P?SY+-`-YSLJ3QL@1:,'VV"ZN6_AC@V=0K+6,24+P9B'BV<&5+ MRN\BI7IR"'5BB_'.5A!MMI;+27L,V&OBC99Q5U.T&7,_XZG\)LN51WFV#:QX M`'[MY0/[\&9#9XUXCP&DAWBK9=`V5,4,XG^BJ3@GD<_UR5E79/-W$E6O1ZV. M[X)9=H.]]2Q'`=3FOFD;GR`-S+#\%Z*ZM6)&=BN->0H33&]%9)G^..'H]DKG M6*P4;P;B!\Q`S&X@KEZA`:*U`C!/>YS@LWNC<^`5BK8,=I]B1EUZMT[N[AU` M#6AC<52"%9;CA&*M;UZA*JQJ8`$FGFF8JAG%6[AK,6DFM^*Q1'Z<6'3ZI',< MEDNW8!#1NEU[BFL^DAU,7]M;Z?^P]M?HJ@".>.^RG[(MWH)$/.>3&6TH74@# MP:*%Q07',LO1(M+MF]<`944#"R[QC(97S2A>`7S#N,$IM4AM(L2*79"0XT3S M'O[K'-\PG3*((]IP\4:/XVEU#07@])U65DR\F<-V+-;JSK]H:V%D0V'NA9%0 M8>@`N^?"R/V@>2]Z,DI\8V/_SYARHBP-8FT4,0X3@>FS6K.6 M'ATVFX*,-?<*!)%`-9(ZMKYX]#N-+%ZXH9$7^2W5O0V%N>M>J#!T^-ZS[MW/ M>1W4O6!%NEN.V=;6RE7ZX=[-L[OM+-=1E?"]!^=V(R:<$QURFT*0'>(I"'*! M"FTV@#90!'UMK1SA$Q(DNZ6;071(N@3WIPQV4'Q MTX7'27KTO`.N+G(#1HWDQP9,@$\Z1*.Y]+?8[NMETX!&/D_F:-$3LF.`&M`' MK]!6;TI%OZ,B_W4DU]WJL[+U5A%]A)H^@LM5P;D9#%6$8D-?8+QU6<[;R MN]M68=EOEEV:-\UV M.2&8O@;/&*XF[!ZWH%L,N\-GKGCLVRZNYW/BJ_;@>NTOO.B1/*A/Z2[2?AE' MR4RLOD#KR0MU"@,8+FU+7!JO@\6A`WD=HEMVX"&#IH>K`LAQ`><*I2_T/S-/ M$/7D_U!+`P04````"`!$1I4_9;\IR$45``#V3`$`%0`<`&-E`L``00E#@``!#D!``#M75ESX[@1 M?D]5_H/C/'MLSV23S-1.4O(UY2KO6&5[LLE3"B(AB0E%*"#I([\^``^)!P`V M>(@MQ2]SB(U&'Q\:5P/X^:^O*__HF?+08\'7X_,/9\='-'"8ZP6+K\<_'D\F MCY>WM\=__"?W^1?\Q(2(]$;4'XY37TOAXOHVC]Y?3TY>7EP\NG M#XPO3C^>G9V?_OV7NT=G25?DQ`L$S\"AQT>"_DN8_'C''!(EHA:*O\ZXGS/X M=+JI2TLA_W>2DYW(GT[./YY\.O_P&KK'F8CR,Z"2G/RU1I_I=/[Y\^?3Y.N& M5#!RHPUMD>]/I^G'8V&XHZ/4=)SY]('.C^3?/QYN2W4XE-.U3\+H@\-6IY+B M](+XTF:/2THC46/"(GI;TZ_'H;=:^S3_;)+DFXO/'92]A&DFWA/B28$BZ46M+( M-D_BQ)N4.<%T:GKK4XSFM.ED(([\8R>B%]I(,-"LX": M9I+#63:QGQ*Y5=Q[$-IE*^(%)RNZFE'>H[AEOGT(FFM]DK+N4]8JZW[%I7,2 M^X"(TD;>C'[G3ORW5`]]C6C@4C>O24IC%:J3 M:O**?.:4N/NRUV-/-/>I>E3K&W*U- M=+EKM71#NE?7JU=\J_0@@RNG='.1:>)M/;/#\/@_/V+S>7EHU-7I-?UZ($8]GC$G[(P=<C;,J>M%VL<4#A3KKU-`E?^=?V?V'LFOI`Q MG$27A/,W+UC\C?AQ=>II52:S$*S,J,[7N9BUT[B.B4H%$AI`QBB@,G$<%@OI M'JA#A:1B0O:=1IE.U>8/(,VC@(D4*QXL]`/!P,P/Q7CF-G@6PC#^]IU6O:WZ ME&E?^H35FP;Y0=XKE\^\]6E4;TTY71//O7Y=BWD=%1'F/EI27M*@XD2+$IEM M("6PNMQ>6Q`20&PS@/P!SR#.-'@S#=K0NK>S(]4N^VGD-LW6E$=O4Y\(80-7 M#AC6>2!L=$<&!AM\XRRL;JW` MB)OT3HE':@M6#C2U$)7*Q98!JVV]E1/VSW!*,#F;$-FOL3!7T/8=$S6/0(^X(Y M"W5[C8IX9HN%6:,;A!IIYQY]-A@U,-R?`>W[U#=!RHD M\!P1T=7KKEM9*[K;%\P,85%PI,8`.K<96>`$P1S'\N@TB$BR\F4\S;6AT_>KXL3R: M\HTQ]\7;YE%NEM7A13;+[8`BV/'20F\KR,#XH^B?Q61#9@6$575J,<5,M@DE M&C+LB`#J9QDX=#Q1K,\KY8>,R"`C,?0.AVAFY6T-0Q3K^JE8RCT8Y>8+OFF3 M4EA(3@R2QG;GD9GG"UEI*$:9,94.;,,C51):>L0C0^&@`I94;%-+XW9)15V6'Q-(^I6]>@[FPSW=;? M&CKL+@>I9^5U'4<4G>$E67L1\>\H">G]S/<6R=:9QOLPXDU^L9$8-0ZL%(6# MH8DMBA6..T8"<\0W4.0#``4%:HI:&NA%RO\P5M\WT*OL>(7-@P[:%=]]@ M0A'P]JB%[+)]C.H!L#7!EAD["@P$!&6L`-WWTZ;.L4?F,VJ,-RL#= M66>$8D5BXKJ)^,2?$L^]#;(IE2WBS[3-,G+^Y8*,];W,^?R&L]V:=-Z?I!>5!IU&#J9@J+^&-;#XH=Z+I. MC?.6QOD*;CPT*@1WN8I5YM4_8AE4/BX)EWLYH2.F1-2]B*,?@1>&L1@*IS^N MDV7[[65Y^@%H:U;UP:H]*]28ZM%(K0;!+2K-3.'3:7D% M?;K/F;%JG]&@I*\5D@8##+LN4J\T<9)7S\%`]B+%WO4;83F04 M4]"FC1/][JF1''AN:I]VLRQ5[V'S55--?;;P\VG%?'?BO\.]259_<7'TUR#N MWA\F>W^8[/UALO>'R?;JF:JJ:\=^I.K]8;+&ZX9D=[<17[/!KZ&J);#HN(U] M/8$RD$.5:H[I6B.BF%)V:Q2$XT$ MW29W,*!61?!J>"9A2L,+18Q*A+ORPOSIDRCF@9Q*3'R?OI=@F+)@O3K0)"G@N(I;7-][/ M$Z$>F>]6G*KYNMFJ*7_%ZTJS'D`OUIB@2`%(^II^GE M!SJLQ`#%1OH##:DPCKQE]TJ$`Y\EUY)GCQ?5$GH`M-M+CPVT>%ULHR/0Z0TL M4>R\/])DO?\;#2@GONSUW97032H1><]4C0>[0GF7"RN$%R&MM(9VRT#>&6;^ M-.[UI&LJQ9*[1'F64`4@!HK\:E(%!5[7-^L#]+.2T2:U84RG?FP:/SX<%CX[@V/7#$;$CIL5"MLLEX8O:<5T3 M2?$QB"K)2("'.X>!="MBO9'WYJ&'&D\4"U-YYD-)]J)2JB=PX46V=_4W%]D' M=+30W1HML#I0K$YI]8&&1VA8W`MP0+6T1H2!,8JEK.WH[D98[9(%0M!8R)H- M_U@07M`YXUF:_1-YI>'UJ]`NO<"&OR6[4*`TP!W45-HF&J8FO`._W=D7.&`< M5*!-#XR@]0C1LT9](6;%]37%!JH2:NM4V!'7I)<56A3,N8H/V_4 MX\40`]52F_(-I0U>K.[*LN!MD8'@E+>6L3?(]KBUC-)6=OUFDT*K&]$7>XL@ MO7OB)`B%H%*OP$W^YR?=]C?1#&6O/N%>*!2[2J;&4\H]YFK.S.ZPQN)[ M4@/7.%*P&QKU;`Q_%A7T<4LA3R39\K)@GZ/I07OYYF4B>3A?1R%$0DDY"L(:5DZLZ1M:;P(ZF8' M(**L*\D1-FZ*C$;LFKQ)`X'ARUS6C"Y-V;W#%L@&W9"EJR+'U;@9>&DZH")[ MIOYA=VNE!_JR6#X.13FV3J])V_KMXVB'BB])N+SQV4OX?ICX_3#Q M^V'B]\/$[X>)WP\3'_1AXL(U&IO.3WMEN)Y4\>"`@2_*L\56ZEG$>:5A4:RV M].3[]I[?YFI M)W;YVE17=F.W*!,L6._F4K8^A0C).E?GJE$=O0F#E9>TV93:O MC$'*((=;&\5M,`7DC^,$6+Q>IU,&XN?*W`9SQE<)OG7Q'E:JWNT#:T,.H+;J MVX`([!@4A\(&A5$O(`(9PZ$\5?'L\Z>S1$'Y2Q)=Y37]Z=[TTY+^@Q)^P[@N MAP9(7HBI1O*Q6H.E=YBUYJ7V`*LMCZ_F6E#,G?+-4REJ+7NU_JER-B3Y--8N M.]2-S*A*::^[@67QI$?*"HD/-WG42C^%,DT+V_JQPZSBMU43G MVS",Y44U]_/M[>+ACT!4->5B\!71J4^<)+)4IVDM2N:^M2B)?##3W@@VPQFK M6E`8&@(D3><_)#I>F>:'#/MABAR=@YC.!KU]"8!B M6#1Q_Q6'41*MG]@#=5C@>+[,,-R>3WMB0'4U6!^RBLWS=`-4,=;)W'[QS7;B M@-+)WUX42)_6&T)P=3+*N#LT5W3-J>,E)A#_]FF673]9R=3>_R:_5YJ539', M2Z`B(\%^4)"R5N8J@GH(\23$86*AZ"H2S>1NNY@<7K%X%LUC?^*DMXW6!\^- MI-LALY[T0+%H89Y=8-`LSC!3_#Q=1[D-(A(LO)E/4Q&O7[.3B_+JZQ=OFY>=+^>W*9LO MZ%N5/5#`=C'@+@!L*1^*!!NA,JQ'Q]<^W``NJ'NV!UGFH M2&YOO)T`V0(4*/)[=H#BOC`\JE7R";#V@7*;(EI+*(J,=R+0UKW*UMEHA,KQ M06"EZK:FJ@S%6EE=U"LZIYQ35WWQ,)A>BZ0J_9[#R*Q^GQBJU81B0Z`NYVWP M+'HO)M<_&L&CH-4"ITB[YZ#1J]TG8$JUH%B`4H$ZF14F-SHII_PV10PQIU9D MSQ'4:(1^(T^],A1K1W51IYR*"9NKO@0;2J[%485\SS%D5+Y/_%0KPK'LHXB7 MY?E]>H]<\_2BH9RA0U.7VW-8PGJ7&3U3GZ_=*:^<"4O%G-V"KTC=.U MG'[/(656?XB)VJ8FI&LA0DX>4_?.(S//3Q9[(!C2%#'!J%ID_Y%D-D+/8*I5 MAB+1O"YJ\D".YT0T.4-ZP[AB.;$1839,M)@#,=ES%+8P5)^XA%6/8B^C6XYF M!;'],.LEB?UPDG9[->HPZ;E=142Q=K*/M_?UCS;097_](0=P-R#&\"A7_L*^ MS_RT9&H.E[9,]_/,3S?3]7#FQUH`%'L+8A*6;81/G/_$'J="+3>6&E#E6C&8 M/@^0C?2XXF9;&#%[TP#"J:4T23AMEN+PHFROT;77J'HX\.[5J,-@OZN(*"*R M1HD;+R"!T_-XHR53<\NP9;J?XXUNINMAO&$M`(HIU@-=9QW4_?R.!8LGRE?9 M@LJ=7#FYG_G>0AG46Y3MB+D!LMI0K?1[<0AZ,(Y3B115V MR&U14G&'R/\-&&HQM,]XT=Q.HKR<3XC]3 M'LETJ,=X)FH6&D;4-42VSGR,M\I!^!PD1+N8N8[V`.24RJ7])(\\1D?_]B:I=Z+JYW"J] M='U*NT!)D3>*I?Y$SOMDZ#[U2:`^HVDF*L*A3K0/&&A2S=KQ"H8H5M63 M('5!Q-!"S-^D8"1U!9=OWDFE+MZV)%EBV.2%W#V_UAC@UGW%+,Z"QQ^DAP;Y+N\7/B M<"/H;)`:0@@Z"5P9HK^3%54]2CY\3?;MT+JF<1]([[UMV378CGXI->&^5+%L MR?8JX)A[M#:22C'UZ_(#5@$=C+2I8L0W[7?0Q'!]-.S6\=[W%+[?D%BRN/4T<0BPJO5VN?O5&:OU/P2VDU M(W^O!TJ?/];32#_6NLR0G0.S-Y35-*V%;,DS/P/-"B[?A7C@^($:9A?P,W$J0```K=,#`!4`'`!C97)P+3(P,3$P.3,P7VQA8BYX;6Q5 M5`D``P_D\4X/Y/%.=7@+``$$)0X```0Y`0``[7W_<]LXDN_OK^K]#[B\5[69 M*F>2K'?N*G.WNE)L.:-;1_)9RLS.3;W:HB78YHY,>$G*B?>O?P!(BM\`$"`: M).SDA]V)R>X&A/YTH]$`&__QGU_N=N@!QTE(HC^_>/O]FQ<(1QNR#:.;/[_X MM'HU79W,YR_^<_*__]=__,NK5^@#CG`;6WP7O`HC*C/:X!>(TO^8\(?G9!.DO*L5 M]B]7\:X0OO'5\=OO_^2;%_D762O-1HIR+^TZ//? M]/;=NW>O^=L#*16T30^T5;D_O,Y>OJ`#AU`V=#'9X4M\C=A_/UW.I7UZ]YI1 MO([P#5//FJ3![CRXPCO:+)>3/M[C/[](PKO['2Z>W<;X6BQP%\6R4WK%1 M>ONO;)3^CZ"9U]:==M]?05=W[-$Y_5>M7?PEQ=$6;XN6F6P%''C37,E<\D$V MV=2D[AAZ25S_.1L+=SO:8>8&]!$TR:L3)44:/KDF, M"HXC5/`<(>8].=M_O"Y'K#W*T[@.K"#>%+^8_K-CE'**UQM"G>M]^JHV8-N)(&*CV:JB?D0F$E!*4)]V!P/OW_ZH!5^5+QP=Q?0W&.#XZX-QJ>/G#.1C M$S^\)9O]'8Y2'J]YA.3C%Y-+?$\'A?:-CODM1@E'=)@AFL:U[!E]&::/:+N/ M:23,G\3XGL0I^^L>QR')L)\+6_(C%=&''W3**;-8[O3O%5VK`K:SGY(%K(L?(( MUOW7<0YLP8CEE00,('4OT5MG*EHAH2=*QK/[(1%B75+.9@`-0>IU3`1KZA'N$-, MR#<[D0637Z6E`,>QKB"-V3)&2_&5WAVY`&H%NF]=O@@;$'Z#:\H2+0 M/0U;8Q;54F.DT6SPR(8*O:2!,'W^'9.V"_^Q#[=\]!A1&0C_@<:U28)IP$R# MWCWKQNZ1R=Z0W8[^ICC8\;AW$[`>(/QE=RI(>7ODOMHZ#\ICUBC[ZY;L:,LCQ]5>>`A)Q.V5A[!)?E)S MN`C"[2E??E$#^14',5T'3*^2-`XVS9!;E[Q(7FKJW-BJI?&(K:#J[)P'1=64#&E4TSQ/*(*5>BW M@O3_/3=\27.$[A!FX8)+W\]3,:O;@*+S$YOY+^+P@3K_"Q:#L`BBN?W4@S,? M$"-.*V/JT4>8^-.L8;FAF_@R+4(J9;Q M31"%_^3!P33:GH<1[<'[?4+_FR2G8;+9D60?XS7^DDH6NA82\F'K)<'*>"WZ M;&?"_1J6FW(?>9/EY8?I8OX_T_5\N4#3Q2DZGR]F:'F&WG]:T7^M5N.:KPV@ M"("&Z\;<0U!IU!#(MCJO5V;(>$*5[P66[F=[/D^[ M-=59$$TADY/EXN?9Y7K^_GR&5K/%?'F)%LOU;&2+-`8$Z:NLYF$-/>[J08V> M&'1H9V/7-<'"(@F8/!D8JST\_R7D!`I/R4ZS/`)7@ MAU>'!69^4(`E9ZFOW)9NDVVQ;RKN-=O.1Q$3-/H1U`$P*SU\.B!F+2*:2_R` MHSU^__@Q^#N)3_9)2NZH2Z0KF`^8W,3!_6VXN<0W;%$C7D'T%Y`/6!\!5C;; MO\=V44^O=N6VVT/$;@;'DYFW]8H-7T?.Q)Q@)+ MQ%Z[=0,VEU-:,@"D!S'I[H4+B"QC0X>?IT%^QU#F;SJ+VTF>Y.QL_Y4+0`<) M_%!=*0-E0OQ<-,$@M8<;T5Y<68GLXUP\,R/0A9FGUL06<,]FDG5O*+(5WU=O M*L"K15^MA:XJ*Y-)]<@W^Y0QSF3GWW+<\;EI4YN;Z)1U4TY/,6]GY$6G5^8E M69QZ:5XPQ2I^">(XB%*=G2\#GG9Y"A4/U!?1W?T"*TBA;$KKRV>%A,G)\N/' M)9W\ULN3OZ!?II>7T\5Z]'RFB?I%WR5KH^:0$=)@%7Z';(`U5T8DW]@R8=(Q M([C,K$G/'!J2;B962T2]"D9!65F1^;,@,X2&GHEU[E_I\&H:V;!(!-ZV&@B0 MV8;5T_+NUMC3J+;RY-#GKK:*8P#2)<1,LBG%/6567>5S+F'T'2FGN.PNA.(2 MEQ:QQVD.*+ITF/'//^815>%==IA.'+^;L.3#H<=B96TFO;*+.31;DMN7EH!) M0<67VQD=JA".:TY&&"!]=%0W)!W.THQZPSG9T^P,0(.FTI3"=3NY)09+934YTJ%4WLMEH*YX8ZZ9A M,%UL%6L9&UUF`7AW".088OPCL_P)NH_)0[C-OJ'(\P0X0#,G%&".VS[#DSG1"@72,F``*+"8 MXU8XI=WA2^^;&/-_".>Y3KK\9RGHK*#;V3[`G*=J0XYB.=>D?(4.[\:%<+<: MB?:(UX$L)2_!/#@VH.=$8(!DE?J3E!=L))N05UC]'*:WK`YC"9V@X/)X@H3` ME6RB]!)90),F-**.Q4['DPD4!"62B104)183ZBR(=X^LT"8KNTD=R1F6K!R[ M"?,?J"*T0G=W#P`F564C9F*56=I.NOP'*NBL,-[9/L!$JVI##G(YUX2_0KEB_4C? M=NN1:`]Y'=-2\A+2@X,#>H(%1HAT5_6*`^>.$_F\EPJ!)MF4ZB6>@.93:!P= M2WR-)Y,I"$PD4RDH3&Q6K5]PO`D3?GU$ZT"C>/FJSU&L8W4X[$))_3Y!K&RU M6E/$EQK\DX(HNY5)\#W#R(&F`0I(#S4U`L]NQDH$Z@/X:>'!GJ*;1]E*V MQ:Q#*CY1U2"%/",A[`7\^:IF,]J')NJ,[9,3[(SAY>C;SEJJE1V@4`$AMP`5 MA_0PQ5"H<7PR"P8ZPG-:##PQVSY\Z@>V+`"G>7S+,\BY.=,%!#71":_"3WDR MA0/B1^_@%P1^=*;I?%#X@%P'R14?E7WRZB8([E^SZ?LUWJ5)\81/Z*_>O'UU M_)9/Z?GCOZVH>^+[Y\OKLS`*HDT8["[R>TTEWR":L!1GR;18[`YX&/3*\J2' M7DN*0Q\Z`EA%Y-7R?'XZ7<].T?OI^71Q,D.KGV:SL3\S-](_Z:.?QGD0#<[* MT9`^4!O!WM;!U:Z)9/'+I@WE+V&LI=82D%T4,C4L(".='/Y&O_$G8Y]N$NNA MC661GIJHY30"?(K5.`(25QLX2*%^@W]LH7\`IUUL:P0K5-*%=)!8A6`F!`8.?=^!0=KD`_)7=!! MW457`%Q.9P?RKO8A#L(KVE`@7LHU*5ZQJ_'*&^9_RUZ/C?Q.A1+ML6]8@(R\ M8@5#HP3JZFE@B/"S!,\<)-+S[9`P&2$2.`\C/*?_E(8!+8)F#%`A@`D`6BU" M.$61<(WYOR0O)W]/YOJV8MH3O4QYS5G^0">8XMWI%\R=V2J7.[!R/<*>(_YB M;,?52]=25V6G[>&-^;.1'8R9*F6.I:6C0`()6T"^9LVO*[4-ODF.0/%YC"H2>J(:N#L$I18L^1UD#+;[&`#VY%6DPML[:C(LX4%\Z`/"J MYP9SNJ2"/9\B?E?0ZS@AZ`Y\(ZU^5:M>U6H7*QC\!KKR'0N*? MLOGZ&:/L3R.B;,`%]F9#]K1'E_Q#2W;&?X%3R7I;@[18?BM)[=9S&KV`V'I6 M-Z-8ZZD8)\5;5+[V8-=`2[/$1`.-A:&"H[).'``1X^0VY9$1I`IH\75/O\ED$Z"]RSTXJT=Y+C/"8LATTK'1;+/03]7MEN M6VFUI-H^T!`P*:B.$*?+;L4J*+F%>7-\@S4` M!K,]K(RN#K_G"C?YEI5SP`T:4^_O]CM6]ON4U3-C%9E4;XAK7X3.9(MG_R;98$!]*3M4`/LD`?8I(TOU_7(^[* M_.3$;I;=M9XXRO84;?188V>L71D>3N7I2KNNZNXUM@@:76MKSJ.QJG:/I&%2 M-[:`>G+IFEX@,D[1V,'(`Q_<_@!-AU0C\^XPZ>D^T]X[NZF36??48(1?31F` M02.;J9?%=(@B1EG<&1\_0 MG_LT]SUJ#VL?^(!\&P*4M2QD=7T&4GS$X\/W'H+L@&BPBY5]5@"F\6$'B`X< M?)BCH8KR4QS_5:+^Z*93*_MH+4"H58_[/Q#5Q-R MK*HY)_5OK4L*;PZOZ"F9&.FB;@-*EM(T1D,0:'K#$9"8+ZQ"Z?E@1N8YG:!F M.#][B6D7PDV*M^(SYF5G&X`U9\S'S831RIC,>VCGFXW:D]N7@9A)28L4WSV6 M'..:8P_(D/[*K)NI/G]ILQXB%70.&!RPV=V<-44W[/+ M9Y+F?-<`?Q=9/EIR,BNCZVK=;C)02)=;DI1I4KP11.CC6E"G#HGN>-=M0T9= M6L+`L`#UO*#H8%ZU>/?4P2!SE8!P&#F'H9.[T,E9N%AI`F;/9/(-UY5%9LWS M-:7F6M)@!=FQ0`W*M0^"LZS:O`AIZ.6!&!74WSU7^,E+ MUSL'X'`._SP,KL)=F(8XF4;;54HVO]^2W99Z.Y8S3A\E)RI,V?(1U&>SLDC3 MWMG9I$%K6Z1D80?/'@V*2S1?G M\^G[^?E\/9^M>-G(U4_3R]E/R_/3V>7J#[Q^Y/K7YPY,V80Q(#1'F3@ZS]]I MT;:G"/#34UK]`)L,#(]-J3FK;M_+XW=Z.A;9E.[Q.R6+T':&!9`K!PZ)(^ZJ M273S:HWCN^J(/A_P:'AA./@,Z&^IUIC26`HWN0@>6>7!IIM5D!3>54AB9Q.* M5BU]J5BR`OHBA@G_"^5_^K-)I-06T1G=!KX%E!58#Z-X6!\(H?_,XP51`8"G MJG2I6[-7^\A!HTZPJ!,DNIC;'0:%YI.X-`CT$4]Q_9,> MC]V]$B;]`ICP==M3W"JA)6%2(4-5.NI3T[%MR`P,I)>N&G=-Z+!6[IKP!7E0 MFVH#P8Y?]20#'B/U9TIWB4'I+4]#H'#(:P#O0Q8/X"#!RZM=>,.+QLG#7FWZ MP_5_G?26=PII]L?2]C2:45TBU,4]R4D0IT$5(H^L35OUQ%@[S5N%.MBJ-PJ- MC"_05()CF''77@4:1=2Y"7E&`FXE"IY]T%UNUC(- MWBPIE0O)SL6C<,D(IRM7N0)=E57R`D]-=1HK?SWE#>,=N5F'M'I"B>R[7(WPO.QA19N93]N?JF=NP3O MD]Q\@9N:5.7](3\8=H0.,E$N%%6E,LNJRT6%8&_.%C@R".(6AG5G!MM&Z0^? ML3V#K@">K%FSB3V3\LT(^V#G69CAF)&-=I2B'7$X\S:N(X&>YJ^>H5O3\47@ MUV=0[#CH`?QS./)8S8C+"ZI2!I`.DYP$3?;UL!9%AIO8CQ)_3E4R2[/%V[-+: M%MEM%N$5:K9P^@=C-7]X#C*Z*NM6ZM_ZPN?P,!__?-]V_>O$7W08P> M&-&_HQ^.WKQYP_Z'$N8+$Q3LTUL2A_^D3.R[J(A$&)%]FJ3T+QIC/4W8R*OW M6P)GR!,Q=WO#.9?F:\N#!>+6;$\0M*2J#@LTB"?9$P^=G50WI&L\ MFWO[=:KJ-KY3]<)N(MIH.3O]4=5SVZ7]Z9W"J?T[>OO#T;_]\&]'QV]^X`[N M[1^/WKW[X]';=S\4Q"&'#']9<7PH2-%_[:DS/'YSA)B-"=+-/2AK$B%`8%<V[ M^*KU[$<'&O"="H[QQIU[&U[/$5WR>Q.7^QC?XBBA:Z1Y MM"%W^)PDK*;8\GH=?&D&Z?VXBXC=E-LNNNK75\M`R[A11=1E**MFHUD9ZQH+ MRGC02\;U759]CUPCRCIR1-835,12TXU(S4Q()6SS&=6@$\V(X&Y.07)X?UU8 MEJX[QD+S*)M`_.C":G^5;.+P"F_?[]-/498]S!_>\T]!+O$&AP^",C<0HMJ; M2SU$0>6+>_\*L$VK/CW02C^;"VXDJKD`5$I`5_L4%3*.4$T**L5XDSWNCU!1 MIMD6[^V`VX8 MHIQ`>NP7_+@FS#PHE&MR+M/H6*]OAS3;MM2IV=P^VG2JHYC@R@?]X-(:`^7G MET_A9*Z.TO5/XAJI_:E]H]GI]FR$@GZ3Z<6W6ZY<QU/JKMUU;>0=::W:0KD"HWU1:QWAK(RUE/JCS2->!UHVE2E?!WK'_0E)85 M#)COE>AXY&(TYDJ6^48+-?MSKU<#5[KDFO=X.;XR"<;?:;32_VXDV3U=WE1D M4JM9^^XCL8ET<>G?=.082:ZJ=L$#2EC?BP/+OX03/,SZ7JUE`;11?/6)[CU: M$L*V?VX10MF3I`=@/KDM7\MXFFSU.Q-._+TU2Z91D8VHM=^VC0:]T"J&`HJK M:[)@\,+W3G.0^%A(T0(E&CX4`B>#GHXE^R@M[K4Y$=;55A.59UV%1+:'_Q0M M6Y]<%TXW5`P@#[J"8.&_.!F M#0]/&0:*`Y<00!C4U<5[O&V[X;:W4].5#D]&9PMV=?O6;D\J7HEU"=+HP._0)-$>]!;XQ>0U_`\+#VAW"(F2W"ERG,R^W.,H&3L>A,"&PC7"H6/T MZU;$7E*/6'W1"HQ!Z/7$\IQW5QO&%U\^;M M^JI??E&U)0#&W)#IW(CIW(`!SZ>[VG`Q3)R+-UA\RY?KY,EUL^.JK#BXEEUM M4/=3=KD)_03V2'1TKK\G8J3UL#I+#&^J$:+'H91FA+=KL@3M`]A26O\3IR@3*WN-2K ML^X,F6--&+PWR?10Z%B)D-57FE/GGIYYTQ]P\CMEX@I_&A73W"!PO'JE M\AR)!J6DVBCA!M80LXC M=)[>71HJU)\<_$)%RV"?$2L@[Q(0;KUD?UQ(O:./)7]-@:'M$?M"8T1/*$_Z MZI#*?")<>DZG%\#>437^`%'>_R!D&WR(29)TD"JFJ@HTBLALJOSJ6S9 MSJ%*92L*<(I9)OPYRE\<(?Z*_H>]'+FZIEIS1&^<&[4OA;256I;#`0'408+A M@3G%#Y?+U0JMIN>SU5-&@+3^*0P&!O9SIV&2U2VXQ.D^CEBAJ^EN1SX'=/02 MWDV1X]/GJGI"'2Y[B]#O&X"OU&JLPU@T9.3>]$!YA'):7LVMI,[]K`?F98`0 MTE-]`O/K9F[8HR^0A/?:PR"3^75-;#YO4"IGA:<+RV,M6+[+8!GA&[8?YP

V(9, M6_(PO:U368C.;DB6!^AN%`][PP:$_GD%]MG:RZ69ML:UEV7F.A\RQY^DRVO> MD179M7^M59XK7Z[6:'GF@_V,%1T$;=IZE+E".ORK=)$O097^-"SS1F!/%8-7A5B$HH>9$6:"Q M2P^=E6GDB\OEV7S]-+0FAO./5SB!-,1N*7KNU,:'>W(_1V.TKR490,E M6K3Y+^^@M<*I5C_LW$Q7$W(0JSDGQ6N>FJ@0%-5#QP6ZGH:)D2+JIJ!D*8UC M-/B`!DR.4,28=85=L[PA=_B\?3Y209&/C9#"RKX4;=I%&&+!E)J(QKG6<"PA+4`^B;]`$%8#:><%FEJ\ZNUQ^1,N+V>5T/5\N5NC][&QY M.4/+]4^S2S3[Z\5LL1H[^]T7"[(YV!H-P_FS!8E(O4.YCY77.GJPN8R=RR4Z`-Y[+G$?53.$EK_:IVN'WXRX0E'S,]%BMK,^F5G;EI MMB2W."T!DX*J96Y'->QY<+[,"!"DC\+JIJ?#65J?)]@#S8T-`D'F]P\@S$F> M-=IDKGX`O'D0H^O&YKHQN:OHR7',U"]6ZHB0/`V+#,(APR!((_AQA0_0W`4P M3/@M+LOU]+R>L:!>=3;R(1P(C!B'RGU0,NCAG33>;])]3#MU'YZIJCU[\505KS@G8ZOZX3S9+SB\N:46/WV@+O8&+_9W5SA>7K>J MA;P/DG#3`%XOWGRL#'FM3*-7/^TLQK1)N2F929H4Y"BG1QD#^ZRC74G_"'&N M<0VP'XJ(E7+K!FLDHK1D;R$,FD\8"&@760Z:G MV5I@'7S)EP/O<83;W]IT4!V2T!(JR]R?LFV0>%S>ABK#)^:97,3D(4Q"$J%K M$A>9"DHW=HS6I42B.>+-W)V0N)JN&Q`54+$Z(""R+&\!@B+/BU[FKT=VL;:@ MD*=TO8*%WEE%W;T!.&PXLFY743( M77UULLQ3-&H<'DMEF2[UQL6=B.J*C#4AJ8Z,94(Z8V,_(#W$LF\(9)LN M_4[GYY\8J>^+/V<@-UP`NH?YH"7;[V-\2R?;\`%GT^\"I\MK.@?3OW9[UKT+ M$J[=/@:H?79$'51Z*4JG+']Y6RC7G)853'K92%XMVT8ELJW.5O MMRUWXZISRLKD3MJ#JHVQ,RXWM3AE(HWIS%= M&Q09"+VMFNPN&JN5<_]Z/`3T/03/Q5&P\"@[(D)CHHO+V4^SQ6K^\PS-%_3O MV3>[AL'<,[7L`3]@3&]Q+/A99R2FT65TLH]C'&T>UW$0);2G[(=%6_[7+F!_ M?0C"B,U]TSA,Z"\[Y?OE%S@.R;88F88W&K#%X@/+(5JT^X!ON#$!\-+#]%;Q M>>$`[4\841[6(1JZY;)1(1Q5Y(W\M>*`]D1&`&SC6TKW#5>^S?SF.((O4#M> M7X'7X#$?:Z8>B307B6)?DK7)"T546D55/Y0WC;*V4=9X=='YS1.YM8"OS!<] MV02AV\2@VX2@7\M\H[!1_24&?,\&6]07WWS4E_*LGL6S6L@[7\`/LFQWMESW MRS*AXK(G;);Y#:..T_'?3+P?+)^)D0\7!,V".*(]26A4QC=O^=%=5I\UV]!M M.!5-ZEP+G=16KDVS+P"YI^Z6Y-ZGBW>2G4Z?+DX/AQ5XR:J+V65VHH&?7=A2 MO`1Q@N[I,H^?8QCY&(,N#HBALNKFV\%4FN.H0(.:$QVBC,U9!0E;P6>'P/)/ M?+)JU3Z<`(-&E6Q:<(:KH;]P8!''&1VZ$SJEA-&>=C6O[$:BY#V^IJOTP[%3 MG,R^I'%`8CHU!?'C/,5WB=8Z=H"6:E]:.&H)X`"VTS&`.-GOJH-=)\#=M#NI MQ=6(N0A4MH#*)M`5;Z-VROP(U=I!O*$C/Z/M(2R,#`AET7"Y_GJ_FRP6B?^;G8M!Z^M>Q2UT^%Q^@_G+J&7F! MH4.]51K0WN%(=@ZY@ZH68@FH`'ROG_\E.#M/#H4OYYNTO`A3$.<2&S*91/Y M^+MIPLJ:7?YJ@&2E5&9D![%\]Z`HUL[^S00C)@^%45G4'94B MQW5'3DV$#`')NB-TT5+I1;\2:X?*B#X+4V>KD(K MYO;_G=`!>//ESM/U!;)5RS/P!L,%9(>2#VB0 MYII0DUJY/IU>V#FPCA;DCDC)V"BN4;Q'!<&X7D!+M\1$!W6;5'&4MC42;$`_ M3'."'CX=[7;D(#!G+ MG)$VHVT:R;"','6/]!M59IQTQ4Q.;JD,&K?5%W1)@BG\V%[\>1A#-GW7#XZW,=W]*;[&<8RW MXNM,M.FECKY%#VQKDOXX,K-V:R8VUN2>%`_0.0DB'^Y#T=>WPK;4$)&:58-- M95,#@\I=I`^*)T5ON$"9OOL&Q-F8CGL>/>"(MA9J.&T!K=1AUVB! M[4K0#VB+JC=A8DU53ID=56A\,R&1CA7F(X>$U'`J+"JC&0A`SD-J$"1E/CG[ M\_'Y0$;?VP*`9DPO>Q'C^R#:0&VC*MF;R0DN\[DV:[]D\ M-YSINVTPI(T;(J<4).'5#F?JS)6K$2XK^12ALX0//`I2]L]9/"1KU2PV$DN9 ME"^\,[LN/"AC)ATH*:(G(;LZDAH5A.YR)4[QI\B=E!SYK'!4S!+/'Z#NW/O,"7VS/YGR-?:A MQ'CIW(+*V73VGP9"&.@Q2<=`J^UP/EM,F6]L`J!J9)\=[VEL6YZUTW';$A:5 MYVZQP)N6I%>N;*O=G*%Y-05,\F>'M;:']B73O-K$U'A1V5B#L\/,A@>9NQ#> M`<(4@7L!/8\/W4*AS\C'P^)OW,,K]R0)4YZZR]80&N=79"R*(RQM%O`#![)> M.?'TPN;,3AZT!$SR9][9F$+CRN,%'3B16EB;4WW$8`1PN3S0`HXLY;$63NQI MMAX*>"9'6_R'GM[-YC9'].`1>/S\O9OB]G/7(!NPL,P=*]S\3UXP:GE]BJ_2 MTS#A"]F+&-^%^[L&K+7IBY(OW?1V%1UT^P-1C$6C+46YA4[N296$557G9V`+ MJI'+'6CKG1BKIE&&H(NM4E-@;'"!U?YPBRR>U6M@BY$=L(5>YI0C5]IV@3)I MN0N7.!O.@1>W#BTCVB<^L?!."M=^6K3Y*'706MF55C]`@J&NEN1&I>:<\*I5 MA'MG^C+8<7?-YO=;LMNB^=U]3!YX\;B1PR,]E1,CS=3M2,E2VM!H>(+RT8Z@ MQ'QSXR;,"A6#E0]+.4@8R1RR$R`-YXAI6!_C3<@G"?KO'HK9,&V?L;!*]\,4B,6O3QPH8)MY$S/D#"6[A:-`>0!2Y0&CWFYU>GF M'_LPQAY9$54LS`YITQ?%2KOI[4I/ZO8')%.DTYJB"&4G]^2"_M!;MF%+ M+92^O<=Q^LB#P1EEN&?<1_Q/;[[ZT,<#,599HT9E%UNE4.78H(.:+1SCC7_4 MEQ.QTRO1Q]!W+]9NW+#-)%3&BA=\1;5)3G5R%;9!RC$0H-U M.S404%JLEPB%FBM&`">;/TKR[#!"=/.*+MGOZE!%%::O`[6R^65PW`YZV\$& MXRV_:6Z>)'M63GUY?4+N[DBT2LGF]^920I>^O/>@B]ZVBKU>?V`*V7>VI:QF MW\$]*4BR2V(+(F:B&1GB='PML=I?)9LXO.?X.>(7L+#\0,'B07D]?:008V6V M"N&KV6K5\,>%(]@BPRT6L\HA.FA\?B!3W+?@#F;CKC+8P2>-)4653+%^R,C` M0[%JZ\Y6!GDC9I$69RIC_KM@BUG@OR`I]N1;VTYM*L,E@=X5D1$_?Z@,@QP" MQ&5@WAL;JI";O7_JV#")FWNB8YR(F'6%AE;+Z\*)\[A*$1*K&00QL8P!+`I1 M]P@X*I8VIA>*2-@;D0@_.Y][U4/DZTM1:0,P"",2+0`)`A(QGS@B&0ES+D)? M)X!K![^,SOM%%AS<=")@!X`;Q\>;9=I[<`J\OML\9H\^PEFD31;31$YK4O`\ MA]D'.$*3[95Y-Q`@-F%O$`M]->70P&U/+C[M#PV%4IT99A"'&#,LTM`5;GF_KG!2\>3`P-L M.)^]VM_?[_C'GL&.W6!_MB.?Y]$UB>_X="*YHMB0*Q\W;2XKG\]7)^7+UZ7*&EF?H9+KZ"9V=+W]!\\79\O+C M=#U?+L:U1E.@D)Y:K%NF)G-IH%XA$RJ+-"`LV<10)46,%C%B5*'VYO9AUZB4 MS1B#X7+(*G[9_'\1A-L&Z$6O#E7YJJ\LJU2U6P&ILE<3JZHX52&<%'^-75=* M,/)$-6+-*E$E1;4:E!.EP56OZZ&QK!I='L*R!T]%X#XD[&1*%8&Z1C!5KFY*E&M MLIP[;0+6P^RKRKS*Y4&97O@6,XTJZE3VT^EP?F9V?8TWZ?)Z]F5S2]6%+X,4 M+R,60$VC+?L/^VSM(=BQ4QDG)$K#:!]&-\M['`MWQ*#$Y>-H+\[*6*!^#8"O M!.B*W"*MA4_H&GHV_[!`)Y\N+V>+DU_1^G*Z6)U[L*P&0R2!1D7=5]A*+9W+ M$S<:J"G):XMADUXF@QTB*:0@)B;[2BRYY2?[^3\JLHY0*0V5XKZ9F`Q#3\;( MQO[*YR*FW4WQQ2[8\"R*8@>RFTGYO4^;R<%7%K*>.?OR1]"@Z2<7+1$3OO.1 MH)"2X"W:1ULTVC#1Z8;E' MI&Y!L3&D8IR<+!>KY?G\=+J>G:+5FOZ';5BN:IN4JY'W@'0T3$PTT=CK47!4 M-GA,P#.7T61C1."8/=P1/+0@)0F?FX`LFT,C#0WV5GD5!=D1LQ3`N3U:>/ M'Z>7OS+WOII_6,S/YB?3Q1I-3TZ6GQ;K^>(#NJ#AS\E\-K+7A\4L<0*9NHL! M$5UZ)3<&]D0<&;OH94<2ZI8I]2J\B<+KGJ!7D7P1FG6+EU4I+ MDBW2C/D.&U?:?):[6(;]@_@DSZ!-U2:7KA2?C,4<#Z2WJII[7IKLU0TPST`( M]O7=L`CD7^!5B/^0^SM>HK$:"/H3Y`V!4^F7>$,B=L[]7 MG]XO+T_G"WZV8;%I7[&%[:@D%\" M"P2+X=QC5GA-$@^(7^:_N?G2"MGBENS@W)(I1W&#='(^FZ[&]ER2P2?J(:L# MLDY3XK!#=T/#;WE]CI,$:V0TM.EK(%72`^!6HS\`L[A.6UT05W%[A'H=!1-C M'8AL0\'6-)<1400UPSN&$)OU,R)>EIR3^1D!N("9+"IP"K012G1TIA$T*)NE M.\`3"AI]`"H!89A:4/%-YHN3Y<<96D__ZDE%")WT@;ZZP;;%N]H'*8\L;T,?][73VEX#7[5OK:EN"?1%N])#`P.N.C$H*K(*Q,5+ ME+WU*#J``(F\K#`@3$Q]9((WW]^0A]=;'&;ND?ZCZ17IH[_-(MKIQTM\$S+G M'*6+X*Z)/!5)<=Y22&)WZE+1JN792[%DQ0E,$<,D>XK*QX@]'_E`IDI51&=H M&XLN:/]L%-PTH"=_EOZWQS@JLPG;L0-H4*0=G MG7)R^!.QO\>%HGC\B7+8ZM"KD9204RO/.=1.<;*)PWOV(9T,<0*2)O!J)##X M$[0*!,.Z9`TT5ADJH*P\]@2;(DVU(2K79Q.I%4H!8%5*=X7;DWT<,UL)DTVP M^Q4'L7BJ[R++?Z^RVT=I M$#^>A;OVY(ZR%SY@7*8PHC6^(DPW M2)M8[M*^XZQN-M%9QS>(\R`A]0WZ';9C98!PGUI+"0HY4;UH.-6XO@9GA"8ZT;$HMW.804 M-?PW*`!@+VP3`NU-P5T@K],7V.9/4?'8!T2+E40T1E6$WQIA$[9J;;M%Z\7^ M:A=NSG8D:%7MD;VO(;7V'@"G@O8@4%H7VX71*G6!T.P9X@]]P*=(,:1S+$78 MK)`UD:G2KN.X@MS=D8A7C,ANNUGNTR0-HBUUZ^+H0H.A'F,H&2`B#8T>@<0; MZG8ZHPX5^R'VX$19T8\CE-\_5"'TP2*T$-",1/114X]'%'RMJ,0$:*ZW%\N, MT!E]T@S4.Z@:6XPM*I!-1DG;,-N,;>'=&XU-GG*KL9IQY._\V&R4::^UW:A6 M%^15KA;,\XUU[X`N MTJ0$ZG*E"\%>(9?!706/`0_+;V[Q=K_#RVL^P[P/$KRET\X]CI*LX&@6'1]X\ES47PR)Y-/P?Q=AU<[9K`!9>;CS:@7+LSVM"_S_)$-V!W%"?`P5J9 M%*+89^R<\-45HT15<:@J#UT]U@ASF8@+1;]QL6.?,P?'/'$&M[KS`A-?.?7N MS%"]=(ZRGY#]#MI15KF9FA4[/CW]$C8CC`%:,G>@YBT-Y5+[CL%@3K9'!T'< MKG&[QHY8Z8>/16JR M7W,>1GB>XKO6RAM,H&X4IB'0K:/5_D6.XRN=?ECXSV[Q6MZR(_'(I"$NSG>W MJ`]D?2=H:ARZ+J]3KH&#\]_>S%8TMH',V&:GNV11&MXW6U/!Z$E9V\"WO/$/ M-K:G^YA=A,CW8'\.=GN\3&];GQ=ITQ=3?S>]_45:.OVQG+@UFNFX-DO)G5V6 ME7U=M$4947Y&X`AQNB/$*3VX(TM+^\1800T#[6)KW(0U)L1@YRJW2.-WI)#= M+HC1`WO(]CB2[`1BR-F>'\"4EZZY@MCH'CP_':GOP@4,:A]>8W!A88(>.?'B M]7:,C:O*KO3C&:'/CER$@2Y#D^-&;6<5ODY#&Q)J0WAS.,0Q?[[8WUW107P2 MGMP288:^'`IC`WOS):^BP1*,LR]L0=$Z2:@DJGIM`9&]^4A;AC(840,=1M)F MF>3_0#'>!2GUQA0`#SCAWWI24\%W]SORB#%*N,B5Z6A!81HNV M80W#P`3T+F,(C!QN*48D1I^B,$492;:_DQ,]94@HW:4]*(9SBPN"49VZD4F"+DZ>C&6R>?IDNOH)G9TO?UFAL\OE1[2\ MF%U.U_/%!S0]6<]_GJ_GL]6/WVQ-!SI/TMI&CS7F4;YZ@(PU>@I5QQK&0ETX MMIZ_S$FL8=X78X]FVD17K'&0]_1CC;X8[_)_=K:C]GZ&LCN]WU,TR2%B#?\L M4Q1KS!<_SU9/(M;PQ-8,8PW?K&WT6.,LC()H`QQK]!2JCC6,A;IP;#U_F3NW M9MXA8[=FVD3+J9W-%]/%R5-P:GV!V^74[`Q"[=(,97>ZM*=H9U#Y_B=C9'PS M5AW7'R0^_;C>$[,TC#5\,\S18PW-Q`SHW@GHGLFHB5FC6(*DPFE$S(%)%"&TT5> M$RJ?.:J].)[8QS<6C8G=8-/NFTWUGMC'MJK1)W;-E`/HK@#H;L"HV4D?7RSXK-_$2Q?7"Y_GI_2@/G] MK\)MM&]VTWMR']MR!IW26[+8X3MX'2;AI MS^9]N,OIVXS;UK_TZ2N,.S%L6>D_C&1Q=W&^7(WO#7H!A5AJKV7M)D)JYNTO M4J%/R(V%U6)IRZB_+K0J9J?GB-=CL,7/:%`]SJ":\:"7C.L[=.!CBJA>KY:S M'B'._)5A^]@S;(^>..F?)>F?$AENO3;.+@;4.DR^/S%?G%S.IJL9VYY@RZ_1 MK=@8(%U+*>M\0Z\ETKC(=+Q?X!*6&CL!3R>=!@Y72)DS0.-RG>LNZ?D5APBJ!A079"\K'N*\3*ZOLU"N4`>H^;W!?T_D&3 M@A.]+'B_H_X`E>R9T[@FL?`4T+@>PA*!!`H/=;_13UKI0IZ026@9Q+O,(")\ MPZH:R>,U;^SBQ:0!_Z\9Y5YC?+@9DT[HUV'*UI$-\VF_R$>J^L+*--LM`"R. M:D+E!E0A\R0]+!AO(A^I.FK+]R42':@)*E`PUE$1Y]=R34?LS]V>WTU_06(6 M>J)I2FWM:I\6&:@%'6\:H=+^[!C9/$HQ_:WI4]"T;!8>2M=&&`L``00E#@``!#D!``#M75MSXS:6?M^J_0_>GF>WW<8L)#3X\.;=V_,W)SCPZ(H$FP]O/B].9XO+V]LW__B___R/G_[K]/3D M9QQ@AB*\.EF^GMS$OY$HC$]N@X@SB-`&G_SK"PI6)Q?G[WXX/SD]%:5\$OS^ MH_C/$H7XA-<6A#^^A.3#FZW7[]_2]GF[+OS\W=G__IXM_"> M\!:=DH#S##S\YH33_Q@F/]Y1#T6)J(7B+TOFYPR^/]O7I:00_W>:DYV*GT[? M?7?Z_;NW+^'J32:B^`RH)"=_J=%G.KU[__[]6?)U3\H9K:(];9'OW\_2CV^X MX4Y.4M,QZN,'O#X1?S\_W"IE>G\F*,X"O!'N>:01\N_0$ON\VH1/]+K#']Z$ M9+OSNO1 M;`IA/+U29 M60<)%Q$W^);SFJ]O>3S9XC:2U9ETD.@2A4\W/OT:MI'D4+B#!%D$V`5ESJ`31S/-H M'$2\V[BG/O$([J@&L`XK^ERB'>%Q;!%1[_=N4IO:.EC[LY+ M&O#..B+\_Q;QDC+>3XO`]HE&70UN4I$=JQ=JP`&AS((2"IYV/(%Y?]_5R"D/ M*_)\1+]1=AF'$8^++.0NNZ$,\\:R0'Y7,?6LK4B?QO-']-)-T@,;2YC<;FF0 M--\OB#$>AOB/F/>-U\^XLY@U;EUDI%XL^FP.FVL>K*/7VV!- MV3;ID%I)J>-G8SS0>0"EX%24;<=PR#\E0O,N^?=2+?@EPL$*K_)ZA'A&(]&D MHKPJGWHE[KZ8,E$F'40G`^@U"I?)*#H.3S<([\?P@\@OQ[&I)D[+$,(X:\_3#9%V/O#V],BG!G"T.`BIP-;H-' MT7.JM"U]K.J5?BQK4`3,C)6U0[!)NGWA/Q]T!;,[HU M=`EM4*HH]X\G$-8G$3VILHQ#SHKN!)EHDGSX@=F'-^_.WYZ/P-$+#P>($3I[ M(:'*WS*:JMM+-,-[O^Q-"E-&X>Z$5\FQ91ZC]&\FX><@W&&/3SGPZHIN$0FJ M/FZBR_VLI!O>UU*/4KAN"K<7V2;>5[/3(."$\3%S,Z0 ML4%,MV_Y/Y6!H490C0H'@N%AH@X)*C7`\:#`0`Z%[R8*A5D8XBA4C'[D'S/; M53X.[_ZZDVF#"@KW[QD)"%09N!4)4NTN8R:LJT6!@J8$ABK-8)A0>)W"E"G# MHLSK`(D:#[>0(6:)(K'&_US_$9-GY(N9]BRZ1(R]DF#S"_+CZOS!J$QF;%B9 M@9&DP@MMI[,,8)4J!,Z`K-W"798U#Q^PA[G*O"/^A*/,.-7`!"#-XY..=+S@ M,M`0B"D]1[?&-K>!R`Y2]OH)5Z$C^Y09LO1IO-#0:`"$0IF#W/7?3]3U]PSO M$%E=O^QP$(H%HGGTA%G)%!5$&)3(S`PI,5[\F.L+A!6(L1QM_SU1M.EPI;/H M5+!B`14@__^]C?^K>WH&B39TAUGT>N^C=.&'C]9V8B;)(ZMB4F529!]O`$5& M..5JH6K3#`S&TJW1C%+GGQD-JPD\&'$3L%+BP2!E!!P=T&1*ER$&J4H+O*P* MY^9B\3;VQ4Z:*\S%]TAB+OYO'V<;MF9;RJ)L_Y;2./5YFU6VASF>';:3`7Q/ MAFS7-.P)8R%NR[;JCB]RU^>E$%+`<&`Z$#90V'+$MCWK'<$XM##3^D0#3YO5 M!]%FEM?3CG#(::)9,'S/4B'H^9\N3SP0(5.)D7S,QO4'`PH,'@ M1#M8H0Q";7T"DR;UN#4DO4?0DO@D(EBSU1 MGZL4BCE$]*I(&9@6RVP,+C;2+:0MU89L+H6S=FM$7=!;O_>TF;`.LM'L0C4& M#C50N`PO:%45T#F^AS7?[):=$]?O(I035?8/5HC&`"W`]D&M:DH@:78/5ADZ M!QL60.A?G2)YO$/`HHP8CW M6^:UQ",'E9&J)LAJ8NQ61JAX`8H<4QJ*?-`DH1@Y>IJ5,H&,E)M;*9_&7JPQ MND^OW[+:8<%[JJEF=PH:-FX;`-'6@3.F;0,=IV6&&PI:SLS@6PVF.CZZH\'F M$;-M,0;7>C`UR;X+DY",`5KZ1#1`,R6,Y'EH.4>W)F:*6]ZN\#)2+F<8ELPJW0I9AIJ#$(I==/\*:%/4.=37'7S-ZQ^9[,(I#!&610 M-@$\070S[3+E+)U=ZU.C18V142"CS3"]CT&Y:_O%ZXK?!ME&JGMQ4H/[.(H8 M6<:1&$T^4M%*:!!Q^;DHF^0>?1RJ9HK],-_?/V65^:1`WJMAV[<3VV*YE88# M;[(`[R\8YT:*7J`I!3UPVX5-@>0P=W7U_#Z7.%%9=M^3AN)P1T:-8D3H5%R, MT:!4$\0JMV'4N=G#"9][+^G@2"E<&RZ]%DSQ>9]MJ7P>.4`:U#%!1YV5O43) M.*`Q6ZU(JLP](JO;()NW%Q2O;JH`%\AW5S07&#F@C%4V@1B$N5N9D@<<(1+@ MU35B`>_$P]+!]#7Q2/WL(K3`_LQB8X&10\Y891/(09B[-;HO:)B/?MS14)Q4FJ\+CXC4[\,P*5V_]@)4>N3([&8,H\AH6I/%5?\18+9N MG,:9:.,,=.S@:E3)!#\R9G*(_##1_&!AD+!X0NF[.QZ?+>/511Q]#D@8QGQB MD_Z8Z!P>KA55SP%:LZK/%\Q9C1R@%LW4*._W"L%Q3+#S<. M_HK47_@YQ?+R#O?+G"4"KY)T_CUFR7!:NVS65$BZDJ8L-/P9>N"SC*V,H#A3 MW_!<([0JEY=O$Q7#61P]\9'SGX?0(X6DBE@*Q1KQ1"'8H+0-Z-6K<&O>(M-V M'D=AA`(QA`1@3D*M`5V1>M*H4ZMM#W:E.MQ:\2NDKX!=L$&)>M9Q^IVON?KM M<`BJQZVEP&HJ5=WG`B@5&>])]K9P=3MC#=K/3G7IKJ;J;9*@;\)7F4J%K8QJ MNKB2JFD)4SEOB^M\8\23>M`&(54A:Y+#-0.%+6$,,%#['QM`&R")5;!)NL%B M^.35HV2Q6O&B>"4A]2A94!Y"@^(S]BI%9#15?4HTP[=/]6ON&F443;#^H'N9 MAR;S,YQ_,PD_!^$.>V1-\.J*;A$)JCYNHLO]K*0;WM=2CU*X;@JW%]DFWE>S M%2/'(H;0\HJ$^>O@4&IZE@<8 MG!Q\U4X\,#1?)]HMJ%_/"0@0:ASX]H^O:X2W) ME\QLQ2\C];M:>(C/2Z7=NI+R@6O/C2N>MKOBT46:%\^`$K M-%*0M5(9-$0!,NXQTSW$2UL[+/03FZ+S@X05C&DH\E>V)!0C14^S,A"H2+FH M3A=-LV/[1`-:UC)K`(H=LV#ZS,S-]"-%D*FB$#P!>,K1]7ZB4>=!O`L<>U', MN,:73XAM:K?^Z4B*3S)720:##1P8%*1=&3B-W/?/+=>X6D@`CBH)DQ_?*9FA M:)]Z4L:DR.&9V^8BTP!;"^U;@`]6BUN+%DK#0'M':*\X$:1!]6P!+PUKM]*( MAS'E#7?`)0VXQC%7.AMTTB"\P&O*LIL_'M$+#J]?N)G2.\W9:S*J`)VT/4)- M^V#:7TTC'2<>S[B0$6:OTJ@&&)-N@-P&68"YP`&NYW,;J$K`KU.-&K1-2L$! M)^&D`,M4UZ,EES'E%S%9O*.ZYUH.&V%[J66D8#^.46&+8CU)HFAL4ST_I;K^ M[(;W7&03I,^>>:^/#`4AUU^8*U@E_^?(\9H2O% ME7='K#%/IAZAQL$:9-]-C@[AL7(+[TG%).U\#-7O,SN18ZI:M+[SO?.**S9XQ0QO\*=XN,9NO:V?<$CM4(-:J;.8+L[(CA5\7 M`T#`:,A?`[2Y+ M[/)$6%=VPX-2GBFS:R90*JUSE6Z=CI1K/HLN$6.O7'/IHYPF9?*5$U"9D>*T MC<*@308POO9.U>V2E44N#(MX$G\DH0Q\3ANNG'C\0G_&R-V0YEJTR"0O!"ZM.3#X<80&=18]PJ*8/7E M@4U?CUNSV'QG@="YE@2N?ZJ]F`QT:8>EBB<^`)RM?HO#*.E:'ND#]FC@ M$5_L6CX<.7VD0$,I6D6?560.[Z6*X<[LVVT3]"@NJ-P)8$4%T4[[$7TLHW0[ MC?@*&AV58<-O@S^;W2*$V*9!X&%1FLT?0*<=K*8.4FT8>` MHH'`!',K;9&8*.2Z\-GX%8V7T3KV9UYZGW5]KM!(>I@AJ$F=!;:!@8X#:+U` M8XG3@$9Z9Y%O:JKCP!T@ ME5L;I/(3^O.`*[K+'N&;KV=AB&OC$A!M?L6\EM995)N8Z#B(;I#(PN7XHXK8 MM]L=(DR843RD&*%@0Y8^3K6]?LD.M(O'(+X2WZ\N%[4IFR\8&95U%O]=3'B< M]F`HH5M7_G/;,8Q"?(73OP5K7:(=B9"O/F]G6/"PX@XMZ&ZC:&N\([4(`_'< M>HJ@KGD^:>?FQ>19D*DR*:B%@K,GE`-IK!=ERL5^=6$JVN M\SW#?)JYDK_-`"57@K)"/GE`:M6W"\9J5<[EOR3=0CG)D5[:VCS!;RBGZ;OE MY2:/4IA!;/?IBCI5!\>,-K>.'+GY'.\>O1K-Q"OTC=/PG'[R"-4;H)\)^+ZN MOT!JB,5<`X*6Q$^2:!!`*HKH,%DMX@(L]6:PCLQ:=6,Y9]L7.!_$.WS$XU$\ M.3Y*F23GVPA7$R9*`(.83![2+4QE%^0P`=HL5XUJ4-!M4[;5LRY6S[BXM%/? MJEG[VI/?5,VN/=P5*W1K0[O"1B(+'=H^CMB2J3Y4FS*= MUG'$;B;KM3<.*"P;2A/$K:;Y7!MMT$WXUF-XU;CMTO-PZI9^VH[786<^)-1"O5O2(`" MS_*XJ"53?;LR93JM<5$WDW48%QE7W&7*.8)QT0/>99WH?'U'@\TC9MLLM74G M/^X\DH(Q$K\G%<$_4YXKIP*XCER!<2NXHK`&F M.0:6Y6)8V&8Z(@#+>BUQ!A@P/BF2:08C"9E#0`6:XIC#C+1Z"QM,1SNF$!HF MCS3GEQ]>TE!VB0RP@"2^*@HX!%QC\QPCQJH$L;!)M<\+9.3W<7+%GS&+Q-[% M1;SD,G/;B':DCJN=^6BO387P<13@78QY#-P;RN?6F6R5(?;W[@!;28V^H34< MZ/\"J%<9Y]CH+LCAUG[9;J:SFNVVFN5VJ7%8-6M?+:>KD%VV]HYW]:A]HVG? M0L;5'%HM]EAZ5=&(>Y?1^0@`N+<`[ZZREXA4BY(0TNI+LC+2X3&E4\#L378= MRZD\S"ZNO/-I&#,\9QL49-?AS8*5:!3S]44<\K]AFV?;%1-(;34':1ZY,@HH M=N"0N;$-A^%Z"10)[ZS5G8&2((_Y=8+!FF$7YU&`KN46VJ*VI`^0U-+CAMY! MF_TBWFX1>YVO%V03D#7Q4!!EY_UX9W=/?>*)XR5#H;_H0=X'AUR>5>[.^X)5 MYNMLU(C\?=A5]656>4I"2GN>@P693N(?P,2IM3`2#>W"K^AO/:5#^* M\-L=^G1PSZG#?6OM1`=P?*U<[5ZR[1!I'FRHZ"9>A8Y>%;V!_&.&K\K'`6=J MW'[92GPJTR<:X?((1A98CY9#):W>CW1_DDA*=&`#RD5Y5&U^08JJ6XC:,\- M'J%0Q68K^]P&&+`V!M,7])31S]8,U?XAYHK66[$9;ZBJ0+XN=H_?T2_ M4789AQ'=PWRQMS,!>)PZOO+F%6^%E;)11188.8*!V#5B.+.9RI7O,.\GC:F1*'QUY M1"^#C1[V$C1.)P"4A_OLE)1#7O=7%4H5?2"D:E5'$#L@KJ)&>M;NW5/QSR[: MT_!UM2T7]J5^08PA\6IM'\_+YLP!\W^#,O4'935E>GDVMUZ?>MIO4@BBV0C: MK)FW:$LK5*?Z@#HK#]AJZW)WDK^(ER'^(^;F1=+:JE,8,B^6(2I$C'MAIB[^V&/I^M,$F;*?]'M77RGWY- M!1"S-%%O$'U"V^IS`CJ2?.%?1C+5]"4W%ZEF9C?]2IV<7R-L^92DR-Y/E?@D;-5!++BITK` M2CY-QKT:A=IYM7[&I5H)R6Y\M*EX7/HM,T/YVV0\K%.IG6LC_-T9,'L.;R/)DF(IL,@`` M*MH.!&KFFOL&CCH@_X)]_Y\!_1HL,`II@%?B?@3,*F@`T98&Z"K:R>#"1.4N M`W9E#9I'LHZ*D%^H'W/=V.L-\>O7!FII2HBHTDP,"7H5NR"@QEGN^??'GZRG MT>L![R@3AV+$`9I8#@`]:7GJ+B>=&!Q`"G>:R"LJ4&5RCHZ.!*V7O#/;4"9/ MY$@I2E@H4TP,`CKUNGB^PE?A\./G[N[CI4^\&Y^BV@$MU?>2LXO?)^9JM6I= M'%WBJG#S,1-U6>`Y+-$FM\N&\S@*(Q2L>!"2QWY`@7(/H"LP,608*-^I-]!6 MH\#.$'G!PU3GAO]2'2PT4%5R@U6JR4`#IF:W_&"-MP($QTP1EF5+,YC-,)#0 M28%0I)LH%-2JV@!#B;L"#G\?]"ZC_25,]XF!GW!$N-S#;8$9^G:M8^KJ/>%5 M[./Y.NE`+E"(5[Q7V>$@S-H-0\$FO1_AXO5`D[V]-ON*V*ITX59N&-M\<-Y\^HKQ`K-GXN'P(]XN M:\N,8/I\?MA(/UPSZ1._U-Q4%;#W(%TR'VV6:N20O7[!S"-A^7F`_*B*%+0& M)?(L**"$L\`U-]=QH`N2:RPO!"J?_L$[1%;:&*NEB?)'2F0TSD(28I+C@%`A MR5C>]8/!CFOVP-6%H$]**@=AF?2O@D6=@0:!9$4@"P_[]8G,!8ZXJ1)--PPG M_Y#"LI$NG\HIZ9P%)-0TQT&C1IJ1/\MWC9C_*EY-$Q=P`H\7E"N6RJH=+S;29097TSD+1JAICH-%C31N/6[7 M.C]W5WVK"IH#!C.$9GR;&4XAOVNP_&+;PGVNLEB0=2QY`HM7VR?'$E97,1.O M(R0;3;*-:-%3?3@-+K#?,M%88+R]"!R[M(5I##N/1F'VU^0W"#&6/&VO$/X% M^3$V0'"=7@_@`KW;^%4:YHCP+)]J(<=_UBS!=;2.6EJB(TSJ12^!L M,D%OB)14W&/B5KU[,_LB_K/D4O-?_A]02P,$%`````@`1$:5/\6TKQII!P`` MLS4``!$`'`!C97)P+3(P,3$P.3,P+GAS9%54"0`##^3Q3@_D\4YU>`L``00E M#@``!#D!``#M6M]SXC@2?K^J_1]\/-T]$&!R.[=)36;+$)/Q'=BL#9.9>]D2 M=@/:M26O+"?A_OIKV3C\L%$(F:OAZLA+L-3=[J\_M:26_.'GIS@R'D"DE+.; M1N>BW3"`!3RD;'[3F/A-T^_9=N/GCS_\Z<.?FTWC#A@((B$TIDNCG_U&99H9 M-I-H0)(Y&%_N"0N-;KOSOFTTFTKK*0VOTV`!,3$D$7.0#HDA34@`-XV%E,EU MJ_7X^'@1@(`D(JF\"'C<>M?N=-I7E\J9"&)@LL]%?`LSDD7RIO%'1B(ZHQ`V M#/2>I=?XCBUCCY<77,S12KO3^C(<^/GK2V%\4W+0JPOQB++?M\2?IB(JS5^V M5/>4I%"*,\Y8%M1^-=N= MYF7G^54P5TSL=>ZJ)7B$+RO$GF.%$E0#B#)DD@7/@$)82^>2*007<_[0PHX: MIYXJ\5J1T;FZNFKEO0T<%H:1#PS"&)=$XMC+V\K6)*%LQE=-V*BTKLM(>S`S MQ*C-C1&>H M'Q//ULS+N4==$JFYR5\`R(9!<>[;:GFV7MI?4_81UP)R6BT]Q)I<,5 MMP=CO=ZJM0SR-XS]B`C$NP!)$4"5B.WN%UCY\7!6C+]L6?[KF:4*2\^1=&:?-%7^,_X:6@XRX?<,=69XYME'`,)U;PQU_LCR4'XX\ZY/E M^/9GR[`=?+;.=%7HZI%TT8_X8UK0M'[4TW/Y"GIZIO_)Z`_<^_.D5HW_+4V# MB*>9`%?,":/_SKTV68@.@#OK9BG^3U?L'"JLXZY3+$-K4_C@>G>F8_\KSZ$\ MA0:V8RGJNA,??_EGXG3$^5D<$[%T9SZ=,RP+`\*D&00\8Q*+V!&/:(![D%T& M#]324_FN0J4_&0Y-[ZLBS[?O'+MO]TQG;)B]GCMQQK9S9XPP37NV=>94QVF/ M)%22R)<\^'V7N:T^/3^7%7YZYL@>FP.<(MW>/\\4:"@8<,+2$5F2:00XQ?4X M>U"[>7SRLRD7(67J5,'ALII;KU'5$_BW"H$#U\1]QLC\:G8'5CY9XM+WV?+& MMGKV)UW7N[6=?!ETW/$YS?1IML$,,,I%+9U[I'3,_=1N5U-ODR?+L5WOS-#+ M60A8-E<3K&C5Y\Z/U=RQ3/\<;VV\A^0W+GI9*K%$$BE.7GTN`'<(/HFJ-.B% M]>R\K[`S-/^!*=&;X-(TM+RBENJ[GH7;",,W!V?BM,055>V8/.V2M.[0$_+W M"B%%T6J,S2_GR&L7D3CF+-^.W1,A?4T)?&$U3^"-#Q-8#U+!2Z=_CB8X,!#W)C M&A7UU"SUFJJIV7G7O.QU&]W7Z%`TK^V!?ON[5_'?Q2[\U>U'_; M<(@SFYI.H:B\N5+>=-X?'9/=KQ\.<2428DOK&#^T'V[L<2)WH%:Q!9%,RY;F MVM3![F@_V="YLZNC?F@<6'VGDWN`4^=ZPV>G:0:J,O)!/-``4JR.B*"@ZJ5[ M,B^K*G63_>OKU(IK\?Q[EFM4`TG$TL9Y5TTVB`UW-[@`9@K9G>!94HI2%&D8 M!'L%">1-8T8B-6TP&D7JP.JF(46FKLESX6EQJXG^"0BI+)L3'*4\'.<.A)DH MUNJ]T1@)'@"$:5_P6.%2%MW9GF.Q`6?S,:BOG:9R(S1OL/&F.+T0EA"FQT9% M+:\C0L/;3%!T=P%?@0@DW%PQLSDN7A3=Q(AM*'7$2"@0UB-^';8U0_E@]A>X MNJ<3%H(8"?J`%(TB3-)XO2O/8;Y*:PMQ+OFMQ_[K(&NOQ-9EPQB>9`W#1VF? M&.GUYZ1KY^L&]L$J_V-8%5'=Z/GVYB"P&SH%VN);RFM9MG_?`>X!5LD9=)>5 M8[\[X'-!D@4-/)BK`5PE^ACE$Z/\<`CZ8?!&.V\<&M]F\%>.LU[(\H/D3XQO MK=?U^7V8PBDFM^X0IH;1P\1/C-!;*B"0N&M"I^,DXDN`&UL550%``,/Y/%.=7@+ M``$$)0X```0Y`0``4$L!`AX#%`````@`1$:5/UY_PY<(#0``%;,``!4`&``` M`````0```*2!KUD``&-E`Q0````(`$1&E3]EORG(114``/9,`0`5`!@` M``````$```"D@09G``!C97)P+3(P,3$P.3,P7V1E9BYX;6Q55`4``P_D\4YU M>`L``00E#@``!#D!``!02P$"'@,4````"`!$1I4_3P-[<2I```"MTP,`%0`8 M```````!````I(&:?```8V5R<"TR,#$Q,#DS,%]L86(N>&UL550%``,/Y/%. M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`1$:5/\D&KG`Q0````(`$1&E3_%M*\::0<``+,U```1 M`!@```````$```"D@8C9``!C97)P+3(P,3$P.3,P+GAS9%54!0`##^3Q3G5X C"P`!!"4.```$.0$``%!+!08`````!@`&`!H"```\X0`````` ` end XML 19 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 20 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Sep. 30, 2011
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Consolidation

 

The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”).  The unaudited consolidated financial statements include the financial condition and results of operations of our wholly-owned subsidiary, Cereplast International, S.A., a Luxembourg company organized during the year ended December 31, 2008, for the purpose of conducting sales operations in Europe.  Intercompany balances and transactions have been eliminated in consolidation.  The results of operations for interim periods are not necessarily indicative of the results that may be expected for a full year.  These financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2010.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements.  Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, the allowance for doubtful accounts and the fair value of stock options.  Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents. At various times throughout the year, we may have exceeded federally insured limits.  At September 30, 2011 and December 31, 2010, balances in our cash accounts exceeded federally insured limits of $0.25 million by approximately, $4.0 million and $2.3 million, respectively.  We have not experienced any losses in such accounts and we do not believe we are exposed to any significant credit risk on cash and cash equivalents.

 

Concentration of Credit Risk

 

We had unrestricted cash, cash equivalents, and short-term investments totaling $4.0 million and $2.4 million at September 30, 2011 and December 31, 2010, respectively.  The unrestricted cash and cash equivalents are held for working capital purposes.   We do not enter into investments for trading or speculative purposes.  Some of the securities in which we invest, however, may be subject to market risk.  This means that a change in prevailing interest rates may cause the principal amount of the investment to fluctuate.  To minimize this risk, we intend to maintain our portfolio of cash equivalents and short-term investments in a variety of securities, including commercial paper, money market funds, debt securities and certificates of deposit.  Due to the short-term nature of these investments, we believe that we do not have any material exposure to changes in the fair value of our investment portfolio as a result of changes in interest rates.  We actively monitor changes in interest rates.

 

Concentration of credit risk with respect to accounts receivable is limited to certain European customers to whom we make substantial sales.  As of September 30, 2011 we had one large European customer that accounted for $6.9 million, or 33% of our accounts receivable balance, which is past due.  We have another large European customer with $6.1 million, or 29% of our receivable balance, which is expected to be paid as current invoices come due, during the period December, 2011 through February 2012, in accordance with agreed payment terms.  Agreed upon payment terms for both of these customers are 90 days from receipt of goods.  These customers have acknowledged to us their agreement with the amounts owing and no amounts recognized in revenue or recorded in accounts receivable from these customers are in dispute.    To reduce risk, we routinely assess the financial strength of our most significant customers, using standard credit risk evaluation methods with reference to publicly available and customer supplied information, and monitor the amounts owed to us, taking appropriate action when necessary.  As a result of the recent deterioration in the general economic conditions in Europe and the slow payment by some of our European customers, we have increased our allowance for doubtful accounts by $1.7 million to reflect management’s assessment of credit risk associated with these customer balances.  We are working with all customers to mitigate credit risk and ensure collection of all outstanding amounts.

 

Other Concentration

 

During the nine months ended months ended September 30, 2011, we had two significant suppliers that accounted for 34.0% and 27.6% of total cost of goods sold, respectively.  During the same period in the prior year, we had two significant suppliers that accounted for 25.7% and 24.7% of total cost of goods sold, respectively.  No other suppliers accounted for more than 10% of cost of goods sold during these periods.

 

Restricted Cash

 

We had restricted cash in the amount of approximately $43,000 on September 30, 2011 and December 31, 2010. The restricted cash amount consists of a “Certificate of Deposit” which supports a “Letter of Credit” for a leased facility.

 

Fair Value of Financial Instruments

 

The carrying amounts of our financial instruments as of September 30, 2011, which include cash equivalents, accounts receivable, accounts payable, accrued expenses, loans payable and convertible subordinated notes approximate their fair values due to the short-term nature of these instruments.

 

Accounts Receivable

 

We maintain an allowance for doubtful accounts for estimated losses that may arise if any of our customers are unable to make required payments. Management performs a review of the receivables past due from customers on a monthly basis and reserves against uncollectible items for each customer after all reasonable means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was approximately $1.8 million and $66,000 as of September 30, 2011 and December 31, 2010, respectively.

 

Inventory

 

Inventories are stated at the lower of cost (first-in, first-out basis) or market and consist primarily of raw materials used in the manufacturing of bioplastic resins, finished bioplastic resins and finished goods. Inventories are reviewed for excess and obsolescence and a reserve is established accordingly. Inventories consisted of the following (in thousands):

 

 

 

September 30, 2011

 

December 31, 2010

 

 

 

(Unaudited)

 

 

 

Raw Materials

 

$

2,029

 

$

936

 

Bioplastic Resins

 

1,542

 

318

 

Finished Goods

 

41

 

44

 

Packaging Materials

 

66

 

53

 

WIP

 

 

41

 

Obsolescence Reserve

 

(192

)

 

Inventory, Net

 

$

3,486

 

$

1,392

 

 

Property and Equipment

 

Property and equipment are stated at cost and depreciation is computed on the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are between five and seven years. Repairs and maintenance expenditures are charged to expense as incurred. Property and equipment consist of the following (in thousands):

 

 

 

September 30, 2011

 

December 31, 2010

 

 

 

(Unaudited)

 

 

 

Equipment

 

$

5,506

 

$

5,074

 

Construction in Progress

 

952

 

135

 

Furniture & Fixtures

 

296

 

279

 

Automobile

 

25

 

25

 

Leasehold Improvements

 

228

 

51

 

 

 

7,007

 

5,564

 

Less Accumulated Depreciation

 

(2,894

)

(2,213

)

Property and Equipment, Net

 

$

4,113

 

$

3,351

 

 

Intangible Assets

 

Intangible assets are stated at cost and consist primarily of patents and trademarks. Amortization is computed on the straight-line method over the estimated life of these assets, estimated to be between five and fifteen years. Intangible assets consist of the following (in thousands):

 

 

 

September 30, 2011

 

December 31, 2010

 

 

 

(Unaudited)

 

 

 

Intangible Assets

 

$

196

 

$

206

 

Less Accumulated Amortization

 

(36

)

(33

)

Intangible Assets, Net

 

$

160

 

$

173

 

 

Deferred Income Taxes

 

Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences.  Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment.

 

The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any.  Tax positions taken are not offset or aggregated with other positions.  Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority.  The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

 

Interest and penalties associated with unrecognized tax benefits are classified as additional income taxes in the statement of income.

 

Revenue Recognition

 

We recognize revenue at the time of shipment of products, when the following fundamental criteria are met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred; (iii) the price to the customer is fixed or determinable; and (iv) collection of the sales price is probable.

 

Certain of our product sales are made to distributors under agreements with generally the same terms of sale and credit as all other customer agreements. Revenue from product sales to our customers, including our customers who are distributors, is recognized upon shipment provided the above noted fundamental criteria of revenue recognition are met. The sale of products to our customers who are distributors is not contingent upon the distributor selling the product to the end-user, and our current agreements with distributors do not have any rights of return.

 

Marketing and Advertising

 

We expense marketing and advertising costs as incurred. Marketing and advertising costs for the three months ended September 30, 2011 and 2010 were approximately $0.1 million and $0.2 million, respectively.  Marketing and advertising costs for the nine months ended September 30, 2011 and 2010 were approximately $0.3 million and $0.5 million, respectively.

 

Stock-Based Compensation

 

Compensation cost for all stock-based awards is measured at fair value on the date of grant and recognized over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes valuation model.  Such value is recognized as expense over the service period, net of estimated forfeitures, using the straight-line method. Adjustments to this expense are made periodically to recognize actual rates of forfeiture which vary significantly from estimates.

 

Loss Per Share Calculations

 

Basic loss per share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares available. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Our diluted loss per share is the same as the basic loss per share for the three months and nine months ended September 30, 2011 and 2010 as inclusion of any potential shares would have had an anti-dilutive effect due to our generation of a net loss.

 

Legal Proceedings

 

From time to time, we may become involved in various lawsuits and other legal proceedings, which arise in the ordinary course of business. Legal proceedings are subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.

 

Comparative Figures

 

Certain of the prior year figures have been reclassified to conform to the presentation adopted in the current year.

XML 21 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
GROSS SALES $ 5,414 $ 1,515 $ 20,849 $ 2,519
Sales Discounts, Returns and Allowances (45) (2) (628) (70)
NET SALES 5,369 1,513 20,221 2,449
COST OF SALES 4,475 1,132 17,701 1,778
GROSS PROFIT 894 381 2,520 671
Research and Development 280 106 789 302
Selling, General and Administrative 3,689 2,233 8,457 5,432
LOSS FROM OPERATIONS BEFORE OTHER EXPENSES (3,075) (1,958) (6,726) (5,063)
OTHER EXPENSES        
Restructuring Costs   (275)   (586)
Interest Expense, Net (513) 1 (999)  
TOTAL OTHER EXPENSE, NET (513) (274) (999) (586)
NET LOSS BEFORE PROVISION FOR INCOME TAXES (3,588) (2,232) (7,725) (5,649)
Provision for Income Taxes 0   0  
NET LOSS (3,588) (2,232) (7,725) (5,649)
OTHER COMPREHENSIVE INCOME        
Gain (Loss) on Foreign Currency Translation (54) 52 (93) 52
TOTAL COMPREHENSIVE LOSS $ (3,642) $ (2,180) $ (7,818) $ (5,597)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share) $ (0.23) $ (0.17) $ (0.50) $ (0.49)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, BASIC (in shares) 15,778 12,925 15,470 11,400
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, DILUTED (in shares) 15,778 12,925 15,470 11,400
XML 22 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2011
Dec. 31, 2010
Current Assets    
Cash $ 4,030 $ 2,391
Accounts Receivable, Net 19,119 5,289
Inventory, Net 3,486 1,392
Prepaid Expenses and Other Current Assets 1,593 65
Total Current Assets 28,228 9,137
Property and Equipment    
Property and Equipment 7,007 5,564
Accumulated Depreciation and Amortization (2,894) (2,213)
Property and Equipment, Net 4,113 3,351
Other Assets    
Restricted Cash 43 43
Deferred Loan Costs 1,459 266
Intangible Assets, Net 160 173
Deposits 49 14
Total Other Assets 1,711 496
Total Assets 34,052 12,984
Current Liabilities    
Accounts Payable 3,207 2,567
Accrued Expenses 2,095 1,251
Capital Leases, Current Portion 36 9
Loan Payable, Current Portion 1,504 149
Total Current Liabilities 6,842 3,976
Long-Term Liabilities    
Loan Payable 3,318 2,119
Convertible Subordinated Notes 12,500  
Capital Leases, Long-Term 59  
Total Long-Term Liabilities 15,877 2,119
Total Liabilities 22,719 6,095
Shareholders' Equity    
Preferred Stock, $0.001 par value; 5,000,000 shares authorized and none outstanding      
Common Stock, $0.001 par value; 495,000,000 shares authorized; 15,793,553 and 12,992,195 shares issued and outstanding at September 30, 2011 and December 31, 2010, respectively 16 13
Additional Paid in Capital 61,992 49,737
Accumulated Deficit (50,658) (42,933)
Accumulated Other Comprehensive Income (21) 72
Total Shareholders' Equity 11,329 6,889
Noncontrolling Interests 4  
Total Equity 11,333 6,889
Total Liabilities and Shareholders' Equity $ 34,052 $ 12,984
XML 23 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, except Share data, unless otherwise specified
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Loss $ (7,725) $ (5,649)
Adjustment to Reconcile Net Loss to Net Cash Used in Operating Activities    
Depreciation and Amortization 694 588
Allowance for Doubtful Accounts 1,780 33
Common Stock Issued for Services, Salaries and Wages 874 1,333
Amortization of Loan Discount 57  
Loss on Disposal of Leasehold Improvements   15
Impairment of Intangible Assets 64  
Changes in Operating Assets and Liabilities    
Accounts Receivable (15,609) (1,263)
Deferred Loan Costs 223  
Inventory (2,095) (210)
Deposits (35) 56
Prepaid Expenses and Other Current Assets (1,514) 92
Restricted Cash   (43)
Accounts Payable 269 (315)
Accrued Expenses 864 58
NET CASH USED IN OPERATING ACTIVITIES (22,153) (5,305)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of Property and Equipment, and Intangibles (1,290) (184)
NET CASH USED IN INVESTING ACTIVITIES (1,290) (184)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments on Capital Leases (13) (23)
Proceeds from Capital Leases 96  
Noncontrolling Interest Activities 4  
Payments made on Notes Payable   (59)
Proceeds from Loan Payable, Net of Loan Costs 2,500 20
Proceeds from Convertible Subordinated Notes, Net of Issuance Costs 11,225  
Proceeds from Issuance of Common Stock and Subscriptions, Net of Issuance Costs 11,363 7,507
NET CASH PROVIDED BY FINANCING ACTIVITIES 25,175 7,445
FOREIGN CURRENCY TRANSLATION (93) 52
NET INCREASE IN CASH 1,639 2,008
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 2,391 1,306
CASH AND CASH EQUIVALENTS, END OF PERIOD 4,030 3,314
Cash Paid During the Year For:    
Interest 417 2
Income Taxes 0  
Shares issued under a private placement, shares 2,596,500 2,842,642
Shares issued under a private placement $ 11,208 $ 7,507
XML 24 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
INCOME TAX
9 Months Ended
Sep. 30, 2011
INCOME TAX  
INCOME TAX
7. INCOME TAX
We are subject to U.S. and California income tax. Subject to limited statutory exceptions, we are no longer subject to federal, state and local or non-U.S. income tax examinations by tax authorities for years before 2006. We are not presently liable for any income taxes nor are we undergoing any tax examinations by the Internal Revenue Service. No Deferred Tax Assets or Deferred Tax Liabilities are included in our balance sheets at September 30, 2011 or December 31, 2010.
Our policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.
XML 25 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
MAJOR CUSTOMERS AND FOREIGN SALES
9 Months Ended
Sep. 30, 2011
MAJOR CUSTOMERS AND FOREIGN SALES  
MAJOR CUSTOMERS AND FOREIGN SALES
6. MAJOR CUSTOMERS AND FOREIGN SALES
The following customers accounted for 10% or more of gross revenue in the periods presented:
                                 
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2011     2010     2011     2010  
Customer A
    68.0 %           27.0 %      
Customer B
    29.2 %           26.8 %      
Customer C
                26.3 %      
Our gross sales were made up of sales to customers in the following geographic regions (in thousands):
                                 
    Three Months Ended September 30,  
    2011     2010  
North America
  $ 81       1.5 %   $ 440       29.0 %
International
                               
Italy
    5,262       97.2 %     1,022       67.5 %
Other
    71       1.3 %     53       3.5 %
 
                       
 
                               
Gross sales
  $ 5,414       100.0 %   $ 1,515       100.0 %
 
                       
                                 
    Nine Months Ended September 30,  
    2011     2010  
North America
  $ 749       3.6 %   $ 1,139       45.2 %
International
                               
Italy
    12,470       59.8 %     1,022       40.6 %
Germany
    5,494       26.4 %     210       8.3 %
Other
    2,136       10.2 %     148       5.9 %
 
                       
 
                               
Gross sales
  $ 20,849       100.0 %   $ 2,519       100.0 %
 
                       
XML 26 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUBSEQUENT EVENTS
9 Months Ended
Sep. 30, 2011
SUBSEQUENT EVENTS  
SUBSEQUENT EVENTS
8. SUBSEQUENT EVENTS
Purchase of Manufacturing Facility in Italy
Effective October 24, 2011, Cereplast Italia S.p.A (“Cereplast Italia”), our wholly owned subsidiary, completed its acquisition of an industrial plant and the real estate on which the industrial plant is located in Cannara, Italy. The Deed of Sale between Cereplast Italia and Societa Regionale Per Lo Sviluppo Economico Dell’Umbria — Sviluppumbria S.p.A, provided for an aggregate purchase price of €4,577,750 ($6,355,748). In connection with the acquisition, Cereplast Italia entered into the following financing transactions:
   
Mortgage loan with Banca Monte Dei Paschi Di Sienna S.p.A for the principal of €3,440,000 ($4,776,096). The loan bears interest of Euribor (6-month) plus 5.7%. The loan is for a term of 15 years with interest only payments for the first two years, payable January 1 and July 1 each year and principal and interest payments thereafter according to an amortization schedule. Twenty percent of the principal is guaranteed for 10 years by Gepafin, a local government agency; €400,000 ($555,360) of the principal is guaranteed by Eurofidi through December 31, 2016.
   
Credit facility with Intesa Sanpaolo for up €500,000 ($694,200). The facility is for a term of eight months with a floating interest rate based on Euribor (3 month), currently 5.85%. Interest is deferred for the first two months of the term. Cereplast Italia obtained a guarantee of 60% of the amount drawn on the facility from Eurofidi.
   
Credit facility with Unicredit Bank for up to €600,000 ($833,040). The facility is for a term of 18 months with a floating interest rate based on Euribor (3 month), currently 5.93%. Cereplast Italia obtained a guarantee of 60% of the amount drawn on the facility from Eurofidi.
We estimate that in addition to the purchase price, Cereplast Italia will incur estimated additional fees of €400,000 ($555,360) in connection with the acquisition.
Registered Direct Offering
On November 10, 2011, we entered into a Placement Agent Agreement, relating to a registered direct offering of up to an aggregate of 3,125,000 Units (“Units”), pursuant to which Lazard Capital Markets LLC served as the lead placement agent and Ardour Capital Investments, LLC served as the co-placement agent. Each Unit consists of one share of common stock, par value $0.001 per share, and one warrant to purchase 0.75 of a share of the Company’s common stock. The sale of the Units is being made pursuant to subscription agreements, dated November 10, 2011, between the Company and each of the investors in this offering. The investors have agreed to purchase the Units for a negotiated price of $1.60 per Unit, resulting in gross proceeds to the Company of approximately $5,000,000, before deducting the placement agents’ fees and estimated offering expenses payable by us. The net offering proceeds to the Company from the sale of the Units, after deducting the placement agents’ fees and other estimated offering expenses payable by the Company, are expected to be approximately $4,345,000.
The per share exercise price of the warrants is $2.20. The warrants are exercisable at any time on or after the date that is 180 days after the initial issuance on the date of closing and will expire on a date that is five years from the date of closing. The closing of the sale and issuance of the Units is expected to take place on or about November 16, 2011, subject to the satisfaction of customary closing conditions.
XML 27 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
9 Months Ended
Sep. 30, 2011
Nov. 11, 2011
Document and Entity Information    
Entity Registrant Name Cereplast Inc  
Entity Central Index Key 0001324759  
Document Type 10-Q  
Document Period End Date Sep. 30, 2011  
Amendment Flag true  
Amendment Description Cereplast, Inc. is filing this Amendment No. 1 (the ?Amendment?) to its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2011, filed with the Securities and Exchange Commission on November 14, 2011 (the ?Form 10-Q?), to revise the disclosure in ?Concentration of Credit Risk? and ?Revenue Recognition? in Note 2 of the notes to the financial statements contained in the Form 10-Q. No other changes have been made to the Form 10-Q. This Amendment speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   15,793,553
Document Fiscal Year Focus 2011  
Document Fiscal Period Focus Q3  
XML 28 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Share-based Compensation Arrangement by Share-based Payment Award    
Expense related to vesting of employee stock options $ 157  
Director and Employee Services
   
Share-based Compensation Arrangement by Share-based Payment Award    
Number of shares issued 153,796 78,605
Dollar value of shares issued 657 301
Exercise of Common Stock Warrants
   
Share-based Compensation Arrangement by Share-based Payment Award    
Number of shares issued 35,000  
Dollar value of shares issued 155  
Prepaid Services
   
Share-based Compensation Arrangement by Share-based Payment Award    
Number of shares issued 12,000  
Dollar value of shares issued 59  
Prepaid Services and Rent
   
Share-based Compensation Arrangement by Share-based Payment Award    
Number of shares issued   151,302
Dollar value of shares issued   770
Settlement Agreement
   
Share-based Compensation Arrangement by Share-based Payment Award    
Number of shares issued 4,062 20,162
Dollar value of shares issued 20 75
Early Termination Fees
   
Share-based Compensation Arrangement by Share-based Payment Award    
Number of shares issued   31,250
Dollar value of shares issued   125
Board Member Services
   
Share-based Compensation Arrangement by Share-based Payment Award    
Number of shares issued   12,500
Dollar value of shares issued   $ 50
XML 29 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
LEASES
9 Months Ended
Sep. 30, 2011
LEASES  
LEASES
5. LEASES
We currently operate out of El Segundo, California, Seymour, Indiana and Bönen, Germany. The leases underlying these three facilities are summarized below:
California Facility — The El Segundo facility consists of approximately 5,475 square feet of corporate office space. The lease commenced on March 1, 2010 and has a term of five years. The lease was subsequently amended on April 1, 2011 to add additional office space. The lease term relating to the additional office space expires on May 31, 2013. Our current monthly rent is $13,124, with 3% annual escalation.
Indiana Facility — The Seymour facility consists of approximately 105,000 square feet used as a manufacturing and distribution facility for our products. The lease commenced in January 2008, with a ten year term expiring in January 2018. Our current monthly rent is $25,000.
Bönen Facility— The Bönen facility consists of approximately 1,000 square feet of corporate office space. The facility is subject to a lease with monthly rents of approximately $2,000 expiring in December 2018.
XML 30 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 18 113 1 false 7 0 false 3 true false R1.htm 0010 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.cereplast.com/role/BalanceSheet CONSOLIDATED BALANCE SHEETS false false R2.htm 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.cereplast.com/role/BalanceSheetParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R3.htm 0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME Sheet http://www.cereplast.com/role/StatementOfIncome CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME false false R4.htm 0030 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.cereplast.com/role/CashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R5.htm 0035 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Sheet http://www.cereplast.com/role/CashFlowsParenthetical CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) false false R6.htm 1010 - Disclosure - ORGANIZATION AND LINE OF BUSINESS Sheet http://www.cereplast.com/role/DisclosureOrganizationAndLineOfBusiness ORGANIZATION AND LINE OF BUSINESS false false R7.htm 1020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.cereplast.com/role/DisclosureSummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R8.htm 1030 - Disclosure - CAPITAL STOCK Sheet http://www.cereplast.com/role/DisclosureCapitalStock CAPITAL STOCK false false R9.htm 1040 - Disclosure - LOANS PAYABLE AND CONVERTIBLE SUBORDINATED NOTES Notes http://www.cereplast.com/role/DisclosureLoansPayableAndConvertibleSubordinatedNotes LOANS PAYABLE AND CONVERTIBLE SUBORDINATED NOTES false false R10.htm 1050 - Disclosure - LEASES Sheet http://www.cereplast.com/role/DisclosureLeases LEASES false false R11.htm 1060 - Disclosure - MAJOR CUSTOMERS AND FOREIGN SALES Sheet http://www.cereplast.com/role/DisclosureMajorCustomersAndForeignSales MAJOR CUSTOMERS AND FOREIGN SALES false false R12.htm 1070 - Disclosure - INCOME TAX Sheet http://www.cereplast.com/role/DisclosureIncomeTax INCOME TAX false false R13.htm 1080 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.cereplast.com/role/DisclosureSubsequentEvents SUBSEQUENT EVENTS false false R14.htm 9999 - Document - Document and Entity Information Sheet http://www.cereplast.com/role/DocumentAndEntityInformation Document and Entity Information false false All Reports Book All Reports Process Flow-Through: 0010 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Sep. 30, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME Process Flow-Through: 0030 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Process Flow-Through: 0035 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) cerp-20110930.xml cerp-20110930.xsd cerp-20110930_cal.xml cerp-20110930_def.xml cerp-20110930_lab.xml cerp-20110930_pre.xml true true